Cluster Information | Plasmid Cluster ID | C792 |
Reference Plasmid | NZ_CP064203.1 | |
Reference Plasmid Size | 3973223 | |
Reference Plasmid GC Content | 0.39 | |
Reference Plasmid Mobility Type | conjugative |
mutid | gname | pos | count | tissue | frequnt | biotype | consequence | impact | nucchange | aachange |
---|---|---|---|---|---|---|---|---|---|---|
M0101386 | JJEBMEPF_03689 | 3846240 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 351A>G | Gln117Gln |
M0101387 | JJEBMEPF_03690 | 3846321 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 298C>T | Leu100Leu |
M0101388 | JJEBMEPF_03691 | 3846737 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 483C>T | Ser161Ser |
M0101389 | JJEBMEPF_03691 | 3846859 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 361T>C | Leu121Leu |
M0101390 | JJEBMEPF_03691 | 3846932 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 288T>C | Ser96Ser |
M0101391 | JJEBMEPF_03691 | 3846933 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 287G>A | Ser96Asn |
M0101392 | JJEBMEPF_03691 | 3847127 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 93T>C | His31His |
M0101393 | JJEBMEPF_03686 | 3847331 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -4656C>T | None |
M0101394 | JJEBMEPF_03692 | 3847503 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 60C>A | Pro20Pro |
M0101395 | JJEBMEPF_03692 | 3847554 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 111G>A | Leu37Leu |
M0101396 | JJEBMEPF_03692 | 3847623 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 180G>A | Glu60Glu |
M0101397 | JJEBMEPF_03692 | 3847632 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 189C>T | Ser63Ser |
M0101398 | JJEBMEPF_03692 | 3847644 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 201T>C | Val67Val |
M0101399 | JJEBMEPF_03687 | 3847819 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -3813T>A | None |
M0101400 | JJEBMEPF_01318 | 1364706 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 249T>A | Arg83Arg |
M0101401 | JJEBMEPF_01318 | 1364760 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 303T>C | Phe101Phe |
M0101402 | JJEBMEPF_01318 | 1364775 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 318T>C | Ala106Ala |
M0101403 | JJEBMEPF_01318 | 1364865 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 408G>C | Val136Val |
M0101404 | JJEBMEPF_01318 | 1364871 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 414A>G | Ser138Ser |
M0101405 | JJEBMEPF_01318 | 1364874 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 417C>T | Ser139Ser |
M0101406 | JJEBMEPF_01318 | 1364922 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 465G>A | Ala155Ala |
M0101407 | JJEBMEPF_01318 | 1365120 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 663T>G | Ala221Ala |
M0101408 | JJEBMEPF_01313 | 1365218 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -4903T>A | None |
M0101409 | JJEBMEPF_01319 | 1365359 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1135A>G | Thr379Ala |
M0101410 | JJEBMEPF_01319 | 1365372 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1122G>A | Val374Val |
M0101411 | JJEBMEPF_01319 | 1365501 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 993C>T | Ser331Ser |
M0101412 | JJEBMEPF_01319 | 1365578 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 916C>T | Leu306Leu |
M0101413 | JJEBMEPF_01319 | 1365579 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 915G>A | Pro305Pro |
M0101414 | JJEBMEPF_01319 | 1365594 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 900T>A | Gly300Gly |
M0101415 | JJEBMEPF_01319 | 1365638 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 856A>G | Ile286Val |
M0101416 | JJEBMEPF_01319 | 1365642 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 852T>C | Val284Val |
M0101417 | JJEBMEPF_01319 | 1365645 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 849A>C | Thr283Thr |
M0101418 | JJEBMEPF_01319 | 1365810 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 684C>T | Tyr228Tyr |
M0101419 | JJEBMEPF_01319 | 1365837 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 657G>A | Gln219Gln |
M0101420 | JJEBMEPF_01319 | 1365882 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 612G>T | Met204Ile |
M0101421 | JJEBMEPF_01319 | 1366100 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 394A>C | Ile132Leu |
M0101422 | JJEBMEPF_01319 | 1366170 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 324T>A | Thr108Thr |
M0101423 | JJEBMEPF_01319 | 1366224 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 270C>T | Asp90Asp |
M0101424 | JJEBMEPF_01320 | 1366744 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1216T>G | Phe406Val |
M0101425 | JJEBMEPF_01320 | 1366763 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1197C>G | Val399Val |
M0101426 | JJEBMEPF_01320 | 1366844 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1116G>C | Pro372Pro |
M0101427 | JJEBMEPF_01320 | 1366871 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1089A>G | Ser363Ser |
M0101428 | JJEBMEPF_01320 | 1366952 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1008T>C | Phe336Phe |
M0101429 | JJEBMEPF_01320 | 1366994 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 966T>G | Gly322Gly |
M0101430 | JJEBMEPF_01320 | 1367222 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 738A>T | Thr246Thr |
M0101431 | JJEBMEPF_01320 | 1367840 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 120A>G | Leu40Leu |
M0101432 | JJEBMEPF_01320 | 1367867 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 93T>A | Ile31Ile |
M0101433 | JJEBMEPF_01319 | 1368102 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -1609C>T | None |
M0101434 | JJEBMEPF_01319 | 1368144 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -1651T>C | None |
M0101435 | JJEBMEPF_01321 | 1368672 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 243T>C | Thr81Thr |
M0101436 | JJEBMEPF_01321 | 1368675 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 240C>T | Ser80Ser |
M0101437 | JJEBMEPF_01321 | 1368771 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 144T>C | Phe48Phe |
M0101438 | JJEBMEPF_01321 | 1368909 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 6T>C | Cys2Cys |
M0101439 | JJEBMEPF_01322 | 1369015 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 27A>C | Gln9His |
M0101440 | JJEBMEPF_01322 | 1369024 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 36C>T | Ser12Ser |
M0101441 | JJEBMEPF_01322 | 1369030 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 42A>G | Lys14Lys |
M0101442 | JJEBMEPF_01322 | 1369033 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 45T>C | Leu15Leu |
M0101443 | JJEBMEPF_01322 | 1369069 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 81A>T | Gly27Gly |
M0101444 | JJEBMEPF_01322 | 1369240 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 252C>T | Ile84Ile |
M0101445 | JJEBMEPF_01322 | 1369243 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 255T>C | Asn85Asn |
M0101446 | JJEBMEPF_01323 | 1370401 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 285C>T | Ser95Ser |
M0101447 | JJEBMEPF_01323 | 1370404 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 288C>T | Pro96Pro |
M0101448 | JJEBMEPF_01323 | 1370911 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 795A>G | Gly265Gly |
M0101449 | JJEBMEPF_01323 | 1371022 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 906G>A | Glu302Glu |
M0101450 | JJEBMEPF_01323 | 1371055 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 939A>G | Gln313Gln |
M0101451 | JJEBMEPF_01323 | 1371071 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 955T>C | Leu319Leu |
M0101452 | JJEBMEPF_01323 | 1371082 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 966C>A | Thr322Thr |
M0101453 | JJEBMEPF_01323 | 1371091 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 975G>T | Ala325Ala |
M0101454 | JJEBMEPF_01323 | 1371094 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 978A>C | Arg326Arg |
M0101455 | JJEBMEPF_01323 | 1371109 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 993C>G | Val331Val |
M0101456 | JJEBMEPF_01323 | 1371202 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1086A>G | Gln362Gln |
M0101457 | JJEBMEPF_01323 | 1371256 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1140A>G | Gly380Gly |
M0101458 | JJEBMEPF_01324 | 1371563 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 252A>T | Ala84Ala |
M0101459 | JJEBMEPF_01324 | 1371575 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 264G>A | Leu88Leu |
M0101460 | JJEBMEPF_01324 | 1371671 | 3 | Skin | 0.04 | protein_coding | splice_region_variant&stop_retained_variant | LOW | 360G>A | Ter120Ter |
M0101461 | JJEBMEPF_01325 | 1371728 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 47G>A | Arg16Gln |
M0101462 | JJEBMEPF_01325 | 1371747 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 66T>C | Ala22Ala |
M0101463 | JJEBMEPF_01325 | 1371750 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 69C>T | Ile23Ile |
M0101464 | JJEBMEPF_01325 | 1371765 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 84T>C | Asn28Asn |
M0101465 | JJEBMEPF_01325 | 1372016 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 335T>C | Leu112Ser |
M0101466 | JJEBMEPF_01325 | 1372035 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 354C>T | Thr118Thr |
M0101467 | JJEBMEPF_01326 | 1372568 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 330C>T | Tyr110Tyr |
M0101468 | JJEBMEPF_01326 | 1372580 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 342C>T | Ser114Ser |
M0101469 | JJEBMEPF_01326 | 1372739 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 501T>C | Phe167Phe |
M0101470 | JJEBMEPF_01326 | 1373016 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 778A>G | Asn260Asp |
M0101471 | JJEBMEPF_01326 | 1373249 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1011C>G | Thr337Thr |
M0101472 | JJEBMEPF_01326 | 1373255 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1017C>T | Asp339Asp |
M0101473 | JJEBMEPF_01326 | 1373400 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1162T>C | Leu388Leu |
M0101474 | JJEBMEPF_01326 | 1373402 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1164G>C | Leu388Phe |
M0101475 | JJEBMEPF_01327 | 1373667 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 141T>C | Asn47Asn |
M0101476 | JJEBMEPF_01327 | 1373793 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 267C>T | Ser89Ser |
M0101477 | JJEBMEPF_01327 | 1373898 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 372A>C | Ala124Ala |
M0101478 | JJEBMEPF_01327 | 1373907 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 381G>A | Thr127Thr |
M0101479 | JJEBMEPF_01327 | 1373961 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 435C>T | Ile145Ile |
M0101480 | JJEBMEPF_01328 | 1374100 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 78T>C | Gly26Gly |
M0101481 | JJEBMEPF_01328 | 1374178 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 156A>G | Ile52Met |
M0101482 | JJEBMEPF_01341 | 1391140 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 195T>C | His65His |
M0101483 | JJEBMEPF_01342 | 1391562 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 903C>T | Gly301Gly |
M0101484 | JJEBMEPF_01342 | 1391715 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 750C>A | Gly250Gly |
M0101485 | JJEBMEPF_01342 | 1391758 | 4 | Skin | 0.06 | protein_coding | missense_variant | MODERATE | 707T>A | Leu236Gln |
M0101486 | JJEBMEPF_01342 | 1392036 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 429A>G | Thr143Thr |
M0101487 | JJEBMEPF_01343 | 1393263 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 699G>A | Leu233Leu |
M0101488 | JJEBMEPF_01343 | 1393272 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 708T>C | Ser236Ser |
M0101489 | JJEBMEPF_01323 | 1371013 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 897G>C | Val299Val |
M0101490 | JJEBMEPF_00565 | 629796 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 174G>A | Lys58Lys |
M0101491 | JJEBMEPF_00565 | 629829 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 207A>G | Ala69Ala |
M0101492 | JJEBMEPF_00565 | 629844 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 222T>G | Val74Val |
M0101493 | JJEBMEPF_00565 | 629883 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 261C>A | Thr87Thr |
M0101494 | JJEBMEPF_00565 | 630020 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 398C>A | Thr133Lys |
M0101495 | JJEBMEPF_00565 | 630021 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 399A>C | Thr133Thr |
M0101496 | JJEBMEPF_00565 | 630022 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 400T>C | Leu134Leu |
M0101497 | JJEBMEPF_00565 | 630033 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 411C>T | Asn137Asn |
M0101498 | JJEBMEPF_00565 | 630060 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 438T>C | Tyr146Tyr |
M0101499 | JJEBMEPF_00565 | 630061 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 439G>A | Glu147Lys |
M0101500 | JJEBMEPF_00565 | 630092 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 470T>G | Leu157Arg |
M0101501 | JJEBMEPF_00565 | 630099 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 477A>T | Ala159Ala |
M0101502 | JJEBMEPF_00565 | 630509 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 887T>C | Leu296Pro |
M0101503 | JJEBMEPF_00565 | 630690 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1068C>T | Tyr356Tyr |
M0101504 | JJEBMEPF_00565 | 630696 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1074T>C | Thr358Thr |
M0101505 | JJEBMEPF_00565 | 630813 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1191G>A | Gly397Gly |
M0101506 | JJEBMEPF_00565 | 630870 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1248G>A | Lys416Lys |
M0101507 | JJEBMEPF_00565 | 630918 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1296C>G | Thr432Thr |
M0101508 | JJEBMEPF_00565 | 630922 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1300C>A | His434Asn |
M0101509 | JJEBMEPF_00565 | 630939 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1317T>C | Asn439Asn |
M0101510 | JJEBMEPF_00565 | 631172 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1550A>G | Glu517Gly |
M0101511 | JJEBMEPF_00565 | 631206 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1584T>C | Asn528Asn |
M0101512 | JJEBMEPF_00565 | 631210 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1588A>T | Thr530Ser |
M0101513 | JJEBMEPF_00565 | 631220 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1598T>A | Leu533Gln |
M0101514 | JJEBMEPF_00565 | 631237 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1615C>G | Leu539Val |
M0101515 | JJEBMEPF_00565 | 631258 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1636A>G | Ile546Val |
M0101516 | JJEBMEPF_00565 | 631380 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1758G>A | Gln586Gln |
M0101517 | JJEBMEPF_00565 | 631386 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1764T>C | Leu588Leu |
M0101518 | JJEBMEPF_00561 | 631500 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -4468G>A | None |
M0101519 | JJEBMEPF_00561 | 631504 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -4472T>A | None |
M0101520 | JJEBMEPF_00566 | 631619 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 2019T>G | Thr673Thr |
M0101521 | JJEBMEPF_00566 | 631625 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 2013T>C | Ile671Ile |
M0101522 | JJEBMEPF_00566 | 631712 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1926T>C | Ile642Ile |
M0101523 | JJEBMEPF_00566 | 631805 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1833A>G | Leu611Leu |
M0101524 | JJEBMEPF_00566 | 631985 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1653C>T | Phe551Phe |
M0101525 | JJEBMEPF_00566 | 632086 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1552A>G | Thr518Ala |
M0101526 | JJEBMEPF_00566 | 632246 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1392A>G | Leu464Leu |
M0101527 | JJEBMEPF_00566 | 632327 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1311T>C | Pro437Pro |
M0101528 | JJEBMEPF_00566 | 632345 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1293C>A | Ala431Ala |
M0101529 | JJEBMEPF_00566 | 632488 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 1150C>T | Leu384Leu |
M0101530 | JJEBMEPF_00566 | 632546 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1092A>C | Lys364Asn |
M0101531 | JJEBMEPF_00566 | 632548 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 1090A>C | Lys364Gln |
M0101532 | JJEBMEPF_00566 | 632765 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 873C>T | Ser291Ser |
M0101533 | JJEBMEPF_00566 | 632812 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 826C>A | Gln276Lys |
M0101534 | JJEBMEPF_00566 | 632858 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 780A>C | Leu260Phe |
M0101535 | JJEBMEPF_00566 | 632864 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 774C>T | Tyr258Tyr |
M0101536 | JJEBMEPF_00566 | 632870 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 768T>C | Ala256Ala |
M0101537 | JJEBMEPF_00566 | 633272 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 366T>G | Leu122Leu |
M0101538 | JJEBMEPF_00566 | 633317 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 321A>G | Ala107Ala |
M0101539 | JJEBMEPF_00566 | 633359 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 279T>C | Ser93Ser |
M0101540 | JJEBMEPF_00566 | 633423 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 215T>A | Val72Asp |
M0101541 | JJEBMEPF_00566 | 633467 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 171C>T | Ile57Ile |
M0101542 | JJEBMEPF_00566 | 633507 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 131A>G | Asp44Gly |
M0101543 | JJEBMEPF_00569 | 634259 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 57G>C | Leu19Leu |
M0101544 | JJEBMEPF_00569 | 634268 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 66A>G | Glu22Glu |
M0101545 | JJEBMEPF_00569 | 634337 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 135T>C | Ile45Ile |
M0101546 | JJEBMEPF_00569 | 634403 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 201C>T | His67His |
M0101547 | JJEBMEPF_00569 | 634594 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 392T>C | Met131Thr |
M0101548 | JJEBMEPF_00569 | 634610 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 408A>T | Val136Val |
M0101549 | JJEBMEPF_00569 | 634730 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 528C>T | Gly176Gly |
M0101550 | JJEBMEPF_00569 | 634889 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 687G>A | Thr229Thr |
M0101551 | JJEBMEPF_00569 | 635006 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 804A>G | Leu268Leu |
M0101552 | JJEBMEPF_00569 | 635075 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 873G>A | Pro291Pro |
M0101553 | JJEBMEPF_00570 | 635161 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 18G>A | Leu6Leu |
M0101554 | JJEBMEPF_00570 | 635179 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 36C>T | Ile12Ile |
M0101555 | JJEBMEPF_00570 | 635221 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 78A>G | Gly26Gly |
M0101556 | JJEBMEPF_00570 | 635222 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 79C>T | Leu27Leu |
M0101557 | JJEBMEPF_00570 | 635305 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 162A>G | Ser54Ser |
M0101558 | JJEBMEPF_00570 | 635317 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 174G>A | Gln58Gln |
M0101559 | JJEBMEPF_00570 | 635548 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 405C>T | Gly135Gly |
M0101560 | JJEBMEPF_00570 | 635569 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 426T>C | Val142Val |
M0101561 | JJEBMEPF_00570 | 635647 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 504T>G | Ser168Ser |
M0101562 | JJEBMEPF_00570 | 635692 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 549T>C | Ala183Ala |
M0101563 | JJEBMEPF_00570 | 635698 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 555T>C | Val185Val |
M0101564 | JJEBMEPF_00570 | 635755 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 612A>G | Gly204Gly |
M0101565 | JJEBMEPF_00570 | 635815 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 672C>T | Ala224Ala |
M0101566 | JJEBMEPF_00570 | 635818 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 675G>A | Leu225Leu |
M0101567 | JJEBMEPF_00570 | 635902 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 759G>A | Ala253Ala |
M0101568 | JJEBMEPF_00570 | 635938 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 795T>C | Pro265Pro |
M0101569 | JJEBMEPF_00571 | 636624 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 537G>A | Arg179Arg |
M0101570 | JJEBMEPF_00572 | 637021 | 4 | Skin | 0.06 | protein_coding | missense_variant | MODERATE | 157A>G | Asn53Asp |
M0101571 | JJEBMEPF_00572 | 637221 | 4 | Skin | 0.06 | protein_coding | synonymous_variant | LOW | 357A>G | Leu119Leu |
M0101572 | JJEBMEPF_00572 | 637251 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 387T>G | His129Gln |
M0101573 | JJEBMEPF_00572 | 637452 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 588G>A | Pro196Pro |
M0101574 | JJEBMEPF_00572 | 637467 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 603T>C | Val201Val |
M0101575 | JJEBMEPF_00566 | 637865 | 3 | Skin | 0.04 | protein_coding | upstream_gene_variant | MODIFIER | -4228C>G | None |
M0101576 | JJEBMEPF_00573 | 638044 | 3 | Skin | 0.04 | protein_coding | missense_variant | MODERATE | 99A>G | Ile33Met |
M0101577 | JJEBMEPF_00573 | 638176 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 231C>A | Pro77Pro |
M0101578 | JJEBMEPF_01341 | 1391107 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 228C>T | Tyr76Tyr |
M0101579 | JJEBMEPF_01341 | 1391251 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 84A>G | Lys28Lys |
M0101580 | JJEBMEPF_01344 | 1394076 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 516T>C | Thr172Thr |
M0101581 | JJEBMEPF_01345 | 1394741 | 3 | Skin | 0.04 | protein_coding | synonymous_variant | LOW | 399A>G | Glu133Glu |
Gene Name | vf_gene_id | vf_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | vf_category | gene_description | condition |
---|---|---|---|---|---|---|---|---|---|---|---|
JJEBMEPF_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | experiment |
JJEBMEPF_00130 | VFG050610 | TFP | 100 | 3.7e-94 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
JJEBMEPF_00131 | VFG038176 | OmpA | 100 | 2.2e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | experiment |
JJEBMEPF_00160 | VFG050625 | TFP | 100 | 1.2e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | experiment |
JJEBMEPF_00161 | VFG050640 | TFP | 100 | 2.5e-65 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | experiment |
JJEBMEPF_00162 | VFG050655 | TFP | 100 | 1.7e-102 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | experiment |
JJEBMEPF_00163 | VFG050670 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 1 | Adherence | methyl-accepting chemotaxis protein | experiment |
JJEBMEPF_00283 | VFG037638 | Bap | 99.8 | 0 | 3650 | 5671 | 0.3566 | 1 | Biofilm | biofilm-associated protein | experiment |
JJEBMEPF_00316 | VFG001855 | Hsp60 | 72.8 | 2.5e-221 | 1 | 543 | 0.9982 | 0.9891 | Adherence | Hsp60, 60K heat shock protein HtpB | experiment |
JJEBMEPF_00371 | VFG037747 | LPS | 100 | 3.4e-189 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | experiment |
JJEBMEPF_00564 | VFG037456 | Acinetobactin | 100 | 1.6e-166 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | experiment |
JJEBMEPF_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | experiment |
JJEBMEPF_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | experiment |
JJEBMEPF_00569 | VFG037414 | Acinetobactin | 100 | 3.9e-158 | 1 | 300 | 0.9585 | 0.974 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | experiment |
JJEBMEPF_00570 | VFG037400 | Acinetobactin | 100 | 2.6e-170 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | experiment |
JJEBMEPF_00571 | VFG037386 | Acinetobactin | 100 | 2.8e-146 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | experiment |
JJEBMEPF_00572 | VFG037372 | Acinetobactin | 100 | 3.8e-185 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | experiment |
JJEBMEPF_00573 | VFG037358 | Acinetobactin | 99.9 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | experiment |
JJEBMEPF_00574 | VFG037344 | Acinetobactin | 100 | 9.6e-264 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | experiment |
JJEBMEPF_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | experiment |
JJEBMEPF_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | experiment |
JJEBMEPF_00577 | VFG037302 | Acinetobactin | 100 | 3.5e-169 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | experiment |
JJEBMEPF_00578 | VFG037288 | Acinetobactin | 100 | 2.9e-232 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | experiment |
JJEBMEPF_00580 | VFG037274 | Acinetobactin | 100 | 1.5e-287 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
JJEBMEPF_00581 | VFG037260 | Acinetobactin | 100 | 4.7e-289 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
JJEBMEPF_00582 | VFG037246 | Acinetobactin | 100 | 3e-145 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | experiment |
JJEBMEPF_00583 | VFG037232 | Acinetobactin | 100 | 2.7e-141 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | experiment |
JJEBMEPF_00584 | VFG037218 | Acinetobactin | 100 | 2.5e-223 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | experiment |
JJEBMEPF_00729 | VFG037735 | AdeFGH efflux pump | 100 | 4.8e-264 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | experiment |
JJEBMEPF_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | experiment |
JJEBMEPF_00731 | VFG037705 | AdeFGH efflux pump | 100 | 3.6e-220 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | experiment |
JJEBMEPF_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | experiment |
JJEBMEPF_00779 | VFG050874 | T2SS | 100 | 2e-217 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | experiment |
JJEBMEPF_00780 | VFG050889 | T2SS | 100 | 3.3e-81 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | experiment |
JJEBMEPF_00819 | VFG037560 | Csu fimbriae | 100 | 1.8e-96 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | experiment |
JJEBMEPF_00821 | VFG037586 | Csu fimbriae | 100 | 2.6e-95 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | experiment |
JJEBMEPF_00822 | VFG037599 | Csu fimbriae | 100 | 6.1e-155 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | experiment |
JJEBMEPF_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | experiment |
JJEBMEPF_00824 | VFG037625 | Csu fimbriae | 99.4 | 6.9e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | experiment |
JJEBMEPF_00851 | VFG010906 | CsrA | 80 | 1.1e-19 | 1 | 55 | 0.6548 | 0.8594 | Regulation | carbon storage regulator CsrA | experiment |
JJEBMEPF_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | experiment |
JJEBMEPF_00968 | VFG037678 | PNAG | 100 | 1.1e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | experiment |
JJEBMEPF_00969 | VFG037692 | PNAG | 100 | 9.7e-86 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | experiment |
JJEBMEPF_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | experiment |
JJEBMEPF_01211 | VFG037837 | LPS | 100 | 2e-203 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | experiment |
JJEBMEPF_01213 | VFG037792 | LPS | 100 | 8.6e-151 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | experiment |
JJEBMEPF_01363 | VFG037028 | KatA | 85.5 | 7.7e-265 | 5 | 501 | 0.9822 | 0.9861 | Stress survival | catalase | experiment |
JJEBMEPF_01605 | VFG037807 | LPS | 100 | 3.9e-224 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | experiment |
JJEBMEPF_01745 | VFG050860 | T2SS | 99.7 | 2.4e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | experiment |
JJEBMEPF_01747 | VFG050832 | T2SS | 100 | 1.1e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | experiment |
JJEBMEPF_01748 | VFG050817 | T2SS | 100 | 4.4e-101 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | experiment |
JJEBMEPF_02046 | VFG050972 | T6SS | 100 | 1.3e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | experiment |
JJEBMEPF_02048 | VFG050946 | T6SS | 100 | 6.1e-152 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | experiment |
JJEBMEPF_02049 | VFG051028 | T6SS | 100 | 1.6e-261 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | experiment |
JJEBMEPF_02050 | VFG051084 | T6SS | 100 | 5.5e-212 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | experiment |
JJEBMEPF_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | experiment |
JJEBMEPF_02055 | VFG050959 | T6SS | 99.8 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | experiment |
JJEBMEPF_02057 | VFG051014 | T6SS | 100 | 2.3e-193 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | experiment |
JJEBMEPF_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | experiment |
JJEBMEPF_02059 | VFG050986 | T6SS | 100 | 4e-87 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | experiment |
JJEBMEPF_02060 | VFG051042 | T6SS | 100 | 8.6e-96 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | experiment |
JJEBMEPF_02061 | VFG051070 | T6SS | 100 | 2.4e-287 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | experiment |
JJEBMEPF_02062 | VFG051056 | T6SS | 100 | 1.1e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | experiment |
JJEBMEPF_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
JJEBMEPF_02130 | VFG050911 | T6SS | 73.6 | 0 | 1 | 1010 | 0.9492 | 0.9546 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
JJEBMEPF_02270 | VFG050303 | Ata | 81.6 | 0 | 1 | 1780 | 0.7859 | 0.956 | Adherence | trimeric autotransporter adhesin Ata | experiment |
JJEBMEPF_02384 | VFG037547 | HemO cluster | 93.4 | 7.6e-46 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | experiment |
JJEBMEPF_02385 | VFG037470 | HemO cluster | 97.6 | 5.1e-168 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | experiment |
JJEBMEPF_02426 | VFG050386 | TFP | 100 | 3.1e-196 | 11 | 355 | 0.9718 | 1 | Adherence | type IV pilus twitching motility protein PilT | experiment |
JJEBMEPF_02427 | VFG050400 | TFP | 100 | 8e-211 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | experiment |
JJEBMEPF_02460 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
JJEBMEPF_02577 | VFG038234 | BfmRS | 100 | 9.79999999994247e-314 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | experiment |
JJEBMEPF_02578 | VFG038219 | BfmRS | 100 | 3.3e-133 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | experiment |
JJEBMEPF_02679 | VFG050757 | T2SS | 100 | 6.2e-283 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | experiment |
JJEBMEPF_02789 | VFG050414 | TFP | 99.6 | 4.7e-141 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | experiment |
JJEBMEPF_02857 | VFG037762 | LPS | 98.4 | 7.2e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | experiment |
JJEBMEPF_02858 | VFG037777 | LPS | 98.6 | 2e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | experiment |
JJEBMEPF_02862 | VFG050428 | TFP | 99.3 | 1.6e-240 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
JJEBMEPF_02918 | VFG050802 | T2SS | 99 | 1.3e-106 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | experiment |
JJEBMEPF_02919 | VFG050787 | T2SS | 100 | 9e-216 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | experiment |
JJEBMEPF_02958 | VFG050457 | TFP | 99.5 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | experiment |
JJEBMEPF_02959 | VFG050470 | TFP | 99.8 | 8e-220 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | experiment |
JJEBMEPF_02960 | VFG050484 | TFP | 98.6 | 3.7e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | experiment |
JJEBMEPF_03007 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
JJEBMEPF_03015 | VFG050742 | T2SS | 99.7 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | experiment |
JJEBMEPF_03016 | VFG050727 | T2SS | 99.3 | 6.8e-154 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | experiment |
JJEBMEPF_03017 | VFG050712 | T2SS | 100 | 3e-145 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | experiment |
JJEBMEPF_03047 | VFG038249 | PbpG | 99.7 | 9.2e-182 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | experiment |
JJEBMEPF_03049 | VFG050685 | TFP | 99.6 | 7.9e-289 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | experiment |
JJEBMEPF_03050 | VFG050699 | TFP | 99.2 | 6.3e-269 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | experiment |
JJEBMEPF_03144 | VFG050499 | TFP | 99.5 | 1.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | experiment |
JJEBMEPF_03196 | VFG038205 | Quorom sensing | 98.7 | 1.9e-133 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | experiment |
JJEBMEPF_03198 | VFG038191 | Quorom sensing | 99.5 | 1.5e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | experiment |
JJEBMEPF_03225 | VFG050910 | T6SS | 99.3 | 0 | 1 | 844 | 0.9941 | 0.8903 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
JJEBMEPF_03241 | VFG038155 | Capsule | 97.8 | 7.4e-267 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | experiment |
JJEBMEPF_03243 | VFG038144 | Capsule | 98.8 | 8.7e-196 | 1 | 337 | 0.9941 | 0.997 | Immune modulation | UDP-glucose 4-epimerase GalE | experiment |
JJEBMEPF_03244 | VFG038132 | Capsule | 97.7 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | experiment |
JJEBMEPF_03245 | VFG038119 | Capsule | 99 | 6e-247 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | experiment |
JJEBMEPF_03246 | VFG038105 | Capsule | 99 | 1e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | experiment |
JJEBMEPF_03247 | VFG038091 | Capsule | 76.2 | 4.6e-83 | 1 | 202 | 0.9902 | 0.9806 | Immune modulation | sugar transferase | experiment |
JJEBMEPF_03259 | VFG037897 | Capsule | 84.4 | 2.8e-207 | 3 | 425 | 0.9953 | 0.9976 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | experiment |
JJEBMEPF_03261 | VFG037867 | Capsule | 74.6 | 2.9e-60 | 1 | 138 | 0.9718 | 0.9718 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | experiment |
JJEBMEPF_03446 | VFG050912 | T6SS | 93.1 | 0 | 1 | 1083 | 0.9774 | 0.9909 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
JJEBMEPF_03490 | VFG037822 | LPS | 100 | 5.9e-172 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | experiment |
JJEBMEPF_03645 | VFG050313 | TFP | 99.4 | 1.3e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | experiment |
JJEBMEPF_03646 | VFG050328 | TFP | 99.5 | 1.3e-117 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | experiment |
JJEBMEPF_03647 | VFG050342 | TFP | 99.2 | 8.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | experiment |
JJEBMEPF_03648 | VFG050357 | TFP | 98.9 | 4.8e-97 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | experiment |
JJEBMEPF_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | experiment |
JJEBMEPF_03659 | VFG050443 | TFP | 94.5 | 2.7e-69 | 1 | 144 | 1.0 | 0.9931 | Adherence | pilin | experiment |
JJEBMEPF_03669 | VFG050514 | TFP | 98.1 | 7.1e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
JJEBMEPF_03670 | VFG050527 | TFP | 99.5 | 2.7e-98 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | experiment |
JJEBMEPF_03671 | VFG050540 | TFP | 98.5 | 1.6e-181 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | experiment |
JJEBMEPF_03672 | VFG050554 | TFP | 99.6 | 1.6e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
JJEBMEPF_03673 | VFG050567 | TFP | 99.3 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | experiment |
JJEBMEPF_03674 | VFG050581 | TFP | 100 | 1.9e-84 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | experiment |
JJEBMEPF_03675 | VFG050595 | TFP | 100 | 3.5e-74 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | experiment |
CKHOCAAF_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | experiment |
CKHOCAAF_00130 | VFG050610 | TFP | 100 | 3.7e-94 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
CKHOCAAF_00131 | VFG038176 | OmpA | 100 | 2.2e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | experiment |
CKHOCAAF_00160 | VFG050625 | TFP | 100 | 1.2e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | experiment |
CKHOCAAF_00161 | VFG050640 | TFP | 100 | 2.5e-65 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | experiment |
CKHOCAAF_00162 | VFG050655 | TFP | 100 | 1.7e-102 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | experiment |
CKHOCAAF_00163 | VFG050670 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 1 | Adherence | methyl-accepting chemotaxis protein | experiment |
CKHOCAAF_00283 | VFG037638 | Bap | 99.8 | 0 | 3650 | 5671 | 0.3566 | 1 | Biofilm | biofilm-associated protein | experiment |
CKHOCAAF_00316 | VFG001855 | Hsp60 | 72.8 | 2.5e-221 | 1 | 543 | 0.9982 | 0.9891 | Adherence | Hsp60, 60K heat shock protein HtpB | experiment |
CKHOCAAF_00371 | VFG037747 | LPS | 100 | 3.4e-189 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | experiment |
CKHOCAAF_00564 | VFG037456 | Acinetobactin | 100 | 1.6e-166 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | experiment |
CKHOCAAF_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | experiment |
CKHOCAAF_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | experiment |
CKHOCAAF_00569 | VFG037414 | Acinetobactin | 100 | 3.9e-158 | 1 | 300 | 0.9585 | 0.974 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | experiment |
CKHOCAAF_00570 | VFG037400 | Acinetobactin | 100 | 2.6e-170 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | experiment |
CKHOCAAF_00571 | VFG037386 | Acinetobactin | 100 | 2.8e-146 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | experiment |
CKHOCAAF_00572 | VFG037372 | Acinetobactin | 100 | 3.8e-185 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | experiment |
CKHOCAAF_00573 | VFG037358 | Acinetobactin | 99.9 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | experiment |
CKHOCAAF_00574 | VFG037344 | Acinetobactin | 100 | 9.6e-264 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | experiment |
CKHOCAAF_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | experiment |
CKHOCAAF_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | experiment |
CKHOCAAF_00577 | VFG037302 | Acinetobactin | 100 | 3.5e-169 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | experiment |
CKHOCAAF_00578 | VFG037288 | Acinetobactin | 100 | 2.9e-232 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | experiment |
CKHOCAAF_00580 | VFG037274 | Acinetobactin | 100 | 1.5e-287 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
CKHOCAAF_00581 | VFG037260 | Acinetobactin | 100 | 4.7e-289 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
CKHOCAAF_00582 | VFG037246 | Acinetobactin | 100 | 3e-145 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | experiment |
CKHOCAAF_00583 | VFG037232 | Acinetobactin | 100 | 2.7e-141 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | experiment |
CKHOCAAF_00584 | VFG037218 | Acinetobactin | 100 | 2.5e-223 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | experiment |
CKHOCAAF_00729 | VFG037735 | AdeFGH efflux pump | 100 | 4.8e-264 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | experiment |
CKHOCAAF_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | experiment |
CKHOCAAF_00731 | VFG037705 | AdeFGH efflux pump | 100 | 3.6e-220 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | experiment |
CKHOCAAF_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | experiment |
CKHOCAAF_00779 | VFG050874 | T2SS | 100 | 2e-217 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | experiment |
CKHOCAAF_00780 | VFG050889 | T2SS | 100 | 3.3e-81 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | experiment |
CKHOCAAF_00819 | VFG037560 | Csu fimbriae | 100 | 1.8e-96 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | experiment |
CKHOCAAF_00821 | VFG037586 | Csu fimbriae | 100 | 2.6e-95 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | experiment |
CKHOCAAF_00822 | VFG037599 | Csu fimbriae | 100 | 6.1e-155 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | experiment |
CKHOCAAF_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | experiment |
CKHOCAAF_00824 | VFG037625 | Csu fimbriae | 99.4 | 6.9e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | experiment |
CKHOCAAF_00851 | VFG010906 | CsrA | 80 | 1.1e-19 | 1 | 55 | 0.6548 | 0.8594 | Regulation | carbon storage regulator CsrA | experiment |
CKHOCAAF_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | experiment |
CKHOCAAF_00968 | VFG037678 | PNAG | 100 | 1.1e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | experiment |
CKHOCAAF_00969 | VFG037692 | PNAG | 100 | 9.7e-86 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | experiment |
CKHOCAAF_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | experiment |
CKHOCAAF_01211 | VFG037837 | LPS | 100 | 2e-203 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | experiment |
CKHOCAAF_01213 | VFG037792 | LPS | 100 | 8.6e-151 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | experiment |
CKHOCAAF_01363 | VFG037028 | KatA | 85.5 | 7.7e-265 | 5 | 501 | 0.9822 | 0.9861 | Stress survival | catalase | experiment |
CKHOCAAF_01605 | VFG037807 | LPS | 100 | 3.9e-224 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | experiment |
CKHOCAAF_01745 | VFG050860 | T2SS | 99.7 | 2.4e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | experiment |
CKHOCAAF_01747 | VFG050832 | T2SS | 100 | 1.1e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | experiment |
CKHOCAAF_01748 | VFG050817 | T2SS | 100 | 4.4e-101 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | experiment |
CKHOCAAF_02046 | VFG050972 | T6SS | 100 | 1.3e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | experiment |
CKHOCAAF_02048 | VFG050946 | T6SS | 100 | 6.1e-152 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | experiment |
CKHOCAAF_02049 | VFG051028 | T6SS | 100 | 1.6e-261 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | experiment |
CKHOCAAF_02050 | VFG051084 | T6SS | 100 | 5.5e-212 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | experiment |
CKHOCAAF_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | experiment |
CKHOCAAF_02055 | VFG050959 | T6SS | 99.8 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | experiment |
CKHOCAAF_02057 | VFG051014 | T6SS | 100 | 2.3e-193 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | experiment |
CKHOCAAF_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | experiment |
CKHOCAAF_02059 | VFG050986 | T6SS | 100 | 4e-87 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | experiment |
CKHOCAAF_02060 | VFG051042 | T6SS | 100 | 8.6e-96 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | experiment |
CKHOCAAF_02061 | VFG051070 | T6SS | 100 | 2.4e-287 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | experiment |
CKHOCAAF_02062 | VFG051056 | T6SS | 100 | 1.1e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | experiment |
CKHOCAAF_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
CKHOCAAF_02130 | VFG050911 | T6SS | 73.6 | 0 | 1 | 1010 | 0.9492 | 0.9546 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
CKHOCAAF_02270 | VFG050303 | Ata | 81.6 | 0 | 1 | 1780 | 0.7859 | 0.956 | Adherence | trimeric autotransporter adhesin Ata | experiment |
CKHOCAAF_02384 | VFG037547 | HemO cluster | 93.4 | 7.6e-46 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | experiment |
CKHOCAAF_02385 | VFG037470 | HemO cluster | 97.6 | 5.1e-168 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | experiment |
CKHOCAAF_02426 | VFG050386 | TFP | 100 | 3.1e-196 | 11 | 355 | 0.9718 | 1 | Adherence | type IV pilus twitching motility protein PilT | experiment |
CKHOCAAF_02427 | VFG050400 | TFP | 100 | 8e-211 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | experiment |
CKHOCAAF_02460 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
CKHOCAAF_02577 | VFG038234 | BfmRS | 100 | 9.79999999994247e-314 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | experiment |
CKHOCAAF_02578 | VFG038219 | BfmRS | 100 | 3.3e-133 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | experiment |
CKHOCAAF_02679 | VFG050757 | T2SS | 100 | 6.2e-283 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | experiment |
CKHOCAAF_02789 | VFG050414 | TFP | 99.6 | 4.7e-141 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | experiment |
CKHOCAAF_02857 | VFG037762 | LPS | 98.4 | 7.2e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | experiment |
CKHOCAAF_02858 | VFG037777 | LPS | 98.6 | 2e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | experiment |
CKHOCAAF_02862 | VFG050428 | TFP | 99.3 | 1.6e-240 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
CKHOCAAF_02918 | VFG050802 | T2SS | 99 | 1.3e-106 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | experiment |
CKHOCAAF_02919 | VFG050787 | T2SS | 100 | 9e-216 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | experiment |
CKHOCAAF_02958 | VFG050457 | TFP | 99.5 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | experiment |
CKHOCAAF_02959 | VFG050470 | TFP | 99.8 | 8e-220 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | experiment |
CKHOCAAF_02960 | VFG050484 | TFP | 98.6 | 3.7e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | experiment |
CKHOCAAF_03007 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
CKHOCAAF_03015 | VFG050742 | T2SS | 99.7 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | experiment |
CKHOCAAF_03016 | VFG050727 | T2SS | 99.3 | 6.8e-154 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | experiment |
CKHOCAAF_03017 | VFG050712 | T2SS | 100 | 3e-145 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | experiment |
CKHOCAAF_03047 | VFG038249 | PbpG | 99.7 | 9.2e-182 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | experiment |
CKHOCAAF_03049 | VFG050685 | TFP | 99.6 | 7.9e-289 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | experiment |
CKHOCAAF_03050 | VFG050699 | TFP | 99.2 | 6.3e-269 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | experiment |
CKHOCAAF_03144 | VFG050499 | TFP | 99.5 | 1.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | experiment |
CKHOCAAF_03196 | VFG038205 | Quorom sensing | 98.7 | 1.9e-133 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | experiment |
CKHOCAAF_03198 | VFG038191 | Quorom sensing | 99.5 | 1.5e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | experiment |
CKHOCAAF_03225 | VFG050910 | T6SS | 99.3 | 0 | 1 | 844 | 0.9941 | 0.8903 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
CKHOCAAF_03241 | VFG038155 | Capsule | 97.8 | 7.4e-267 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | experiment |
CKHOCAAF_03243 | VFG038144 | Capsule | 98.8 | 8.7e-196 | 1 | 337 | 0.9941 | 0.997 | Immune modulation | UDP-glucose 4-epimerase GalE | experiment |
CKHOCAAF_03244 | VFG038132 | Capsule | 97.7 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | experiment |
CKHOCAAF_03245 | VFG038119 | Capsule | 99 | 6e-247 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | experiment |
CKHOCAAF_03246 | VFG038105 | Capsule | 99 | 1e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | experiment |
CKHOCAAF_03247 | VFG038091 | Capsule | 76.2 | 4.6e-83 | 1 | 202 | 0.9902 | 0.9806 | Immune modulation | sugar transferase | experiment |
CKHOCAAF_03259 | VFG037897 | Capsule | 84.4 | 2.8e-207 | 3 | 425 | 0.9953 | 0.9976 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | experiment |
CKHOCAAF_03261 | VFG037867 | Capsule | 74.6 | 2.9e-60 | 1 | 138 | 0.9718 | 0.9718 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | experiment |
CKHOCAAF_03446 | VFG050912 | T6SS | 93.1 | 0 | 1 | 1083 | 0.9774 | 0.9909 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
CKHOCAAF_03490 | VFG037822 | LPS | 100 | 5.9e-172 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | experiment |
CKHOCAAF_03645 | VFG050313 | TFP | 99.4 | 1.3e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | experiment |
CKHOCAAF_03646 | VFG050328 | TFP | 99.5 | 1.3e-117 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | experiment |
CKHOCAAF_03647 | VFG050342 | TFP | 99.2 | 8.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | experiment |
CKHOCAAF_03648 | VFG050357 | TFP | 98.9 | 4.8e-97 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | experiment |
CKHOCAAF_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | experiment |
CKHOCAAF_03659 | VFG050443 | TFP | 94.5 | 2.7e-69 | 1 | 144 | 1.0 | 0.9931 | Adherence | pilin | experiment |
CKHOCAAF_03669 | VFG050514 | TFP | 98.1 | 7.1e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
CKHOCAAF_03670 | VFG050527 | TFP | 99.5 | 2.7e-98 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | experiment |
CKHOCAAF_03671 | VFG050540 | TFP | 98.5 | 1.6e-181 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | experiment |
CKHOCAAF_03672 | VFG050554 | TFP | 99.6 | 1.6e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
CKHOCAAF_03673 | VFG050567 | TFP | 99.3 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | experiment |
CKHOCAAF_03674 | VFG050581 | TFP | 100 | 1.9e-84 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | experiment |
CKHOCAAF_03675 | VFG050595 | TFP | 100 | 3.5e-74 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | experiment |
IPHMMGCP_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | experiment |
IPHMMGCP_00130 | VFG050610 | TFP | 100 | 3.7e-94 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
IPHMMGCP_00131 | VFG038176 | OmpA | 100 | 2.2e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | experiment |
IPHMMGCP_00160 | VFG050625 | TFP | 100 | 1.2e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | experiment |
IPHMMGCP_00161 | VFG050640 | TFP | 100 | 2.5e-65 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | experiment |
IPHMMGCP_00162 | VFG050655 | TFP | 100 | 1.7e-102 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | experiment |
IPHMMGCP_00163 | VFG050670 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 1 | Adherence | methyl-accepting chemotaxis protein | experiment |
IPHMMGCP_00283 | VFG037638 | Bap | 99.8 | 0 | 3650 | 5671 | 0.3566 | 1 | Biofilm | biofilm-associated protein | experiment |
IPHMMGCP_00316 | VFG001855 | Hsp60 | 72.8 | 2.5e-221 | 1 | 543 | 0.9982 | 0.9891 | Adherence | Hsp60, 60K heat shock protein HtpB | experiment |
IPHMMGCP_00371 | VFG037747 | LPS | 100 | 3.4e-189 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | experiment |
IPHMMGCP_00564 | VFG037456 | Acinetobactin | 100 | 1.6e-166 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | experiment |
IPHMMGCP_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | experiment |
IPHMMGCP_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | experiment |
IPHMMGCP_00569 | VFG037414 | Acinetobactin | 100 | 3.9e-158 | 1 | 300 | 0.9585 | 0.974 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | experiment |
IPHMMGCP_00570 | VFG037400 | Acinetobactin | 100 | 2.6e-170 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | experiment |
IPHMMGCP_00571 | VFG037386 | Acinetobactin | 100 | 2.8e-146 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | experiment |
IPHMMGCP_00572 | VFG037372 | Acinetobactin | 100 | 3.8e-185 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | experiment |
IPHMMGCP_00573 | VFG037358 | Acinetobactin | 99.9 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | experiment |
IPHMMGCP_00574 | VFG037344 | Acinetobactin | 100 | 9.6e-264 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | experiment |
IPHMMGCP_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | experiment |
IPHMMGCP_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | experiment |
IPHMMGCP_00577 | VFG037302 | Acinetobactin | 100 | 3.5e-169 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | experiment |
IPHMMGCP_00578 | VFG037288 | Acinetobactin | 100 | 2.9e-232 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | experiment |
IPHMMGCP_00580 | VFG037274 | Acinetobactin | 100 | 1.5e-287 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
IPHMMGCP_00581 | VFG037260 | Acinetobactin | 100 | 4.7e-289 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
IPHMMGCP_00582 | VFG037246 | Acinetobactin | 100 | 3e-145 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | experiment |
IPHMMGCP_00583 | VFG037232 | Acinetobactin | 100 | 2.7e-141 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | experiment |
IPHMMGCP_00584 | VFG037218 | Acinetobactin | 100 | 2.5e-223 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | experiment |
IPHMMGCP_00729 | VFG037735 | AdeFGH efflux pump | 100 | 4.8e-264 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | experiment |
IPHMMGCP_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | experiment |
IPHMMGCP_00731 | VFG037705 | AdeFGH efflux pump | 100 | 3.6e-220 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | experiment |
IPHMMGCP_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | experiment |
IPHMMGCP_00779 | VFG050874 | T2SS | 100 | 2e-217 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | experiment |
IPHMMGCP_00780 | VFG050889 | T2SS | 100 | 3.3e-81 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | experiment |
IPHMMGCP_00819 | VFG037560 | Csu fimbriae | 100 | 1.8e-96 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | experiment |
IPHMMGCP_00821 | VFG037586 | Csu fimbriae | 100 | 2.6e-95 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | experiment |
IPHMMGCP_00822 | VFG037599 | Csu fimbriae | 100 | 6.1e-155 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | experiment |
IPHMMGCP_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | experiment |
IPHMMGCP_00824 | VFG037625 | Csu fimbriae | 99.4 | 6.9e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | experiment |
IPHMMGCP_00851 | VFG010906 | CsrA | 80 | 1.1e-19 | 1 | 55 | 0.6548 | 0.8594 | Regulation | carbon storage regulator CsrA | experiment |
IPHMMGCP_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | experiment |
IPHMMGCP_00968 | VFG037678 | PNAG | 100 | 1.1e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | experiment |
IPHMMGCP_00969 | VFG037692 | PNAG | 100 | 9.7e-86 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | experiment |
IPHMMGCP_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | experiment |
IPHMMGCP_01211 | VFG037837 | LPS | 100 | 2e-203 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | experiment |
IPHMMGCP_01213 | VFG037792 | LPS | 100 | 8.6e-151 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | experiment |
IPHMMGCP_01363 | VFG037028 | KatA | 85.5 | 7.7e-265 | 5 | 501 | 0.9822 | 0.9861 | Stress survival | catalase | experiment |
IPHMMGCP_01605 | VFG037807 | LPS | 100 | 3.9e-224 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | experiment |
IPHMMGCP_01745 | VFG050860 | T2SS | 99.7 | 2.4e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | experiment |
IPHMMGCP_01747 | VFG050832 | T2SS | 100 | 1.1e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | experiment |
IPHMMGCP_01748 | VFG050817 | T2SS | 100 | 4.4e-101 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | experiment |
IPHMMGCP_02046 | VFG050972 | T6SS | 100 | 1.3e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | experiment |
IPHMMGCP_02048 | VFG050946 | T6SS | 100 | 6.1e-152 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | experiment |
IPHMMGCP_02049 | VFG051028 | T6SS | 100 | 1.6e-261 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | experiment |
IPHMMGCP_02050 | VFG051084 | T6SS | 100 | 5.5e-212 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | experiment |
IPHMMGCP_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | experiment |
IPHMMGCP_02055 | VFG050959 | T6SS | 99.8 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | experiment |
IPHMMGCP_02057 | VFG051014 | T6SS | 100 | 2.3e-193 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | experiment |
IPHMMGCP_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | experiment |
IPHMMGCP_02059 | VFG050986 | T6SS | 100 | 4e-87 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | experiment |
IPHMMGCP_02060 | VFG051042 | T6SS | 100 | 8.6e-96 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | experiment |
IPHMMGCP_02061 | VFG051070 | T6SS | 100 | 2.4e-287 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | experiment |
IPHMMGCP_02062 | VFG051056 | T6SS | 100 | 1.1e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | experiment |
IPHMMGCP_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
IPHMMGCP_02130 | VFG050911 | T6SS | 73.6 | 0 | 1 | 1010 | 0.9492 | 0.9546 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
IPHMMGCP_02270 | VFG050303 | Ata | 81.6 | 0 | 1 | 1780 | 0.7859 | 0.956 | Adherence | trimeric autotransporter adhesin Ata | experiment |
IPHMMGCP_02384 | VFG037547 | HemO cluster | 93.4 | 7.6e-46 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | experiment |
IPHMMGCP_02385 | VFG037470 | HemO cluster | 97.6 | 5.1e-168 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | experiment |
IPHMMGCP_02426 | VFG050386 | TFP | 100 | 3.1e-196 | 11 | 355 | 0.9718 | 1 | Adherence | type IV pilus twitching motility protein PilT | experiment |
IPHMMGCP_02427 | VFG050400 | TFP | 100 | 8e-211 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | experiment |
IPHMMGCP_02460 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
IPHMMGCP_02577 | VFG038234 | BfmRS | 100 | 9.79999999994247e-314 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | experiment |
IPHMMGCP_02578 | VFG038219 | BfmRS | 100 | 3.3e-133 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | experiment |
IPHMMGCP_02679 | VFG050757 | T2SS | 100 | 6.2e-283 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | experiment |
IPHMMGCP_02789 | VFG050414 | TFP | 99.6 | 4.7e-141 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | experiment |
IPHMMGCP_02857 | VFG037762 | LPS | 98.4 | 7.2e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | experiment |
IPHMMGCP_02858 | VFG037777 | LPS | 98.6 | 2e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | experiment |
IPHMMGCP_02862 | VFG050428 | TFP | 99.3 | 1.6e-240 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
IPHMMGCP_02918 | VFG050802 | T2SS | 99 | 1.3e-106 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | experiment |
IPHMMGCP_02919 | VFG050787 | T2SS | 100 | 9e-216 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | experiment |
IPHMMGCP_02958 | VFG050457 | TFP | 99.5 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | experiment |
IPHMMGCP_02959 | VFG050470 | TFP | 99.8 | 8e-220 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | experiment |
IPHMMGCP_02960 | VFG050484 | TFP | 98.6 | 3.7e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | experiment |
IPHMMGCP_03007 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
IPHMMGCP_03015 | VFG050742 | T2SS | 99.7 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | experiment |
IPHMMGCP_03016 | VFG050727 | T2SS | 99.3 | 6.8e-154 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | experiment |
IPHMMGCP_03017 | VFG050712 | T2SS | 100 | 3e-145 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | experiment |
IPHMMGCP_03047 | VFG038249 | PbpG | 99.7 | 9.2e-182 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | experiment |
IPHMMGCP_03049 | VFG050685 | TFP | 99.6 | 7.9e-289 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | experiment |
IPHMMGCP_03050 | VFG050699 | TFP | 99.2 | 6.3e-269 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | experiment |
IPHMMGCP_03144 | VFG050499 | TFP | 99.5 | 1.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | experiment |
IPHMMGCP_03196 | VFG038205 | Quorom sensing | 98.7 | 1.9e-133 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | experiment |
IPHMMGCP_03198 | VFG038191 | Quorom sensing | 99.5 | 1.5e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | experiment |
IPHMMGCP_03225 | VFG050910 | T6SS | 99.3 | 0 | 1 | 844 | 0.9941 | 0.8903 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
IPHMMGCP_03241 | VFG038155 | Capsule | 97.8 | 7.4e-267 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | experiment |
IPHMMGCP_03243 | VFG038144 | Capsule | 98.8 | 8.7e-196 | 1 | 337 | 0.9941 | 0.997 | Immune modulation | UDP-glucose 4-epimerase GalE | experiment |
IPHMMGCP_03244 | VFG038132 | Capsule | 97.7 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | experiment |
IPHMMGCP_03245 | VFG038119 | Capsule | 99 | 6e-247 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | experiment |
IPHMMGCP_03246 | VFG038105 | Capsule | 99 | 1e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | experiment |
IPHMMGCP_03247 | VFG038091 | Capsule | 76.2 | 4.6e-83 | 1 | 202 | 0.9902 | 0.9806 | Immune modulation | sugar transferase | experiment |
IPHMMGCP_03259 | VFG037897 | Capsule | 84.4 | 2.8e-207 | 3 | 425 | 0.9953 | 0.9976 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | experiment |
IPHMMGCP_03261 | VFG037867 | Capsule | 74.6 | 2.9e-60 | 1 | 138 | 0.9718 | 0.9718 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | experiment |
IPHMMGCP_03446 | VFG050912 | T6SS | 93.1 | 0 | 1 | 1083 | 0.9774 | 0.9909 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
IPHMMGCP_03490 | VFG037822 | LPS | 100 | 5.9e-172 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | experiment |
IPHMMGCP_03645 | VFG050313 | TFP | 99.4 | 1.3e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | experiment |
IPHMMGCP_03646 | VFG050328 | TFP | 99.5 | 1.3e-117 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | experiment |
IPHMMGCP_03647 | VFG050342 | TFP | 99.2 | 8.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | experiment |
IPHMMGCP_03648 | VFG050357 | TFP | 98.9 | 4.8e-97 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | experiment |
IPHMMGCP_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | experiment |
IPHMMGCP_03659 | VFG050443 | TFP | 94.5 | 2.7e-69 | 1 | 144 | 1.0 | 0.9931 | Adherence | pilin | experiment |
IPHMMGCP_03669 | VFG050514 | TFP | 98.1 | 7.1e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
IPHMMGCP_03670 | VFG050527 | TFP | 99.5 | 2.7e-98 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | experiment |
IPHMMGCP_03671 | VFG050540 | TFP | 98.5 | 1.6e-181 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | experiment |
IPHMMGCP_03672 | VFG050554 | TFP | 99.6 | 1.6e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
IPHMMGCP_03673 | VFG050567 | TFP | 99.3 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | experiment |
IPHMMGCP_03674 | VFG050581 | TFP | 100 | 1.9e-84 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | experiment |
IPHMMGCP_03675 | VFG050595 | TFP | 100 | 3.5e-74 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | experiment |
JJEBMEPF_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | prediction |
JJEBMEPF_00130 | VFG050610 | TFP | 100 | 2.8e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
JJEBMEPF_00131 | VFG038176 | OmpA | 100 | 1.7e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | prediction |
JJEBMEPF_00160 | VFG050625 | TFP | 100 | 8.7e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | prediction |
JJEBMEPF_00161 | VFG050640 | TFP | 100 | 1.9e-64 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | prediction |
JJEBMEPF_00162 | VFG050655 | TFP | 100 | 1.3e-101 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | prediction |
JJEBMEPF_00163 | VFG050680 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 0.983 | Adherence | methyl-accepting chemotaxis protein | prediction |
JJEBMEPF_00283 | VFG037636 | Bap | 71.4 | 0 | 41 | 5017 | 0.8776 | 0.9109 | Biofilm | biofilm-associated protein | prediction |
JJEBMEPF_00316 | VFG045692 | Hsp60 | 72.6 | 2.2e-221 | 1 | 543 | 0.9982 | 0.9855 | Adherence | Hsp60, 60K heat shock protein HtpB | prediction |
JJEBMEPF_00371 | VFG037747 | LPS | 100 | 2.6e-188 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | prediction |
JJEBMEPF_00492 | VFG044201 | Achromobactin biosynthesis and transport | 71.8 | 1.4e-187 | 13 | 455 | 0.9694 | 0.9672 | Nutritional/Metabolic factor | diaminobutyrate--2-oxoglutarate transaminase | prediction |
JJEBMEPF_00564 | VFG037456 | Acinetobactin | 100 | 1.2e-165 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | prediction |
JJEBMEPF_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | prediction |
JJEBMEPF_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | prediction |
JJEBMEPF_00569 | VFG037417 | Acinetobactin | 100 | 5.5e-164 | 1 | 313 | 1.0 | 0.9572 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | prediction |
JJEBMEPF_00570 | VFG037400 | Acinetobactin | 100 | 2e-169 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | prediction |
JJEBMEPF_00571 | VFG037386 | Acinetobactin | 100 | 2.1e-145 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | prediction |
JJEBMEPF_00572 | VFG037372 | Acinetobactin | 100 | 2.9e-184 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | prediction |
JJEBMEPF_00573 | VFG037355 | Acinetobactin | 100 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | prediction |
JJEBMEPF_00574 | VFG037344 | Acinetobactin | 100 | 7.2e-263 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | prediction |
JJEBMEPF_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | prediction |
JJEBMEPF_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | prediction |
JJEBMEPF_00577 | VFG037302 | Acinetobactin | 100 | 2.6e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | prediction |
JJEBMEPF_00578 | VFG037288 | Acinetobactin | 100 | 2.2e-231 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | prediction |
JJEBMEPF_00580 | VFG037274 | Acinetobactin | 100 | 1.1e-286 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
JJEBMEPF_00581 | VFG037260 | Acinetobactin | 100 | 3.5e-288 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
JJEBMEPF_00582 | VFG037246 | Acinetobactin | 100 | 2.2e-144 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | prediction |
JJEBMEPF_00583 | VFG037232 | Acinetobactin | 100 | 2e-140 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | prediction |
JJEBMEPF_00584 | VFG037218 | Acinetobactin | 100 | 1.9e-222 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | prediction |
JJEBMEPF_00729 | VFG037735 | AdeFGH efflux pump | 100 | 3.6e-263 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | prediction |
JJEBMEPF_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | prediction |
JJEBMEPF_00731 | VFG037705 | AdeFGH efflux pump | 100 | 2.7e-219 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | prediction |
JJEBMEPF_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | prediction |
JJEBMEPF_00779 | VFG050874 | T2SS | 100 | 1.5e-216 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | prediction |
JJEBMEPF_00780 | VFG050889 | T2SS | 100 | 2.5e-80 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | prediction |
JJEBMEPF_00819 | VFG037560 | Csu fimbriae | 100 | 1.4e-95 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | prediction |
JJEBMEPF_00820 | VFG037570 | Csu fimbriae | 100 | 6.1e-99 | 1 | 182 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuA | prediction |
JJEBMEPF_00821 | VFG037586 | Csu fimbriae | 100 | 1.9e-94 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | prediction |
JJEBMEPF_00822 | VFG037599 | Csu fimbriae | 100 | 4.6e-154 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | prediction |
JJEBMEPF_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | prediction |
JJEBMEPF_00824 | VFG037633 | Csu fimbriae | 100 | 3.6e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | prediction |
JJEBMEPF_00851 | VFG045727 | CsrA | 76.3 | 8.4e-19 | 1 | 59 | 0.7024 | 0.9219 | Regulation | carbon storage regulator CsrA | prediction |
JJEBMEPF_00966 | VFG037647 | PNAG | 100 | 0 | 1 | 812 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA | prediction |
JJEBMEPF_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | prediction |
JJEBMEPF_00968 | VFG037678 | PNAG | 100 | 8.4e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | prediction |
JJEBMEPF_00969 | VFG037692 | PNAG | 100 | 7.3e-85 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | prediction |
JJEBMEPF_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | prediction |
JJEBMEPF_01211 | VFG037837 | LPS | 100 | 1.5e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | prediction |
JJEBMEPF_01213 | VFG037792 | LPS | 100 | 6.4e-150 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | prediction |
JJEBMEPF_01363 | VFG037041 | KatA | 85.1 | 1.8e-265 | 5 | 506 | 0.9921 | 0.996 | Stress survival | catalase | prediction |
JJEBMEPF_01605 | VFG037807 | LPS | 100 | 2.9e-223 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | prediction |
JJEBMEPF_01745 | VFG050857 | T2SS | 100 | 6.2e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | prediction |
JJEBMEPF_01746 | VFG050844 | T2SS | 100 | 8e-128 | 1 | 233 | 1.0 | 1 | Effector delivery system | general secretion pathway protein J | prediction |
JJEBMEPF_01747 | VFG050832 | T2SS | 100 | 8.4e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | prediction |
JJEBMEPF_01748 | VFG050817 | T2SS | 100 | 3.3e-100 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | prediction |
JJEBMEPF_02046 | VFG050972 | T6SS | 100 | 9.4e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | prediction |
JJEBMEPF_02048 | VFG050946 | T6SS | 100 | 4.6e-151 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | prediction |
JJEBMEPF_02049 | VFG051028 | T6SS | 100 | 1.2e-260 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | prediction |
JJEBMEPF_02050 | VFG051084 | T6SS | 100 | 4.1e-211 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | prediction |
JJEBMEPF_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | prediction |
JJEBMEPF_02055 | VFG050962 | T6SS | 99.9 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | prediction |
JJEBMEPF_02057 | VFG051014 | T6SS | 100 | 1.7e-192 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | prediction |
JJEBMEPF_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | prediction |
JJEBMEPF_02059 | VFG050986 | T6SS | 100 | 3e-86 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | prediction |
JJEBMEPF_02060 | VFG051042 | T6SS | 100 | 6.4e-95 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | prediction |
JJEBMEPF_02061 | VFG051070 | T6SS | 100 | 1.8e-286 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | prediction |
JJEBMEPF_02062 | VFG051056 | T6SS | 100 | 8.4e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | prediction |
JJEBMEPF_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
JJEBMEPF_02130 | VFG050931 | T6SS | 100 | 0 | 1 | 1064 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
JJEBMEPF_02270 | VFG050302 | Ata | 100 | 0 | 1 | 2265 | 1.0 | 1 | Adherence | trimeric autotransporter adhesin Ata | prediction |
JJEBMEPF_02384 | VFG037544 | HemO cluster | 100 | 1.6e-47 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | prediction |
JJEBMEPF_02385 | VFG037467 | HemO cluster | 100 | 4.8e-170 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | prediction |
JJEBMEPF_02426 | VFG050395 | TFP | 100 | 2.9e-201 | 1 | 355 | 1.0 | 1 | Adherence | type IV pilus twitching motility protein PilT | prediction |
JJEBMEPF_02427 | VFG050400 | TFP | 100 | 6e-210 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | prediction |
JJEBMEPF_02460 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
JJEBMEPF_02577 | VFG038234 | BfmRS | 100 | 7.29999999998336e-313 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | prediction |
JJEBMEPF_02578 | VFG038219 | BfmRS | 100 | 2.5e-132 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | prediction |
JJEBMEPF_02679 | VFG050757 | T2SS | 100 | 4.6e-282 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | prediction |
JJEBMEPF_02789 | VFG050418 | TFP | 100 | 1.2e-140 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | prediction |
JJEBMEPF_02857 | VFG037762 | LPS | 98.4 | 5.4e-188 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | prediction |
JJEBMEPF_02858 | VFG037783 | LPS | 99.5 | 7e-211 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | prediction |
JJEBMEPF_02862 | VFG050428 | TFP | 99.3 | 1.2e-239 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
JJEBMEPF_02918 | VFG050806 | T2SS | 100 | 8.5e-107 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | prediction |
JJEBMEPF_02919 | VFG050787 | T2SS | 100 | 6.7e-215 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | prediction |
JJEBMEPF_02958 | VFG050455 | TFP | 99.8 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | prediction |
JJEBMEPF_02959 | VFG050470 | TFP | 99.8 | 6e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | prediction |
JJEBMEPF_02960 | VFG050490 | TFP | 99.7 | 5.5e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | prediction |
JJEBMEPF_03007 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
JJEBMEPF_03015 | VFG050748 | T2SS | 100 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | prediction |
JJEBMEPF_03016 | VFG050725 | T2SS | 100 | 7.1e-155 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | prediction |
JJEBMEPF_03017 | VFG050712 | T2SS | 100 | 2.2e-144 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | prediction |
JJEBMEPF_03047 | VFG038247 | PbpG | 100 | 2.4e-181 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | prediction |
JJEBMEPF_03049 | VFG050685 | TFP | 99.6 | 5.9e-288 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | prediction |
JJEBMEPF_03050 | VFG050699 | TFP | 99.2 | 4.7e-268 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | prediction |
JJEBMEPF_03144 | VFG050496 | TFP | 99.7 | 3.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | prediction |
JJEBMEPF_03196 | VFG038203 | Quorom sensing | 100 | 4.5e-134 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | prediction |
JJEBMEPF_03198 | VFG038191 | Quorom sensing | 99.5 | 1.1e-103 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | prediction |
JJEBMEPF_03225 | VFG050932 | T6SS | 99.2 | 0 | 1 | 846 | 0.9965 | 0.9029 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
JJEBMEPF_03241 | VFG038167 | Capsule | 99.1 | 5.4e-269 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | prediction |
JJEBMEPF_03242 | VFG038161 | Capsule | 91.9 | 4.5e-303 | 61 | 613 | 0.9021 | 1 | Immune modulation | LTA synthase family protein | prediction |
JJEBMEPF_03243 | VFG038152 | Capsule | 98.8 | 7.7e-196 | 1 | 339 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | prediction |
JJEBMEPF_03244 | VFG038141 | Capsule | 98.4 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | prediction |
JJEBMEPF_03245 | VFG038129 | Capsule | 99 | 2e-246 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | prediction |
JJEBMEPF_03246 | VFG038116 | Capsule | 99 | 4.5e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | prediction |
JJEBMEPF_03247 | VFG037934 | Capsule | 85.6 | 1.2e-95 | 1 | 201 | 0.9853 | 0.9757 | Immune modulation | sugar transferase | prediction |
JJEBMEPF_03255 | VFG037998 | Capsule | 98.4 | 1.4e-211 | 1 | 371 | 1.0 | 1 | Immune modulation | DegT/DnrJ/EryC1/StrS family aminotransferase | prediction |
JJEBMEPF_03257 | VFG037938 | Capsule | 95.5 | 6.9e-161 | 1 | 290 | 1.0 | 1 | Immune modulation | glucose-1-phosphate thymidylyltransferase RfbA | prediction |
JJEBMEPF_03258 | VFG037923 | Capsule | 98.6 | 3.5e-207 | 1 | 352 | 1.0 | 1 | Immune modulation | dTDP-glucose 4,6-dehydratase | prediction |
JJEBMEPF_03259 | VFG037908 | Capsule | 94.4 | 5.4e-231 | 1 | 425 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | prediction |
JJEBMEPF_03260 | VFG037893 | Capsule | 80.3 | 3.7e-175 | 1 | 378 | 1.0 | 0.9947 | Immune modulation | polysaccharide biosynthesis/export family protein | prediction |
JJEBMEPF_03261 | VFG037878 | Capsule | 97.9 | 6.5e-80 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | prediction |
JJEBMEPF_03446 | VFG050906 | T6SS | 93.9 | 0 | 1 | 1103 | 0.9955 | 1.0018 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
JJEBMEPF_03490 | VFG037822 | LPS | 100 | 4.4e-171 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | prediction |
JJEBMEPF_03645 | VFG050321 | TFP | 99.7 | 3.4e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | prediction |
JJEBMEPF_03646 | VFG050328 | TFP | 99.5 | 1e-116 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | prediction |
JJEBMEPF_03647 | VFG050353 | TFP | 100 | 4.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | prediction |
JJEBMEPF_03648 | VFG050367 | TFP | 98.9 | 3.6e-96 | 1 | 175 | 1.0 | 0.9943 | Adherence | pilus assembly protein PilP | prediction |
JJEBMEPF_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | prediction |
JJEBMEPF_03659 | VFG050440 | TFP | 100 | 1.2e-73 | 1 | 144 | 1.0 | 1 | Adherence | pilin | prediction |
JJEBMEPF_03669 | VFG050511 | TFP | 100 | 1.7e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
JJEBMEPF_03670 | VFG050535 | TFP | 100 | 8.9e-98 | 1 | 184 | 1.0 | 1 | Adherence | type IV pilus modification protein PilV | prediction |
JJEBMEPF_03671 | VFG050537 | TFP | 100 | 2.3e-184 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | prediction |
JJEBMEPF_03672 | VFG050551 | TFP | 100 | 3.2e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
JJEBMEPF_03673 | VFG050570 | TFP | 100 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | prediction |
JJEBMEPF_03674 | VFG050581 | TFP | 100 | 1.4e-83 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | prediction |
JJEBMEPF_03675 | VFG050595 | TFP | 100 | 2.6e-73 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | prediction |
CKHOCAAF_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | prediction |
CKHOCAAF_00130 | VFG050610 | TFP | 100 | 2.8e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
CKHOCAAF_00131 | VFG038176 | OmpA | 100 | 1.7e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | prediction |
CKHOCAAF_00160 | VFG050625 | TFP | 100 | 8.7e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | prediction |
CKHOCAAF_00161 | VFG050640 | TFP | 100 | 1.9e-64 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | prediction |
CKHOCAAF_00162 | VFG050655 | TFP | 100 | 1.3e-101 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | prediction |
CKHOCAAF_00163 | VFG050680 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 0.983 | Adherence | methyl-accepting chemotaxis protein | prediction |
CKHOCAAF_00283 | VFG037636 | Bap | 71.4 | 0 | 41 | 5017 | 0.8776 | 0.9109 | Biofilm | biofilm-associated protein | prediction |
CKHOCAAF_00316 | VFG045692 | Hsp60 | 72.6 | 2.2e-221 | 1 | 543 | 0.9982 | 0.9855 | Adherence | Hsp60, 60K heat shock protein HtpB | prediction |
CKHOCAAF_00371 | VFG037747 | LPS | 100 | 2.6e-188 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | prediction |
CKHOCAAF_00492 | VFG044201 | Achromobactin biosynthesis and transport | 71.8 | 1.4e-187 | 13 | 455 | 0.9694 | 0.9672 | Nutritional/Metabolic factor | diaminobutyrate--2-oxoglutarate transaminase | prediction |
CKHOCAAF_00564 | VFG037456 | Acinetobactin | 100 | 1.2e-165 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | prediction |
CKHOCAAF_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | prediction |
CKHOCAAF_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | prediction |
CKHOCAAF_00569 | VFG037417 | Acinetobactin | 100 | 5.5e-164 | 1 | 313 | 1.0 | 0.9572 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | prediction |
CKHOCAAF_00570 | VFG037400 | Acinetobactin | 100 | 2e-169 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | prediction |
CKHOCAAF_00571 | VFG037386 | Acinetobactin | 100 | 2.1e-145 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | prediction |
CKHOCAAF_00572 | VFG037372 | Acinetobactin | 100 | 2.9e-184 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | prediction |
CKHOCAAF_00573 | VFG037355 | Acinetobactin | 100 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | prediction |
CKHOCAAF_00574 | VFG037344 | Acinetobactin | 100 | 7.2e-263 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | prediction |
CKHOCAAF_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | prediction |
CKHOCAAF_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | prediction |
CKHOCAAF_00577 | VFG037302 | Acinetobactin | 100 | 2.6e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | prediction |
CKHOCAAF_00578 | VFG037288 | Acinetobactin | 100 | 2.2e-231 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | prediction |
CKHOCAAF_00580 | VFG037274 | Acinetobactin | 100 | 1.1e-286 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
CKHOCAAF_00581 | VFG037260 | Acinetobactin | 100 | 3.5e-288 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
CKHOCAAF_00582 | VFG037246 | Acinetobactin | 100 | 2.2e-144 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | prediction |
CKHOCAAF_00583 | VFG037232 | Acinetobactin | 100 | 2e-140 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | prediction |
CKHOCAAF_00584 | VFG037218 | Acinetobactin | 100 | 1.9e-222 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | prediction |
CKHOCAAF_00729 | VFG037735 | AdeFGH efflux pump | 100 | 3.6e-263 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | prediction |
CKHOCAAF_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | prediction |
CKHOCAAF_00731 | VFG037705 | AdeFGH efflux pump | 100 | 2.7e-219 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | prediction |
CKHOCAAF_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | prediction |
CKHOCAAF_00779 | VFG050874 | T2SS | 100 | 1.5e-216 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | prediction |
CKHOCAAF_00780 | VFG050889 | T2SS | 100 | 2.5e-80 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | prediction |
CKHOCAAF_00819 | VFG037560 | Csu fimbriae | 100 | 1.4e-95 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | prediction |
CKHOCAAF_00820 | VFG037570 | Csu fimbriae | 100 | 6.1e-99 | 1 | 182 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuA | prediction |
CKHOCAAF_00821 | VFG037586 | Csu fimbriae | 100 | 1.9e-94 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | prediction |
CKHOCAAF_00822 | VFG037599 | Csu fimbriae | 100 | 4.6e-154 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | prediction |
CKHOCAAF_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | prediction |
CKHOCAAF_00824 | VFG037633 | Csu fimbriae | 100 | 3.6e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | prediction |
CKHOCAAF_00851 | VFG045727 | CsrA | 76.3 | 8.4e-19 | 1 | 59 | 0.7024 | 0.9219 | Regulation | carbon storage regulator CsrA | prediction |
CKHOCAAF_00966 | VFG037647 | PNAG | 100 | 0 | 1 | 812 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA | prediction |
CKHOCAAF_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | prediction |
CKHOCAAF_00968 | VFG037678 | PNAG | 100 | 8.4e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | prediction |
CKHOCAAF_00969 | VFG037692 | PNAG | 100 | 7.3e-85 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | prediction |
CKHOCAAF_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | prediction |
CKHOCAAF_01211 | VFG037837 | LPS | 100 | 1.5e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | prediction |
CKHOCAAF_01213 | VFG037792 | LPS | 100 | 6.4e-150 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | prediction |
CKHOCAAF_01363 | VFG037041 | KatA | 85.1 | 1.8e-265 | 5 | 506 | 0.9921 | 0.996 | Stress survival | catalase | prediction |
CKHOCAAF_01605 | VFG037807 | LPS | 100 | 2.9e-223 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | prediction |
CKHOCAAF_01745 | VFG050857 | T2SS | 100 | 6.2e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | prediction |
CKHOCAAF_01746 | VFG050844 | T2SS | 100 | 8e-128 | 1 | 233 | 1.0 | 1 | Effector delivery system | general secretion pathway protein J | prediction |
CKHOCAAF_01747 | VFG050832 | T2SS | 100 | 8.4e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | prediction |
CKHOCAAF_01748 | VFG050817 | T2SS | 100 | 3.3e-100 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | prediction |
CKHOCAAF_02046 | VFG050972 | T6SS | 100 | 9.4e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | prediction |
CKHOCAAF_02048 | VFG050946 | T6SS | 100 | 4.6e-151 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | prediction |
CKHOCAAF_02049 | VFG051028 | T6SS | 100 | 1.2e-260 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | prediction |
CKHOCAAF_02050 | VFG051084 | T6SS | 100 | 4.1e-211 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | prediction |
CKHOCAAF_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | prediction |
CKHOCAAF_02055 | VFG050962 | T6SS | 99.9 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | prediction |
CKHOCAAF_02057 | VFG051014 | T6SS | 100 | 1.7e-192 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | prediction |
CKHOCAAF_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | prediction |
CKHOCAAF_02059 | VFG050986 | T6SS | 100 | 3e-86 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | prediction |
CKHOCAAF_02060 | VFG051042 | T6SS | 100 | 6.4e-95 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | prediction |
CKHOCAAF_02061 | VFG051070 | T6SS | 100 | 1.8e-286 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | prediction |
CKHOCAAF_02062 | VFG051056 | T6SS | 100 | 8.4e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | prediction |
CKHOCAAF_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
CKHOCAAF_02130 | VFG050931 | T6SS | 100 | 0 | 1 | 1064 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
CKHOCAAF_02270 | VFG050302 | Ata | 100 | 0 | 1 | 2265 | 1.0 | 1 | Adherence | trimeric autotransporter adhesin Ata | prediction |
CKHOCAAF_02384 | VFG037544 | HemO cluster | 100 | 1.6e-47 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | prediction |
CKHOCAAF_02385 | VFG037467 | HemO cluster | 100 | 4.8e-170 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | prediction |
CKHOCAAF_02426 | VFG050395 | TFP | 100 | 2.9e-201 | 1 | 355 | 1.0 | 1 | Adherence | type IV pilus twitching motility protein PilT | prediction |
CKHOCAAF_02427 | VFG050400 | TFP | 100 | 6e-210 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | prediction |
CKHOCAAF_02460 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
CKHOCAAF_02577 | VFG038234 | BfmRS | 100 | 7.29999999998336e-313 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | prediction |
CKHOCAAF_02578 | VFG038219 | BfmRS | 100 | 2.5e-132 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | prediction |
CKHOCAAF_02679 | VFG050757 | T2SS | 100 | 4.6e-282 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | prediction |
CKHOCAAF_02789 | VFG050418 | TFP | 100 | 1.2e-140 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | prediction |
CKHOCAAF_02857 | VFG037762 | LPS | 98.4 | 5.4e-188 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | prediction |
CKHOCAAF_02858 | VFG037783 | LPS | 99.5 | 7e-211 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | prediction |
CKHOCAAF_02862 | VFG050428 | TFP | 99.3 | 1.2e-239 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
CKHOCAAF_02918 | VFG050806 | T2SS | 100 | 8.5e-107 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | prediction |
CKHOCAAF_02919 | VFG050787 | T2SS | 100 | 6.7e-215 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | prediction |
CKHOCAAF_02958 | VFG050455 | TFP | 99.8 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | prediction |
CKHOCAAF_02959 | VFG050470 | TFP | 99.8 | 6e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | prediction |
CKHOCAAF_02960 | VFG050490 | TFP | 99.7 | 5.5e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | prediction |
CKHOCAAF_03007 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
CKHOCAAF_03015 | VFG050748 | T2SS | 100 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | prediction |
CKHOCAAF_03016 | VFG050725 | T2SS | 100 | 7.1e-155 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | prediction |
CKHOCAAF_03017 | VFG050712 | T2SS | 100 | 2.2e-144 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | prediction |
CKHOCAAF_03047 | VFG038247 | PbpG | 100 | 2.4e-181 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | prediction |
CKHOCAAF_03049 | VFG050685 | TFP | 99.6 | 5.9e-288 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | prediction |
CKHOCAAF_03050 | VFG050699 | TFP | 99.2 | 4.7e-268 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | prediction |
CKHOCAAF_03144 | VFG050496 | TFP | 99.7 | 3.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | prediction |
CKHOCAAF_03196 | VFG038203 | Quorom sensing | 100 | 4.5e-134 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | prediction |
CKHOCAAF_03198 | VFG038191 | Quorom sensing | 99.5 | 1.1e-103 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | prediction |
CKHOCAAF_03225 | VFG050932 | T6SS | 99.2 | 0 | 1 | 846 | 0.9965 | 0.9029 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
CKHOCAAF_03241 | VFG038167 | Capsule | 99.1 | 5.4e-269 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | prediction |
CKHOCAAF_03242 | VFG038161 | Capsule | 91.9 | 4.5e-303 | 61 | 613 | 0.9021 | 1 | Immune modulation | LTA synthase family protein | prediction |
CKHOCAAF_03243 | VFG038152 | Capsule | 98.8 | 7.7e-196 | 1 | 339 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | prediction |
CKHOCAAF_03244 | VFG038141 | Capsule | 98.4 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | prediction |
CKHOCAAF_03245 | VFG038129 | Capsule | 99 | 2e-246 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | prediction |
CKHOCAAF_03246 | VFG038116 | Capsule | 99 | 4.5e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | prediction |
CKHOCAAF_03247 | VFG037934 | Capsule | 85.6 | 1.2e-95 | 1 | 201 | 0.9853 | 0.9757 | Immune modulation | sugar transferase | prediction |
CKHOCAAF_03255 | VFG037998 | Capsule | 98.4 | 1.4e-211 | 1 | 371 | 1.0 | 1 | Immune modulation | DegT/DnrJ/EryC1/StrS family aminotransferase | prediction |
CKHOCAAF_03257 | VFG037938 | Capsule | 95.5 | 6.9e-161 | 1 | 290 | 1.0 | 1 | Immune modulation | glucose-1-phosphate thymidylyltransferase RfbA | prediction |
CKHOCAAF_03258 | VFG037923 | Capsule | 98.6 | 3.5e-207 | 1 | 352 | 1.0 | 1 | Immune modulation | dTDP-glucose 4,6-dehydratase | prediction |
CKHOCAAF_03259 | VFG037908 | Capsule | 94.4 | 5.4e-231 | 1 | 425 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | prediction |
CKHOCAAF_03260 | VFG037893 | Capsule | 80.3 | 3.7e-175 | 1 | 378 | 1.0 | 0.9947 | Immune modulation | polysaccharide biosynthesis/export family protein | prediction |
CKHOCAAF_03261 | VFG037878 | Capsule | 97.9 | 6.5e-80 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | prediction |
CKHOCAAF_03446 | VFG050906 | T6SS | 93.9 | 0 | 1 | 1103 | 0.9955 | 1.0018 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
CKHOCAAF_03490 | VFG037822 | LPS | 100 | 4.4e-171 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | prediction |
CKHOCAAF_03645 | VFG050321 | TFP | 99.7 | 3.4e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | prediction |
CKHOCAAF_03646 | VFG050328 | TFP | 99.5 | 1e-116 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | prediction |
CKHOCAAF_03647 | VFG050353 | TFP | 100 | 4.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | prediction |
CKHOCAAF_03648 | VFG050367 | TFP | 98.9 | 3.6e-96 | 1 | 175 | 1.0 | 0.9943 | Adherence | pilus assembly protein PilP | prediction |
CKHOCAAF_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | prediction |
CKHOCAAF_03659 | VFG050440 | TFP | 100 | 1.2e-73 | 1 | 144 | 1.0 | 1 | Adherence | pilin | prediction |
CKHOCAAF_03669 | VFG050511 | TFP | 100 | 1.7e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
CKHOCAAF_03670 | VFG050535 | TFP | 100 | 8.9e-98 | 1 | 184 | 1.0 | 1 | Adherence | type IV pilus modification protein PilV | prediction |
CKHOCAAF_03671 | VFG050537 | TFP | 100 | 2.3e-184 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | prediction |
CKHOCAAF_03672 | VFG050551 | TFP | 100 | 3.2e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
CKHOCAAF_03673 | VFG050570 | TFP | 100 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | prediction |
CKHOCAAF_03674 | VFG050581 | TFP | 100 | 1.4e-83 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | prediction |
CKHOCAAF_03675 | VFG050595 | TFP | 100 | 2.6e-73 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | prediction |
IPHMMGCP_00029 | VFG037203 | Phospholipase D | 100 | 0 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | prediction |
IPHMMGCP_00130 | VFG050610 | TFP | 100 | 2.8e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
IPHMMGCP_00131 | VFG038176 | OmpA | 100 | 1.7e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | prediction |
IPHMMGCP_00160 | VFG050625 | TFP | 100 | 8.7e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | prediction |
IPHMMGCP_00161 | VFG050640 | TFP | 100 | 1.9e-64 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | prediction |
IPHMMGCP_00162 | VFG050655 | TFP | 100 | 1.3e-101 | 1 | 178 | 1.0 | 1 | Adherence | chemotaxis protein CheW | prediction |
IPHMMGCP_00163 | VFG050680 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 0.983 | Adherence | methyl-accepting chemotaxis protein | prediction |
IPHMMGCP_00283 | VFG037636 | Bap | 71.4 | 0 | 41 | 5017 | 0.8776 | 0.9109 | Biofilm | biofilm-associated protein | prediction |
IPHMMGCP_00316 | VFG045692 | Hsp60 | 72.6 | 2.2e-221 | 1 | 543 | 0.9982 | 0.9855 | Adherence | Hsp60, 60K heat shock protein HtpB | prediction |
IPHMMGCP_00371 | VFG037747 | LPS | 100 | 2.6e-188 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | prediction |
IPHMMGCP_00492 | VFG044201 | Achromobactin biosynthesis and transport | 71.8 | 1.4e-187 | 13 | 455 | 0.9694 | 0.9672 | Nutritional/Metabolic factor | diaminobutyrate--2-oxoglutarate transaminase | prediction |
IPHMMGCP_00564 | VFG037456 | Acinetobactin | 100 | 1.2e-165 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | prediction |
IPHMMGCP_00565 | VFG037442 | Acinetobactin | 100 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | prediction |
IPHMMGCP_00566 | VFG037428 | Acinetobactin | 100 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | prediction |
IPHMMGCP_00569 | VFG037417 | Acinetobactin | 100 | 5.5e-164 | 1 | 313 | 1.0 | 0.9572 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | prediction |
IPHMMGCP_00570 | VFG037400 | Acinetobactin | 100 | 2e-169 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | prediction |
IPHMMGCP_00571 | VFG037386 | Acinetobactin | 100 | 2.1e-145 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | prediction |
IPHMMGCP_00572 | VFG037372 | Acinetobactin | 100 | 2.9e-184 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | prediction |
IPHMMGCP_00573 | VFG037355 | Acinetobactin | 100 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | prediction |
IPHMMGCP_00574 | VFG037344 | Acinetobactin | 100 | 7.2e-263 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | prediction |
IPHMMGCP_00575 | VFG037330 | Acinetobactin | 100 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | prediction |
IPHMMGCP_00576 | VFG037316 | Acinetobactin | 100 | 0 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | prediction |
IPHMMGCP_00577 | VFG037302 | Acinetobactin | 100 | 2.6e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | prediction |
IPHMMGCP_00578 | VFG037288 | Acinetobactin | 100 | 2.2e-231 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | prediction |
IPHMMGCP_00580 | VFG037274 | Acinetobactin | 100 | 1.1e-286 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
IPHMMGCP_00581 | VFG037260 | Acinetobactin | 100 | 3.5e-288 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
IPHMMGCP_00582 | VFG037246 | Acinetobactin | 100 | 2.2e-144 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | prediction |
IPHMMGCP_00583 | VFG037232 | Acinetobactin | 100 | 2e-140 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | prediction |
IPHMMGCP_00584 | VFG037218 | Acinetobactin | 100 | 1.9e-222 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | prediction |
IPHMMGCP_00729 | VFG037735 | AdeFGH efflux pump | 100 | 3.6e-263 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | prediction |
IPHMMGCP_00730 | VFG037720 | AdeFGH efflux pump | 100 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | prediction |
IPHMMGCP_00731 | VFG037705 | AdeFGH efflux pump | 100 | 2.7e-219 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | prediction |
IPHMMGCP_00746 | VFG050772 | T2SS | 100 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | prediction |
IPHMMGCP_00779 | VFG050874 | T2SS | 100 | 1.5e-216 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | prediction |
IPHMMGCP_00780 | VFG050889 | T2SS | 100 | 2.5e-80 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | prediction |
IPHMMGCP_00819 | VFG037560 | Csu fimbriae | 100 | 1.4e-95 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | prediction |
IPHMMGCP_00820 | VFG037570 | Csu fimbriae | 100 | 6.1e-99 | 1 | 182 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuA | prediction |
IPHMMGCP_00821 | VFG037586 | Csu fimbriae | 100 | 1.9e-94 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | prediction |
IPHMMGCP_00822 | VFG037599 | Csu fimbriae | 100 | 4.6e-154 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | prediction |
IPHMMGCP_00823 | VFG037612 | Csu fimbriae | 100 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | prediction |
IPHMMGCP_00824 | VFG037633 | Csu fimbriae | 100 | 3.6e-193 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | prediction |
IPHMMGCP_00851 | VFG045727 | CsrA | 76.3 | 8.4e-19 | 1 | 59 | 0.7024 | 0.9219 | Regulation | carbon storage regulator CsrA | prediction |
IPHMMGCP_00966 | VFG037647 | PNAG | 100 | 0 | 1 | 812 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA | prediction |
IPHMMGCP_00967 | VFG037664 | PNAG | 100 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | prediction |
IPHMMGCP_00968 | VFG037678 | PNAG | 100 | 8.4e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | prediction |
IPHMMGCP_00969 | VFG037692 | PNAG | 100 | 7.3e-85 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | prediction |
IPHMMGCP_01081 | VFG037177 | Phospholipase C | 100 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | prediction |
IPHMMGCP_01211 | VFG037837 | LPS | 100 | 1.5e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | prediction |
IPHMMGCP_01213 | VFG037792 | LPS | 100 | 6.4e-150 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | prediction |
IPHMMGCP_01363 | VFG037041 | KatA | 85.1 | 1.8e-265 | 5 | 506 | 0.9921 | 0.996 | Stress survival | catalase | prediction |
IPHMMGCP_01605 | VFG037807 | LPS | 100 | 2.9e-223 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | prediction |
IPHMMGCP_01745 | VFG050857 | T2SS | 100 | 6.2e-179 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | prediction |
IPHMMGCP_01746 | VFG050844 | T2SS | 100 | 8e-128 | 1 | 233 | 1.0 | 1 | Effector delivery system | general secretion pathway protein J | prediction |
IPHMMGCP_01747 | VFG050832 | T2SS | 100 | 8.4e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | prediction |
IPHMMGCP_01748 | VFG050817 | T2SS | 100 | 3.3e-100 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | prediction |
IPHMMGCP_02046 | VFG050972 | T6SS | 100 | 9.4e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | prediction |
IPHMMGCP_02048 | VFG050946 | T6SS | 100 | 4.6e-151 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | prediction |
IPHMMGCP_02049 | VFG051028 | T6SS | 100 | 1.2e-260 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | prediction |
IPHMMGCP_02050 | VFG051084 | T6SS | 100 | 4.1e-211 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | prediction |
IPHMMGCP_02051 | VFG051098 | T6SS | 100 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | prediction |
IPHMMGCP_02055 | VFG050962 | T6SS | 99.9 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | prediction |
IPHMMGCP_02057 | VFG051014 | T6SS | 100 | 1.7e-192 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | prediction |
IPHMMGCP_02058 | VFG051000 | T6SS | 100 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | prediction |
IPHMMGCP_02059 | VFG050986 | T6SS | 100 | 3e-86 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | prediction |
IPHMMGCP_02060 | VFG051042 | T6SS | 100 | 6.4e-95 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | prediction |
IPHMMGCP_02061 | VFG051070 | T6SS | 100 | 1.8e-286 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | prediction |
IPHMMGCP_02062 | VFG051056 | T6SS | 100 | 8.4e-87 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath small subunit | prediction |
IPHMMGCP_02094 | VFG050911 | T6SS | 100 | 0 | 1 | 1058 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
IPHMMGCP_02130 | VFG050931 | T6SS | 100 | 0 | 1 | 1064 | 1.0 | 1 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
IPHMMGCP_02270 | VFG050302 | Ata | 100 | 0 | 1 | 2265 | 1.0 | 1 | Adherence | trimeric autotransporter adhesin Ata | prediction |
IPHMMGCP_02384 | VFG037544 | HemO cluster | 100 | 1.6e-47 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | prediction |
IPHMMGCP_02385 | VFG037467 | HemO cluster | 100 | 4.8e-170 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | prediction |
IPHMMGCP_02426 | VFG050395 | TFP | 100 | 2.9e-201 | 1 | 355 | 1.0 | 1 | Adherence | type IV pilus twitching motility protein PilT | prediction |
IPHMMGCP_02427 | VFG050400 | TFP | 100 | 6e-210 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | prediction |
IPHMMGCP_02460 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
IPHMMGCP_02577 | VFG038234 | BfmRS | 100 | 7.29999999998336e-313 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | prediction |
IPHMMGCP_02578 | VFG038219 | BfmRS | 100 | 2.5e-132 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | prediction |
IPHMMGCP_02679 | VFG050757 | T2SS | 100 | 4.6e-282 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | prediction |
IPHMMGCP_02789 | VFG050418 | TFP | 100 | 1.2e-140 | 1 | 258 | 1.0 | 0.9699 | Adherence | type IV pilus biogenesis/stability protein PilW | prediction |
IPHMMGCP_02857 | VFG037762 | LPS | 98.4 | 5.4e-188 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | prediction |
IPHMMGCP_02858 | VFG037783 | LPS | 99.5 | 7e-211 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | prediction |
IPHMMGCP_02862 | VFG050428 | TFP | 99.3 | 1.2e-239 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
IPHMMGCP_02918 | VFG050806 | T2SS | 100 | 8.5e-107 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | prediction |
IPHMMGCP_02919 | VFG050787 | T2SS | 100 | 6.7e-215 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | prediction |
IPHMMGCP_02958 | VFG050455 | TFP | 99.8 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | prediction |
IPHMMGCP_02959 | VFG050470 | TFP | 99.8 | 6e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | prediction |
IPHMMGCP_02960 | VFG050490 | TFP | 99.7 | 5.5e-163 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | prediction |
IPHMMGCP_03007 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
IPHMMGCP_03015 | VFG050748 | T2SS | 100 | 0 | 1 | 758 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | prediction |
IPHMMGCP_03016 | VFG050725 | T2SS | 100 | 7.1e-155 | 1 | 278 | 1.0 | 1 | Effector delivery system | general secretion pathway protein C | prediction |
IPHMMGCP_03017 | VFG050712 | T2SS | 100 | 2.2e-144 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | prediction |
IPHMMGCP_03047 | VFG038247 | PbpG | 100 | 2.4e-181 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | prediction |
IPHMMGCP_03049 | VFG050685 | TFP | 99.6 | 5.9e-288 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | prediction |
IPHMMGCP_03050 | VFG050699 | TFP | 99.2 | 4.7e-268 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | prediction |
IPHMMGCP_03144 | VFG050496 | TFP | 99.7 | 3.3e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | prediction |
IPHMMGCP_03196 | VFG038203 | Quorom sensing | 100 | 4.5e-134 | 1 | 238 | 1.0 | 1 | Biofilm | DNA-binding HTH domain-containing protein | prediction |
IPHMMGCP_03198 | VFG038191 | Quorom sensing | 99.5 | 1.1e-103 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | prediction |
IPHMMGCP_03225 | VFG050932 | T6SS | 99.2 | 0 | 1 | 846 | 0.9965 | 0.9029 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
IPHMMGCP_03241 | VFG038167 | Capsule | 99.1 | 5.4e-269 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | prediction |
IPHMMGCP_03242 | VFG038161 | Capsule | 91.9 | 4.5e-303 | 61 | 613 | 0.9021 | 1 | Immune modulation | LTA synthase family protein | prediction |
IPHMMGCP_03243 | VFG038152 | Capsule | 98.8 | 7.7e-196 | 1 | 339 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | prediction |
IPHMMGCP_03244 | VFG038141 | Capsule | 98.4 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | prediction |
IPHMMGCP_03245 | VFG038129 | Capsule | 99 | 2e-246 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | prediction |
IPHMMGCP_03246 | VFG038116 | Capsule | 99 | 4.5e-160 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | prediction |
IPHMMGCP_03247 | VFG037934 | Capsule | 85.6 | 1.2e-95 | 1 | 201 | 0.9853 | 0.9757 | Immune modulation | sugar transferase | prediction |
IPHMMGCP_03255 | VFG037998 | Capsule | 98.4 | 1.4e-211 | 1 | 371 | 1.0 | 1 | Immune modulation | DegT/DnrJ/EryC1/StrS family aminotransferase | prediction |
IPHMMGCP_03257 | VFG037938 | Capsule | 95.5 | 6.9e-161 | 1 | 290 | 1.0 | 1 | Immune modulation | glucose-1-phosphate thymidylyltransferase RfbA | prediction |
IPHMMGCP_03258 | VFG037923 | Capsule | 98.6 | 3.5e-207 | 1 | 352 | 1.0 | 1 | Immune modulation | dTDP-glucose 4,6-dehydratase | prediction |
IPHMMGCP_03259 | VFG037908 | Capsule | 94.4 | 5.4e-231 | 1 | 425 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | prediction |
IPHMMGCP_03260 | VFG037893 | Capsule | 80.3 | 3.7e-175 | 1 | 378 | 1.0 | 0.9947 | Immune modulation | polysaccharide biosynthesis/export family protein | prediction |
IPHMMGCP_03261 | VFG037878 | Capsule | 97.9 | 6.5e-80 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | prediction |
IPHMMGCP_03446 | VFG050906 | T6SS | 93.9 | 0 | 1 | 1103 | 0.9955 | 1.0018 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
IPHMMGCP_03490 | VFG037822 | LPS | 100 | 4.4e-171 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | prediction |
IPHMMGCP_03645 | VFG050321 | TFP | 99.7 | 3.4e-194 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | prediction |
IPHMMGCP_03646 | VFG050328 | TFP | 99.5 | 1e-116 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | prediction |
IPHMMGCP_03647 | VFG050353 | TFP | 100 | 4.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | prediction |
IPHMMGCP_03648 | VFG050367 | TFP | 98.9 | 3.6e-96 | 1 | 175 | 1.0 | 0.9943 | Adherence | pilus assembly protein PilP | prediction |
IPHMMGCP_03649 | VFG050372 | TFP | 99.7 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | prediction |
IPHMMGCP_03659 | VFG050440 | TFP | 100 | 1.2e-73 | 1 | 144 | 1.0 | 1 | Adherence | pilin | prediction |
IPHMMGCP_03669 | VFG050511 | TFP | 100 | 1.7e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
IPHMMGCP_03670 | VFG050535 | TFP | 100 | 8.9e-98 | 1 | 184 | 1.0 | 1 | Adherence | type IV pilus modification protein PilV | prediction |
IPHMMGCP_03671 | VFG050537 | TFP | 100 | 2.3e-184 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | prediction |
IPHMMGCP_03672 | VFG050551 | TFP | 100 | 3.2e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
IPHMMGCP_03673 | VFG050570 | TFP | 100 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | prediction |
IPHMMGCP_03674 | VFG050581 | TFP | 100 | 1.4e-83 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | prediction |
IPHMMGCP_03675 | VFG050595 | TFP | 100 | 2.6e-73 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | prediction |
Gene Name | compound | identity | evalue | qstart | qend | query_coverage | subject_coverage | group |
---|---|---|---|---|---|---|---|---|
JJEBMEPF_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3.5e-270 | 1 | 484 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-221 | 1 | 416 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 71 | 9.2e-137 | 3 | 331 | 0.9910 | 0.9403 | experiment |
JJEBMEPF_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.6 | 2.4e-263 | 1 | 482 | 1.0000 | 0.9979 | experiment |
JJEBMEPF_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.8 | 0 | 1 | 1059 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 5.6e-221 | 1 | 406 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 9.6e-198 | 7 | 343 | 0.9825 | 1.0000 | experiment |
JJEBMEPF_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 4.1e-54 | 1 | 109 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 99 | 2.5e-263 | 1 | 492 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3e-128 | 1 | 217 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.3 | 1.2e-176 | 28 | 331 | 0.9184 | 1.0000 | experiment |
JJEBMEPF_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 7.4e-218 | 1 | 396 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | experiment |
JJEBMEPF_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-262 | 1 | 465 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_02700 | Cobalt (Co), Nickel (Ni) | 98.3 | 3.1e-235 | 1 | 416 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.6 | 8e-245 | 1 | 448 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 99.8 | 2.2e-247 | 1 | 448 | 1.0000 | 1.0000 | experiment |
JJEBMEPF_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.6 | 3.3e-139 | 91 | 328 | 0.7256 | 1.0000 | experiment |
CKHOCAAF_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3.5e-270 | 1 | 484 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-221 | 1 | 416 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 71 | 9.2e-137 | 3 | 331 | 0.9910 | 0.9403 | experiment |
CKHOCAAF_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.6 | 2.4e-263 | 1 | 482 | 1.0000 | 0.9979 | experiment |
CKHOCAAF_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.8 | 0 | 1 | 1059 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 5.6e-221 | 1 | 406 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 9.6e-198 | 7 | 343 | 0.9825 | 1.0000 | experiment |
CKHOCAAF_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 4.1e-54 | 1 | 109 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 99 | 2.5e-263 | 1 | 492 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3e-128 | 1 | 217 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.3 | 1.2e-176 | 28 | 331 | 0.9184 | 1.0000 | experiment |
CKHOCAAF_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 7.4e-218 | 1 | 396 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | experiment |
CKHOCAAF_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-262 | 1 | 465 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_02700 | Cobalt (Co), Nickel (Ni) | 98.3 | 3.1e-235 | 1 | 416 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.6 | 8e-245 | 1 | 448 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 99.8 | 2.2e-247 | 1 | 448 | 1.0000 | 1.0000 | experiment |
CKHOCAAF_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.6 | 3.3e-139 | 91 | 328 | 0.7256 | 1.0000 | experiment |
IPHMMGCP_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3.5e-270 | 1 | 484 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-221 | 1 | 416 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 71 | 9.2e-137 | 3 | 331 | 0.9910 | 0.9403 | experiment |
IPHMMGCP_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.6 | 2.4e-263 | 1 | 482 | 1.0000 | 0.9979 | experiment |
IPHMMGCP_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.8 | 0 | 1 | 1059 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 5.6e-221 | 1 | 406 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 9.6e-198 | 7 | 343 | 0.9825 | 1.0000 | experiment |
IPHMMGCP_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 4.1e-54 | 1 | 109 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 99 | 2.5e-263 | 1 | 492 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3e-128 | 1 | 217 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.3 | 1.2e-176 | 28 | 331 | 0.9184 | 1.0000 | experiment |
IPHMMGCP_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 7.4e-218 | 1 | 396 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | experiment |
IPHMMGCP_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-262 | 1 | 465 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_02700 | Cobalt (Co), Nickel (Ni) | 98.3 | 3.1e-235 | 1 | 416 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.6 | 8e-245 | 1 | 448 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 99.8 | 2.2e-247 | 1 | 448 | 1.0000 | 1.0000 | experiment |
IPHMMGCP_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.6 | 3.3e-139 | 91 | 328 | 0.7256 | 1.0000 | experiment |
JJEBMEPF_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 8e-268 | 1 | 484 | 1.0000 | 0.9979 | prediction |
JJEBMEPF_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 0 | 1 | 1058 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 3.5e-219 | 1 | 416 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 73.3 | 3.1e-138 | 3 | 330 | 0.9850 | 0.9400 | prediction |
JJEBMEPF_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.7e-262 | 1 | 482 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 0 | 1 | 1059 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.3e-218 | 1 | 406 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 3.3e-199 | 1 | 343 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 9.5e-52 | 1 | 109 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_00896 | Copper (Cu), Gold (Au) | 70.5 | 0 | 1 | 821 | 1.0024 | 0.9976 | prediction |
JJEBMEPF_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 100 | 3.9e-262 | 1 | 492 | 1.0000 | 0.9801 | prediction |
JJEBMEPF_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 6.8e-126 | 1 | 217 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.6e-190 | 1 | 331 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-215 | 1 | 396 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 1 | 1036 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.8 | 5.9e-260 | 1 | 465 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_01549 | Chromium (Cr) | 93.7 | 1.3e-240 | 1 | 446 | 0.9933 | 0.9955 | prediction |
JJEBMEPF_01864 | Arsenic (As) | 100 | 1.2e-185 | 1 | 344 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_02035 | Methyl Viologen [class: Paraquat] | 95.3 | 3.1e-77 | 1 | 149 | 0.9933 | 0.9933 | prediction |
JJEBMEPF_02700 | Cobalt (Co), Nickel (Ni) | 100 | 2.4e-236 | 1 | 416 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.8 | 4.8e-243 | 1 | 448 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 100 | 2.3e-245 | 1 | 448 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_03306 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 2.4e-191 | 1 | 334 | 1.0000 | 1.0000 | prediction |
JJEBMEPF_03307 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 84.5 | 8.2e-163 | 1 | 335 | 1.0030 | 1.0000 | prediction |
JJEBMEPF_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-192 | 1 | 328 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 8e-268 | 1 | 484 | 1.0000 | 0.9979 | prediction |
CKHOCAAF_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 0 | 1 | 1058 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 3.5e-219 | 1 | 416 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 73.3 | 3.1e-138 | 3 | 330 | 0.9850 | 0.9400 | prediction |
CKHOCAAF_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.7e-262 | 1 | 482 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 0 | 1 | 1059 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.3e-218 | 1 | 406 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 3.3e-199 | 1 | 343 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 9.5e-52 | 1 | 109 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_00896 | Copper (Cu), Gold (Au) | 70.5 | 0 | 1 | 821 | 1.0024 | 0.9976 | prediction |
CKHOCAAF_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 100 | 3.9e-262 | 1 | 492 | 1.0000 | 0.9801 | prediction |
CKHOCAAF_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 6.8e-126 | 1 | 217 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.6e-190 | 1 | 331 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-215 | 1 | 396 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 1 | 1036 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.8 | 5.9e-260 | 1 | 465 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_01549 | Chromium (Cr) | 93.7 | 1.3e-240 | 1 | 446 | 0.9933 | 0.9955 | prediction |
CKHOCAAF_01864 | Arsenic (As) | 100 | 1.2e-185 | 1 | 344 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_02035 | Methyl Viologen [class: Paraquat] | 95.3 | 3.1e-77 | 1 | 149 | 0.9933 | 0.9933 | prediction |
CKHOCAAF_02700 | Cobalt (Co), Nickel (Ni) | 100 | 2.4e-236 | 1 | 416 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.8 | 4.8e-243 | 1 | 448 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 100 | 2.3e-245 | 1 | 448 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_03306 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 2.4e-191 | 1 | 334 | 1.0000 | 1.0000 | prediction |
CKHOCAAF_03307 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 84.5 | 8.2e-163 | 1 | 335 | 1.0030 | 1.0000 | prediction |
CKHOCAAF_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-192 | 1 | 328 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00240 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 8e-268 | 1 | 484 | 1.0000 | 0.9979 | prediction |
IPHMMGCP_00241 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 0 | 1 | 1058 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00242 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 3.5e-219 | 1 | 416 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00393 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 73.3 | 3.1e-138 | 3 | 330 | 0.9850 | 0.9400 | prediction |
IPHMMGCP_00729 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.7e-262 | 1 | 482 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00730 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 0 | 1 | 1059 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00731 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 1.3e-218 | 1 | 406 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00733 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 3.3e-199 | 1 | 343 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00738 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 9.5e-52 | 1 | 109 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_00896 | Copper (Cu), Gold (Au) | 70.5 | 0 | 1 | 821 | 1.0024 | 0.9976 | prediction |
IPHMMGCP_01078 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 100 | 3.9e-262 | 1 | 492 | 1.0000 | 0.9801 | prediction |
IPHMMGCP_01199 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 6.8e-126 | 1 | 217 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_01468 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.6e-190 | 1 | 331 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_01471 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-215 | 1 | 396 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_01472 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergise, Wex-cide-128. | 100 | 0 | 1 | 1036 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_01473 | Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Rhodamine 123 [class: Xanthene], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.8 | 5.9e-260 | 1 | 465 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_01549 | Chromium (Cr) | 93.7 | 1.3e-240 | 1 | 446 | 0.9933 | 0.9955 | prediction |
IPHMMGCP_01864 | Arsenic (As) | 100 | 1.2e-185 | 1 | 344 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_02035 | Methyl Viologen [class: Paraquat] | 95.3 | 3.1e-77 | 1 | 149 | 0.9933 | 0.9933 | prediction |
IPHMMGCP_02700 | Cobalt (Co), Nickel (Ni) | 100 | 2.4e-236 | 1 | 416 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_02895 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 99.8 | 4.8e-243 | 1 | 448 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_03029 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 100 | 2.3e-245 | 1 | 448 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_03306 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 2.4e-191 | 1 | 334 | 1.0000 | 1.0000 | prediction |
IPHMMGCP_03307 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 84.5 | 8.2e-163 | 1 | 335 | 1.0030 | 1.0000 | prediction |
IPHMMGCP_03746 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-192 | 1 | 328 | 1.0000 | 1.0000 | prediction |
Gene Name | aro_accession | identity | evalue | qstart | qend | query_coverage | subject_coverage | drug_class | amr_gene_family | resistance_mechanism |
---|---|---|---|---|---|---|---|---|---|---|
JJEBMEPF_00240 | ARO:3000782 | 100 | 0 | 1 | 484 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00241 | ARO:3000781 | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00242 | ARO:3000780 | 100 | 6.34e-279 | 1 | 416 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00354 | ARO:3003817 | 99.9 | 0 | 1 | 904 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant gyrA | antibiotic target alteration |
JJEBMEPF_00409 | ARO:3003808 | 79.8 | 1.11e-140 | 1 | 246 | 1.0041 | 1.0207 | carbapenem | CarO porin | reduced permeability to antibiotic |
JJEBMEPF_00590 | ARO:3004617 | 100 | 3.87e-286 | 1 | 383 | 1.0000 | 1.0000 | cephalosporin | ADC beta-lactamase without carbapenemase activity | antibiotic inactivation |
JJEBMEPF_00729 | ARO:3000779 | 99.8 | 0 | 2 | 482 | 0.9979 | 0.9959 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00730 | ARO:3000777 | 99.9 | 0 | 1 | 1059 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00731 | ARO:3000778 | 100 | 4.14e-279 | 1 | 406 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00733 | ARO:3000620 | 100 | 1.23e-249 | 7 | 343 | 0.9825 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00738 | ARO:3000768 | 100 | 3.7e-69 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_00851 | ARO:3005069 | 89.1 | 5.77e-28 | 1 | 55 | 0.6548 | 0.9016 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01078 | ARO:3004577 | 98.2 | 0 | 1 | 492 | 1.0000 | 1.0000 | macrolide antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01199 | ARO:3000559 | 99.1 | 4.36e-161 | 1 | 217 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01213 | ARO:3003573 | 100 | 2.11e-126 | 1 | 262 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
JJEBMEPF_01347 | ARO:3004574 | 100 | 1.45000001336151e-316 | 1 | 434 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01469 | ARO:3000549 | 96.9 | 2.42e-245 | 1 | 355 | 0.9944 | 0.9834 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01470 | ARO:3000553 | 99.2 | 6.37e-178 | 1 | 247 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01471 | ARO:3000774 | 100 | 1.01e-274 | 1 | 396 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01472 | ARO:3000775 | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01473 | ARO:3003811 | 100 | 0 | 1 | 465 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_01796 | ARO:3001615 | 100 | 2.43e-200 | 1 | 274 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
JJEBMEPF_02024 | ARO:3004573 | 100 | 1.22000000000001e-310 | 1 | 429 | 1.0000 | 1.0000 | phosphonic acid antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_02120 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
JJEBMEPF_02460 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
JJEBMEPF_02463 | ARO:3003395 | 71.5 | 5.38e-60 | 1 | 123 | 0.9919 | 0.9919 | aminoglycoside antibiotic | antibiotic-resistant rpsL | antibiotic target alteration |
JJEBMEPF_02858 | ARO:3005051 | 98.9 | 8.18e-268 | 1 | 366 | 1.0000 | 1.0000 | peptide antibiotic | Intrinsic peptide antibiotic resistant Lps | reduced permeability to antibiotic |
JJEBMEPF_02895 | ARO:3000753 | 99.6 | 1.8e-308 | 1 | 448 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | multidrug and toxic compound extrusion (MATE) transporter | antibiotic efflux |
JJEBMEPF_02999 | ARO:3003288 | 70.9 | 0 | 1 | 1359 | 1.0022 | 1.0171 | rifamycin antibiotic | rifamycin-resistant beta-subunit of RNA polymerase (rpoB) | antibiotic target alteration |
JJEBMEPF_03007 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
JJEBMEPF_03029 | ARO:3004578 | 99.8 | 3.19e-302 | 1 | 448 | 1.0000 | 1.0000 | aminoglycoside antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_03072 | ARO:3003809 | 81.8 | 3.17e-262 | 1 | 438 | 1.0274 | 1.0321 | monobactam | Outer Membrane Porin (Opr) | reduced permeability to antibiotic |
JJEBMEPF_03077 | ARO:3003818 | 100 | 0 | 1 | 739 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant parC | antibiotic target alteration |
JJEBMEPF_03104 | ARO:3007459 | 84.6 | 1.52e-175 | 1 | 277 | 0.9755 | 0.9118 | macrolide antibiotic | macrolide esterase | antibiotic inactivation |
JJEBMEPF_03105 | ARO:3005056 | 100 | 1.1e-278 | 1 | 378 | 1.0000 | 1.0000 | tetracycline antibiotic | tetracycline inactivation enzyme | antibiotic inactivation |
JJEBMEPF_03108 | ARO:3002705 | 99.7 | 7.15e-195 | 1 | 286 | 1.0000 | 0.7079 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_03113 | ARO:3000182 | 100 | 2.04e-276 | 1 | 391 | 1.0000 | 1.0000 | tetracycline antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_03117 | ARO:3002641 | 100 | 4.76e-210 | 1 | 271 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
JJEBMEPF_03121 | ARO:3000412 | 100 | 9.46e-186 | 13 | 283 | 0.9576 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
JJEBMEPF_03127 | ARO:3002705 | 99.8 | 2.79e-276 | 1 | 404 | 1.0000 | 1.0000 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
JJEBMEPF_03131 | ARO:3002660 | 99.6 | 1.07e-205 | 1 | 278 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(6) | antibiotic inactivation |
JJEBMEPF_03132 | ARO:3002639 | 99.6 | 5.98e-202 | 1 | 267 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3'') | antibiotic inactivation |
JJEBMEPF_03176 | ARO:3004089 | 98.5 | 5.04e-187 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
JJEBMEPF_03490 | ARO:3003574 | 100 | 1.6e-218 | 1 | 300 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
JJEBMEPF_03757 | ARO:3003930 | 75 | 6.51e-49 | 1 | 100 | 0.9709 | 0.9709 | tetracycline antibiotic | tetracycline-resistant ribosomal protection protein | antibiotic target protection |
CKHOCAAF_00240 | ARO:3000782 | 100 | 0 | 1 | 484 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00241 | ARO:3000781 | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00242 | ARO:3000780 | 100 | 6.34e-279 | 1 | 416 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00354 | ARO:3003817 | 99.9 | 0 | 1 | 904 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant gyrA | antibiotic target alteration |
CKHOCAAF_00409 | ARO:3003808 | 79.8 | 1.11e-140 | 1 | 246 | 1.0041 | 1.0207 | carbapenem | CarO porin | reduced permeability to antibiotic |
CKHOCAAF_00590 | ARO:3004617 | 100 | 3.87e-286 | 1 | 383 | 1.0000 | 1.0000 | cephalosporin | ADC beta-lactamase without carbapenemase activity | antibiotic inactivation |
CKHOCAAF_00729 | ARO:3000779 | 99.8 | 0 | 2 | 482 | 0.9979 | 0.9959 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00730 | ARO:3000777 | 99.9 | 0 | 1 | 1059 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00731 | ARO:3000778 | 100 | 4.14e-279 | 1 | 406 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00733 | ARO:3000620 | 100 | 1.23e-249 | 7 | 343 | 0.9825 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00738 | ARO:3000768 | 100 | 3.7e-69 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_00851 | ARO:3005069 | 89.1 | 5.77e-28 | 1 | 55 | 0.6548 | 0.9016 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01078 | ARO:3004577 | 98.2 | 0 | 1 | 492 | 1.0000 | 1.0000 | macrolide antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01199 | ARO:3000559 | 99.1 | 4.36e-161 | 1 | 217 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01213 | ARO:3003573 | 100 | 2.11e-126 | 1 | 262 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
CKHOCAAF_01347 | ARO:3004574 | 100 | 1.45000001336151e-316 | 1 | 434 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01469 | ARO:3000549 | 96.9 | 2.42e-245 | 1 | 355 | 0.9944 | 0.9834 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01470 | ARO:3000553 | 99.2 | 6.37e-178 | 1 | 247 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01471 | ARO:3000774 | 100 | 1.01e-274 | 1 | 396 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01472 | ARO:3000775 | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01473 | ARO:3003811 | 100 | 0 | 1 | 465 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_01796 | ARO:3001615 | 100 | 2.43e-200 | 1 | 274 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
CKHOCAAF_02024 | ARO:3004573 | 100 | 1.22000000000001e-310 | 1 | 429 | 1.0000 | 1.0000 | phosphonic acid antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_02120 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
CKHOCAAF_02460 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
CKHOCAAF_02463 | ARO:3003395 | 71.5 | 5.38e-60 | 1 | 123 | 0.9919 | 0.9919 | aminoglycoside antibiotic | antibiotic-resistant rpsL | antibiotic target alteration |
CKHOCAAF_02858 | ARO:3005051 | 98.9 | 8.18e-268 | 1 | 366 | 1.0000 | 1.0000 | peptide antibiotic | Intrinsic peptide antibiotic resistant Lps | reduced permeability to antibiotic |
CKHOCAAF_02895 | ARO:3000753 | 99.6 | 1.8e-308 | 1 | 448 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | multidrug and toxic compound extrusion (MATE) transporter | antibiotic efflux |
CKHOCAAF_02999 | ARO:3003288 | 70.9 | 0 | 1 | 1359 | 1.0022 | 1.0171 | rifamycin antibiotic | rifamycin-resistant beta-subunit of RNA polymerase (rpoB) | antibiotic target alteration |
CKHOCAAF_03007 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
CKHOCAAF_03029 | ARO:3004578 | 99.8 | 3.19e-302 | 1 | 448 | 1.0000 | 1.0000 | aminoglycoside antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_03072 | ARO:3003809 | 81.8 | 3.17e-262 | 1 | 438 | 1.0274 | 1.0321 | monobactam | Outer Membrane Porin (Opr) | reduced permeability to antibiotic |
CKHOCAAF_03077 | ARO:3003818 | 100 | 0 | 1 | 739 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant parC | antibiotic target alteration |
CKHOCAAF_03104 | ARO:3007459 | 84.6 | 1.52e-175 | 1 | 277 | 0.9755 | 0.9118 | macrolide antibiotic | macrolide esterase | antibiotic inactivation |
CKHOCAAF_03105 | ARO:3005056 | 100 | 1.1e-278 | 1 | 378 | 1.0000 | 1.0000 | tetracycline antibiotic | tetracycline inactivation enzyme | antibiotic inactivation |
CKHOCAAF_03108 | ARO:3002705 | 99.7 | 7.15e-195 | 1 | 286 | 1.0000 | 0.7079 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_03113 | ARO:3000182 | 100 | 2.04e-276 | 1 | 391 | 1.0000 | 1.0000 | tetracycline antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_03117 | ARO:3002641 | 100 | 4.76e-210 | 1 | 271 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
CKHOCAAF_03121 | ARO:3000412 | 100 | 9.46e-186 | 13 | 283 | 0.9576 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
CKHOCAAF_03127 | ARO:3002705 | 99.8 | 2.79e-276 | 1 | 404 | 1.0000 | 1.0000 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
CKHOCAAF_03131 | ARO:3002660 | 99.6 | 1.07e-205 | 1 | 278 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(6) | antibiotic inactivation |
CKHOCAAF_03132 | ARO:3002639 | 99.6 | 5.98e-202 | 1 | 267 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3'') | antibiotic inactivation |
CKHOCAAF_03176 | ARO:3004089 | 98.5 | 5.04e-187 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
CKHOCAAF_03490 | ARO:3003574 | 100 | 1.6e-218 | 1 | 300 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
CKHOCAAF_03757 | ARO:3003930 | 75 | 6.51e-49 | 1 | 100 | 0.9709 | 0.9709 | tetracycline antibiotic | tetracycline-resistant ribosomal protection protein | antibiotic target protection |
IPHMMGCP_00240 | ARO:3000782 | 100 | 0 | 1 | 484 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00241 | ARO:3000781 | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00242 | ARO:3000780 | 100 | 6.34e-279 | 1 | 416 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00354 | ARO:3003817 | 99.9 | 0 | 1 | 904 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant gyrA | antibiotic target alteration |
IPHMMGCP_00409 | ARO:3003808 | 79.8 | 1.11e-140 | 1 | 246 | 1.0041 | 1.0207 | carbapenem | CarO porin | reduced permeability to antibiotic |
IPHMMGCP_00590 | ARO:3004617 | 100 | 3.87e-286 | 1 | 383 | 1.0000 | 1.0000 | cephalosporin | ADC beta-lactamase without carbapenemase activity | antibiotic inactivation |
IPHMMGCP_00729 | ARO:3000779 | 99.8 | 0 | 2 | 482 | 0.9979 | 0.9959 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00730 | ARO:3000777 | 99.9 | 0 | 1 | 1059 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00731 | ARO:3000778 | 100 | 4.14e-279 | 1 | 406 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00733 | ARO:3000620 | 100 | 1.23e-249 | 7 | 343 | 0.9825 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00738 | ARO:3000768 | 100 | 3.7e-69 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_00851 | ARO:3005069 | 89.1 | 5.77e-28 | 1 | 55 | 0.6548 | 0.9016 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01078 | ARO:3004577 | 98.2 | 0 | 1 | 492 | 1.0000 | 1.0000 | macrolide antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01199 | ARO:3000559 | 99.1 | 4.36e-161 | 1 | 217 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01213 | ARO:3003573 | 100 | 2.11e-126 | 1 | 262 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
IPHMMGCP_01347 | ARO:3004574 | 100 | 1.45000001336151e-316 | 1 | 434 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01469 | ARO:3000549 | 96.9 | 2.42e-245 | 1 | 355 | 0.9944 | 0.9834 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01470 | ARO:3000553 | 99.2 | 6.37e-178 | 1 | 247 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01471 | ARO:3000774 | 100 | 1.01e-274 | 1 | 396 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01472 | ARO:3000775 | 100 | 0 | 2 | 1036 | 0.9990 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01473 | ARO:3003811 | 100 | 0 | 1 | 465 | 1.0000 | 1.0000 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_01796 | ARO:3001615 | 100 | 2.43e-200 | 1 | 274 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
IPHMMGCP_02024 | ARO:3004573 | 100 | 1.22000000000001e-310 | 1 | 429 | 1.0000 | 1.0000 | phosphonic acid antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_02120 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
IPHMMGCP_02460 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
IPHMMGCP_02463 | ARO:3003395 | 71.5 | 5.38e-60 | 1 | 123 | 0.9919 | 0.9919 | aminoglycoside antibiotic | antibiotic-resistant rpsL | antibiotic target alteration |
IPHMMGCP_02858 | ARO:3005051 | 98.9 | 8.18e-268 | 1 | 366 | 1.0000 | 1.0000 | peptide antibiotic | Intrinsic peptide antibiotic resistant Lps | reduced permeability to antibiotic |
IPHMMGCP_02895 | ARO:3000753 | 99.6 | 1.8e-308 | 1 | 448 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | multidrug and toxic compound extrusion (MATE) transporter | antibiotic efflux |
IPHMMGCP_02999 | ARO:3003288 | 70.9 | 0 | 1 | 1359 | 1.0022 | 1.0171 | rifamycin antibiotic | rifamycin-resistant beta-subunit of RNA polymerase (rpoB) | antibiotic target alteration |
IPHMMGCP_03007 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
IPHMMGCP_03029 | ARO:3004578 | 99.8 | 3.19e-302 | 1 | 448 | 1.0000 | 1.0000 | aminoglycoside antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_03072 | ARO:3003809 | 81.8 | 3.17e-262 | 1 | 438 | 1.0274 | 1.0321 | monobactam | Outer Membrane Porin (Opr) | reduced permeability to antibiotic |
IPHMMGCP_03077 | ARO:3003818 | 100 | 0 | 1 | 739 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant parC | antibiotic target alteration |
IPHMMGCP_03104 | ARO:3007459 | 84.6 | 1.52e-175 | 1 | 277 | 0.9755 | 0.9118 | macrolide antibiotic | macrolide esterase | antibiotic inactivation |
IPHMMGCP_03105 | ARO:3005056 | 100 | 1.1e-278 | 1 | 378 | 1.0000 | 1.0000 | tetracycline antibiotic | tetracycline inactivation enzyme | antibiotic inactivation |
IPHMMGCP_03108 | ARO:3002705 | 99.7 | 7.15e-195 | 1 | 286 | 1.0000 | 0.7079 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_03113 | ARO:3000182 | 100 | 2.04e-276 | 1 | 391 | 1.0000 | 1.0000 | tetracycline antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_03117 | ARO:3002641 | 100 | 4.76e-210 | 1 | 271 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
IPHMMGCP_03121 | ARO:3000412 | 100 | 9.46e-186 | 13 | 283 | 0.9576 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
IPHMMGCP_03127 | ARO:3002705 | 99.8 | 2.79e-276 | 1 | 404 | 1.0000 | 1.0000 | phenicol antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
IPHMMGCP_03131 | ARO:3002660 | 99.6 | 1.07e-205 | 1 | 278 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(6) | antibiotic inactivation |
IPHMMGCP_03132 | ARO:3002639 | 99.6 | 5.98e-202 | 1 | 267 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3'') | antibiotic inactivation |
IPHMMGCP_03176 | ARO:3004089 | 98.5 | 5.04e-187 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
IPHMMGCP_03490 | ARO:3003574 | 100 | 1.6e-218 | 1 | 300 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
IPHMMGCP_03757 | ARO:3003930 | 75 | 6.51e-49 | 1 | 100 | 0.9709 | 0.9709 | tetracycline antibiotic | tetracycline-resistant ribosomal protection protein | antibiotic target protection |
Gene Name | phi_molconn_id | host gene_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | host_descripton | disease_name | function | phenotype_of_mutant |
---|---|---|---|---|---|---|---|---|---|---|---|---|
JJEBMEPF_00022 | PHI:10160 | ksgA | 100 | 2e-154 | 1 | 270 | 1.0000 | 1.0000 | nematodes | skin infection; soft tissue infection; urinary tract infection; meningitis; wound infection | 16S rRNA methyltransferase | reduced virulence |
JJEBMEPF_00029 | PHI:5093 | PLD2 | 99.4 | 5.59999999999536e-313 | 1 | 541 | 1.0000 | 0.9963 | moths | nosocomial infection | phospholipases D | reduced virulence |
JJEBMEPF_00080 | PHI:5094 | PLD3 | 99 | 2.2e-284 | 1 | 487 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
JJEBMEPF_00109 | PHI:3243 | lsfA | 79.7 | 2.3e-100 | 1 | 212 | 0.9953 | 1.0000 | rodents | opportunistic infection | 1-Cys peroxiredoxin with thioldependent peroxidase activity | reduced virulence |
JJEBMEPF_00110 | PHI:5240 | secA | 100 | 0 | 1 | 907 | 1.0000 | 1.0000 | moths | nosocomial infection | iron utilization | reduced virulence |
JJEBMEPF_00131 | PHI:9283 | OmpA | 99.7 | 1.7e-201 | 1 | 356 | 1.0000 | 1.0000 | nematodes | pneumonia | outer membrane protein | reduced virulence |
JJEBMEPF_00137 | PHI:11030 | bipA | 70.9 | 2.1e-247 | 4 | 607 | 0.9885 | 0.9852 | rodents | pneumonic plague | putative GTPase | reduced virulence |
JJEBMEPF_00160 | PHI:10421 | PilG (XC_1183) | 75.8 | 2.9e-50 | 8 | 127 | 0.9449 | 0.9023 | eudicots | black rot | single domain response regulator | reduced virulence |
JJEBMEPF_00240 | PHI:6388 | adeK | 100 | 5.8e-269 | 1 | 484 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
JJEBMEPF_00241 | PHI:6387 | adeJ | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
JJEBMEPF_00242 | PHI:6386 | adeI | 100 | 2.5e-220 | 1 | 416 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
JJEBMEPF_00290 | PHI:7130 | greA | 70.9 | 6.7e-57 | 1 | 158 | 1.0000 | 1.0000 | rodents | salmonellosis | transcription elongation factor | loss of pathogenicity |
JJEBMEPF_00292 | PHI:6594 | carA | 71.8 | 3.1e-156 | 1 | 372 | 0.9815 | 0.9841 | eudicots | bacterial speck (tomato) | encodes the predicted small chain of carbamoylphosphate synthetase | reduced virulence |
JJEBMEPF_00317 | PHI:123702 | dgkA (PALES_47610) | 73.8 | 5.1e-44 | 3 | 124 | 0.9839 | 0.9919 | rodents | nosocomial infection | diacyl glycerol kinase | reduced virulence |
JJEBMEPF_00386 | PHI:123761 | pal | 83.5 | 1.4e-82 | 3 | 187 | 0.9893 | 0.9947 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
JJEBMEPF_00387 | PHI:123760 | tolB | 99.8 | 1.5e-244 | 1 | 426 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
JJEBMEPF_00390 | PHI:123757 | TolQ | 99.6 | 5.7e-121 | 1 | 232 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
JJEBMEPF_00498 | PHI:10561 | pstS | 100 | 2.4e-192 | 1 | 343 | 1.0000 | 1.0000 | primates | nosocomial infection | phosphate-binding protein | reduced virulence |
JJEBMEPF_00563 | PHI:3711 | PCC21 _023220 | 72.9 | 1.4e-83 | 8 | 206 | 0.9614 | 0.9614 | eudicots | soft rot | putative DNA-binding protein | reduced virulence |
JJEBMEPF_00575 | PHI:11832 | basD | 96.9 | 0 | 1 | 980 | 1.0000 | 1.0000 | rodents | pneumonia | acinetobactin non-ribosomal peptide synthetase subunit | reduced virulence |
JJEBMEPF_00578 | PHI:11014 | basG | 100 | 7.7e-232 | 1 | 383 | 1.0000 | 1.0000 | rodents | nosocomial infection | histidine decarboxylase | reduced virulence |
JJEBMEPF_00700 | PHI:6492 | lipA | 100 | 5.6e-202 | 1 | 337 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
JJEBMEPF_00728 | PHI:2962 | glyA | 70.7 | 3.8e-168 | 5 | 416 | 0.9880 | 0.9880 | bony fishes | enteric septicemia | serine hydroxymethyltransferase | reduced virulence |
JJEBMEPF_00757 | PHI:124230 | dctA | 72 | 7.6e-170 | 3 | 431 | 0.9491 | 0.9720 | rodents | salmonellosis | primary dicarboxylate importer | unaffected pathogenicity |
JJEBMEPF_00768 | PHI:123321 | thiG (pspto_0434) | 71.8 | 1.3e-102 | 3 | 257 | 0.9770 | 0.9659 | eudicots | bacterial speck | thiazole synthase | reduced virulence |
JJEBMEPF_00851 | PHI:11447 | csrA | 100 | 6.1e-41 | 1 | 84 | 1.0000 | 1.0000 | moths | nosocomial infection | carbon storage regulator | reduced virulence |
JJEBMEPF_00866 | PHI:11207 | clpB | 100 | 0 | 1 | 859 | 1.0000 | 1.0000 | rodents | nosocomial infection | protein disaggregation chaperone | reduced virulence |
JJEBMEPF_00876 | PHI:124297 | TrmB (OB946_12575) | 99.2 | 3.3e-140 | 1 | 238 | 1.0000 | 0.9675 | rodents | nosocomial infection | tRNA methyltransferase | reduced virulence |
JJEBMEPF_00884 | PHI:11383 | ahpC | 71.7 | 5.5e-82 | 1 | 187 | 1.0000 | 1.0000 | moths | salmonellosis | peroxiredoxin | reduced virulence |
JJEBMEPF_00896 | PHI:8812 | CopA (ABUW_2707) | 98.7 | 0 | 1 | 823 | 1.0000 | 1.0000 | rodents | nosocomial infection | copper-translocating P-type ATPase | unaffected pathogenicity |
JJEBMEPF_00993 | PHI:6782 | kdpE | 98.3 | 7.4e-132 | 1 | 238 | 1.0000 | 1.0000 | rodents | pneumonia | potassium-dependent protein | reduced virulence |
JJEBMEPF_01017 | PHI:11023 | hfq | 85.1 | 9.1e-28 | 1 | 67 | 0.3988 | 0.7283 | moths | pleuropneumonia (pig) | RNA chaperone | reduced virulence |
JJEBMEPF_01211 | PHI:10611 | lpxD | 99.7 | 1.6e-202 | 1 | 356 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acylglucosamine N-acyltransferase | reduced virulence |
JJEBMEPF_01212 | PHI:10610 | lpxA | 100 | 7e-86 | 1 | 157 | 0.9752 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
JJEBMEPF_01213 | PHI:10610 | lpxA | 99.6 | 6.6e-150 | 1 | 262 | 1.0000 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
JJEBMEPF_01216 | PHI:10380 | RecA | 100 | 2e-194 | 1 | 349 | 1.0000 | 1.0000 | nematodes | nosocomial infection | DNA strand exchange and recombination protein | reduced virulence |
JJEBMEPF_01278 | PHI:11208 | clpS | 100 | 2.3e-77 | 1 | 137 | 1.0000 | 1.0000 | rodents | nosocomial infection | ATP-dependent Clp protease adapter protein | reduced virulence |
JJEBMEPF_01471 | PHI:6263 | adeA | 99 | 4e-215 | 1 | 396 | 1.0000 | 1.0000 | moths | nosocomial infection | RND MDR efflux system | reduced virulence |
JJEBMEPF_01472 | PHI:6384 | adeB | 99.5 | 0 | 1 | 1036 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
JJEBMEPF_01473 | PHI:6385 | adeC | 97.2 | 1.2e-255 | 1 | 465 | 1.0000 | 0.9915 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
JJEBMEPF_01495 | PHI:5092 | PLD1 | 98.6 | 1.3e-295 | 1 | 508 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
JJEBMEPF_01566 | PHI:6492 | lipA | 75.5 | 1.2e-148 | 1 | 319 | 0.9726 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
JJEBMEPF_01590 | PHI:123759 | tolA | 98.4 | 4.9e-63 | 1 | 124 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
JJEBMEPF_01644 | PHI:6892 | iscU | 83.2 | 3.8e-58 | 1 | 125 | 0.9766 | 0.9766 | rodents | salmonellosis | Fe-S cluster sensor | reduced virulence |
JJEBMEPF_01763 | PHI:11868 | otsA | 100 | 0 | 1 | 813 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein A | reduced virulence |
JJEBMEPF_01931 | PHI:6090 | katE | 100 | 0 | 1 | 712 | 1.0000 | 1.0000 | moths | bacteremia | hydroperoxidase | increased virulence (hypervirulence) |
JJEBMEPF_02055 | PHI:5090 | tssM | 97 | 0 | 28 | 1274 | 0.9788 | 1.0000 | moths | nosocomial infection | T6SS effector | effector (plant avirulence determinant) |
JJEBMEPF_02094 | PHI:7862 | vgrG | 73 | 3.7e-98 | 742 | 996 | 0.2410 | 0.8339 | rodents | nosocomial infection | T6SS component (valine-glycine repeat G) | reduced virulence |
JJEBMEPF_02270 | PHI:9898 | ata | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | primates | nosocomial infection | trimeric autotransporter adhesin | reduced virulence |
JJEBMEPF_02376 | PHI:7520 | VK055_1952 | 75.2 | 2.3e-212 | 8 | 490 | 0.9857 | 0.9918 | rodents | pneumonia | betaine aldehyde dehydrogenase | unaffected pathogenicity |
JJEBMEPF_02413 | PHI:10510 | ggt | 99.2 | 0 | 1 | 661 | 1.0000 | 1.0000 | rodents | nosocomial infection | gamma-glutamyltransferase | reduced virulence |
JJEBMEPF_02460 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
JJEBMEPF_02521 | PHI:11869 | otsB | 99.3 | 9.6e-163 | 1 | 283 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein B | unaffected pathogenicity |
JJEBMEPF_02525 | PHI:7809 | adeN | 100 | 0 | 1 | 678 | 1.0000 | 1.0000 | moths | nosocomial infection | TetR type regulator | increased virulence (hypervirulence) |
JJEBMEPF_02559 | PHI:124383 | GigC | 100 | 6.5e-170 | 1 | 295 | 1.0000 | 1.0000 | rodents | nosocomial infection | LysR family regulator | reduced virulence |
JJEBMEPF_02567 | PHI:8937 | nuoI (PA2644) | 77.4 | 1.8e-82 | 4 | 180 | 0.9833 | 0.9615 | moths | nosocomial infection | NADH-quinone oxidoreductase | unaffected pathogenicity |
JJEBMEPF_02639 | PHI:10391 | pcoB (ABUW_3227) | 98 | 1.6e-145 | 1 | 251 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein B | reduced virulence |
JJEBMEPF_02640 | PHI:10392 | pcoA (ABUW_3228) | 97.5 | 0 | 1 | 644 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein A | reduced virulence |
JJEBMEPF_02673 | PHI:7668 | gigA | 100 | 1.5e-191 | 1 | 322 | 1.0000 | 1.0000 | moths | nosocomial infection | noncanonical two-component system (TCS) response regulator (RR) harboring a protein phosphatase domain | reduced virulence |
JJEBMEPF_02674 | PHI:7669 | gigB | 99.4 | 3.7e-93 | 1 | 173 | 1.0000 | 0.9301 | moths | nosocomial infection | anti-sigma factor antagonist | reduced virulence |
JJEBMEPF_02689 | PHI:9285 | trxA | 100 | 2.1e-57 | 1 | 108 | 1.0000 | 1.0000 | rodents | pneumonia | thioredoxin A | reduced virulence |
JJEBMEPF_02691 | PHI:123501 | lirL (ABUW_3278) | 81.4 | 1.5e-15 | 1 | 81 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipoprotein | reduced virulence |
JJEBMEPF_02716 | PHI:11295 | relA (ABUW_3302) | 100 | 0 | 1 | 768 | 1.0000 | 1.0000 | moths | nosocomial infection | GTP pyrophosphokinase | reduced virulence |
JJEBMEPF_02720 | PHI:11841 | barA | 100 | 0 | 1 | 935 | 1.0000 | 1.0000 | rodents | pneumonia | histidine kinase | unaffected pathogenicity |
JJEBMEPF_02791 | PHI:6438 | Ndk | 73.4 | 5.7e-55 | 1 | 143 | 1.0000 | 1.0000 | rodents | nosocomial infection | host-responsive regulator/nucleoside diphosphate kinase | increased virulence (hypervirulence) |
JJEBMEPF_02811 | PHI:3040 | ClpP | 77.6 | 5.7e-85 | 9 | 200 | 0.9552 | 0.9275 | rodents | food poisoning | proteolytic component | reduced virulence |
JJEBMEPF_02859 | PHI:124242 | gltP | 73.1 | 2.7e-169 | 1 | 424 | 0.9907 | 0.9703 | rodents | neonatal meningitis | glutamate transporters | reduced virulence |
JJEBMEPF_02870 | PHI:9979 | leuB (PXO_02610) | 72.9 | 1.5e-144 | 1 | 358 | 0.9972 | 1.0000 | monocots | bacterial leaf blight | 3-isopropylmalate dehydrogenase | reduced virulence |
JJEBMEPF_02872 | PHI:9980 | leuD (PXO_02612) | 72.5 | 1.5e-91 | 1 | 211 | 0.9814 | 0.9814 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase small subunit | reduced virulence |
JJEBMEPF_02873 | PHI:9981 | leuC (PXO_02613) | 74 | 1.2e-208 | 38 | 507 | 0.9234 | 0.9751 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase large subunit | reduced virulence |
JJEBMEPF_02879 | PHI:6089 | katG | 96.4 | 0 | 1 | 718 | 1.0000 | 1.0000 | moths | bacteremia | catalase-peroxidase | increased virulence (hypervirulence) |
JJEBMEPF_02999 | PHI:7860 | RpoB | 99.9 | 0 | 1 | 1357 | 0.9963 | 1.0000 | nematodes | nosocomial infection | beta-subunit of the RNA polymerase | reduced virulence |
JJEBMEPF_03007 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
JJEBMEPF_03015 | PHI:123173 | gspD | 96.7 | 0 | 1 | 758 | 1.0000 | 1.0000 | rodents | urinary tract infection | type II secretion (T2S) system that is responsible for secretion of InvL | reduced virulence |
JJEBMEPF_03029 | PHI:4996 | AbuO | 99.8 | 3.8e-246 | 1 | 448 | 1.0000 | 1.0000 | nematodes | nosocomial infection | outer membrane protein | reduced virulence |
JJEBMEPF_03036 | PHI:11772 | dksA (AlS_0248 ) | 100 | 4.4e-97 | 1 | 178 | 1.0000 | 1.0000 | rodents | nosocomial infection | RNA polymerase-binding transcription factor | reduced virulence |
JJEBMEPF_03048 | PHI:6601 | gacA | 100 | 8e-114 | 1 | 211 | 1.0000 | 1.0000 | bony fishes | bacteremia | response regulator | reduced virulence |
JJEBMEPF_03072 | PHI:11092 | oprD | 99.5 | 9.7e-255 | 1 | 438 | 1.0000 | 1.0000 | rodents | pneumonia | outer membrane protein | reduced virulence |
JJEBMEPF_03141 | PHI:9117 | TonB-dependent copper receptor | 99.3 | 0 | 1 | 704 | 1.0000 | 1.0000 | rodents | nosocomial infection | TonB-dependent copper receptor, outer membraneprotein | reduced virulence |
JJEBMEPF_03197 | PHI:11261 | abaM (ABUW_3775) | 98.6 | 1.3e-75 | 1 | 138 | 1.0000 | 1.0000 | moths | nosocomial infection | DUF4902 domain-containing protein | reduced virulence |
JJEBMEPF_03198 | PHI:8774 | abaI | 95.7 | 1.3e-99 | 1 | 183 | 1.0000 | 1.0000 | moths | nosocomial infection | acyl-homoserine-lactone synthase | reduced virulence |
JJEBMEPF_03263 | PHI:124392 | wzc | 93.8 | 3.3e-98 | 1 | 191 | 1.0000 | 0.9492 | moths | nosocomial infection | multidrug-resistant factor | unaffected pathogenicity |
JJEBMEPF_03420 | PHI:8042 | lpxA | 99.8 | 9.7e-258 | 1 | 454 | 1.0000 | 1.0000 | rodents | pneumonia | N-acetylglucosamine-1-phosphate uridyltransferase | reduced virulence |
JJEBMEPF_03490 | PHI:10612 | lpxC | 100 | 1.6e-171 | 1 | 300 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acyl-N-acetylglucosamine deacetylase | reduced virulence |
JJEBMEPF_03594 | PHI:10701 | hisF (A1S_3245) | 100 | 1.5e-143 | 1 | 252 | 1.0000 | 1.0000 | rodents | pneumonia | imidazole glycerol phosphate synthase cyclase subunit | reduced virulence |
JJEBMEPF_03768 | PHI:11120 | rplN | 74.6 | 3.2e-46 | 1 | 122 | 1.0000 | 1.0000 | primates | pertussis | 50S ribosomal protein | unaffected pathogenicity |
CKHOCAAF_00022 | PHI:10160 | ksgA | 100 | 2e-154 | 1 | 270 | 1.0000 | 1.0000 | nematodes | skin infection; soft tissue infection; urinary tract infection; meningitis; wound infection | 16S rRNA methyltransferase | reduced virulence |
CKHOCAAF_00029 | PHI:5093 | PLD2 | 99.4 | 5.59999999999536e-313 | 1 | 541 | 1.0000 | 0.9963 | moths | nosocomial infection | phospholipases D | reduced virulence |
CKHOCAAF_00080 | PHI:5094 | PLD3 | 99 | 2.2e-284 | 1 | 487 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
CKHOCAAF_00109 | PHI:3243 | lsfA | 79.7 | 2.3e-100 | 1 | 212 | 0.9953 | 1.0000 | rodents | opportunistic infection | 1-Cys peroxiredoxin with thioldependent peroxidase activity | reduced virulence |
CKHOCAAF_00110 | PHI:5240 | secA | 100 | 0 | 1 | 907 | 1.0000 | 1.0000 | moths | nosocomial infection | iron utilization | reduced virulence |
CKHOCAAF_00131 | PHI:9283 | OmpA | 99.7 | 1.7e-201 | 1 | 356 | 1.0000 | 1.0000 | nematodes | pneumonia | outer membrane protein | reduced virulence |
CKHOCAAF_00137 | PHI:11030 | bipA | 70.9 | 2.1e-247 | 4 | 607 | 0.9885 | 0.9852 | rodents | pneumonic plague | putative GTPase | reduced virulence |
CKHOCAAF_00160 | PHI:10421 | PilG (XC_1183) | 75.8 | 2.9e-50 | 8 | 127 | 0.9449 | 0.9023 | eudicots | black rot | single domain response regulator | reduced virulence |
CKHOCAAF_00240 | PHI:6388 | adeK | 100 | 5.8e-269 | 1 | 484 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
CKHOCAAF_00241 | PHI:6387 | adeJ | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
CKHOCAAF_00242 | PHI:6386 | adeI | 100 | 2.5e-220 | 1 | 416 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
CKHOCAAF_00290 | PHI:7130 | greA | 70.9 | 6.7e-57 | 1 | 158 | 1.0000 | 1.0000 | rodents | salmonellosis | transcription elongation factor | loss of pathogenicity |
CKHOCAAF_00292 | PHI:6594 | carA | 71.8 | 3.1e-156 | 1 | 372 | 0.9815 | 0.9841 | eudicots | bacterial speck (tomato) | encodes the predicted small chain of carbamoylphosphate synthetase | reduced virulence |
CKHOCAAF_00317 | PHI:123702 | dgkA (PALES_47610) | 73.8 | 5.1e-44 | 3 | 124 | 0.9839 | 0.9919 | rodents | nosocomial infection | diacyl glycerol kinase | reduced virulence |
CKHOCAAF_00386 | PHI:123761 | pal | 83.5 | 1.4e-82 | 3 | 187 | 0.9893 | 0.9947 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
CKHOCAAF_00387 | PHI:123760 | tolB | 99.8 | 1.5e-244 | 1 | 426 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
CKHOCAAF_00390 | PHI:123757 | TolQ | 99.6 | 5.7e-121 | 1 | 232 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
CKHOCAAF_00498 | PHI:10561 | pstS | 100 | 2.4e-192 | 1 | 343 | 1.0000 | 1.0000 | primates | nosocomial infection | phosphate-binding protein | reduced virulence |
CKHOCAAF_00563 | PHI:3711 | PCC21 _023220 | 72.9 | 1.4e-83 | 8 | 206 | 0.9614 | 0.9614 | eudicots | soft rot | putative DNA-binding protein | reduced virulence |
CKHOCAAF_00575 | PHI:11832 | basD | 96.9 | 0 | 1 | 980 | 1.0000 | 1.0000 | rodents | pneumonia | acinetobactin non-ribosomal peptide synthetase subunit | reduced virulence |
CKHOCAAF_00578 | PHI:11014 | basG | 100 | 7.7e-232 | 1 | 383 | 1.0000 | 1.0000 | rodents | nosocomial infection | histidine decarboxylase | reduced virulence |
CKHOCAAF_00700 | PHI:6492 | lipA | 100 | 5.6e-202 | 1 | 337 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
CKHOCAAF_00728 | PHI:2962 | glyA | 70.7 | 3.8e-168 | 5 | 416 | 0.9880 | 0.9880 | bony fishes | enteric septicemia | serine hydroxymethyltransferase | reduced virulence |
CKHOCAAF_00757 | PHI:124230 | dctA | 72 | 7.6e-170 | 3 | 431 | 0.9491 | 0.9720 | rodents | salmonellosis | primary dicarboxylate importer | unaffected pathogenicity |
CKHOCAAF_00768 | PHI:123321 | thiG (pspto_0434) | 71.8 | 1.3e-102 | 3 | 257 | 0.9770 | 0.9659 | eudicots | bacterial speck | thiazole synthase | reduced virulence |
CKHOCAAF_00851 | PHI:11447 | csrA | 100 | 6.1e-41 | 1 | 84 | 1.0000 | 1.0000 | moths | nosocomial infection | carbon storage regulator | reduced virulence |
CKHOCAAF_00866 | PHI:11207 | clpB | 100 | 0 | 1 | 859 | 1.0000 | 1.0000 | rodents | nosocomial infection | protein disaggregation chaperone | reduced virulence |
CKHOCAAF_00876 | PHI:124297 | TrmB (OB946_12575) | 99.2 | 3.3e-140 | 1 | 238 | 1.0000 | 0.9675 | rodents | nosocomial infection | tRNA methyltransferase | reduced virulence |
CKHOCAAF_00884 | PHI:11383 | ahpC | 71.7 | 5.5e-82 | 1 | 187 | 1.0000 | 1.0000 | moths | salmonellosis | peroxiredoxin | reduced virulence |
CKHOCAAF_00896 | PHI:8812 | CopA (ABUW_2707) | 98.7 | 0 | 1 | 823 | 1.0000 | 1.0000 | rodents | nosocomial infection | copper-translocating P-type ATPase | unaffected pathogenicity |
CKHOCAAF_00993 | PHI:6782 | kdpE | 98.3 | 7.4e-132 | 1 | 238 | 1.0000 | 1.0000 | rodents | pneumonia | potassium-dependent protein | reduced virulence |
CKHOCAAF_01017 | PHI:11023 | hfq | 85.1 | 9.1e-28 | 1 | 67 | 0.3988 | 0.7283 | moths | pleuropneumonia (pig) | RNA chaperone | reduced virulence |
CKHOCAAF_01211 | PHI:10611 | lpxD | 99.7 | 1.6e-202 | 1 | 356 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acylglucosamine N-acyltransferase | reduced virulence |
CKHOCAAF_01212 | PHI:10610 | lpxA | 100 | 7e-86 | 1 | 157 | 0.9752 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
CKHOCAAF_01213 | PHI:10610 | lpxA | 99.6 | 6.6e-150 | 1 | 262 | 1.0000 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
CKHOCAAF_01216 | PHI:10380 | RecA | 100 | 2e-194 | 1 | 349 | 1.0000 | 1.0000 | nematodes | nosocomial infection | DNA strand exchange and recombination protein | reduced virulence |
CKHOCAAF_01278 | PHI:11208 | clpS | 100 | 2.3e-77 | 1 | 137 | 1.0000 | 1.0000 | rodents | nosocomial infection | ATP-dependent Clp protease adapter protein | reduced virulence |
CKHOCAAF_01471 | PHI:6263 | adeA | 99 | 4e-215 | 1 | 396 | 1.0000 | 1.0000 | moths | nosocomial infection | RND MDR efflux system | reduced virulence |
CKHOCAAF_01472 | PHI:6384 | adeB | 99.5 | 0 | 1 | 1036 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
CKHOCAAF_01473 | PHI:6385 | adeC | 97.2 | 1.2e-255 | 1 | 465 | 1.0000 | 0.9915 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
CKHOCAAF_01495 | PHI:5092 | PLD1 | 98.6 | 1.3e-295 | 1 | 508 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
CKHOCAAF_01566 | PHI:6492 | lipA | 75.5 | 1.2e-148 | 1 | 319 | 0.9726 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
CKHOCAAF_01590 | PHI:123759 | tolA | 98.4 | 4.9e-63 | 1 | 124 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
CKHOCAAF_01644 | PHI:6892 | iscU | 83.2 | 3.8e-58 | 1 | 125 | 0.9766 | 0.9766 | rodents | salmonellosis | Fe-S cluster sensor | reduced virulence |
CKHOCAAF_01763 | PHI:11868 | otsA | 100 | 0 | 1 | 813 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein A | reduced virulence |
CKHOCAAF_01931 | PHI:6090 | katE | 100 | 0 | 1 | 712 | 1.0000 | 1.0000 | moths | bacteremia | hydroperoxidase | increased virulence (hypervirulence) |
CKHOCAAF_02055 | PHI:5090 | tssM | 97 | 0 | 28 | 1274 | 0.9788 | 1.0000 | moths | nosocomial infection | T6SS effector | effector (plant avirulence determinant) |
CKHOCAAF_02094 | PHI:7862 | vgrG | 73 | 3.7e-98 | 742 | 996 | 0.2410 | 0.8339 | rodents | nosocomial infection | T6SS component (valine-glycine repeat G) | reduced virulence |
CKHOCAAF_02270 | PHI:9898 | ata | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | primates | nosocomial infection | trimeric autotransporter adhesin | reduced virulence |
CKHOCAAF_02376 | PHI:7520 | VK055_1952 | 75.2 | 2.3e-212 | 8 | 490 | 0.9857 | 0.9918 | rodents | pneumonia | betaine aldehyde dehydrogenase | unaffected pathogenicity |
CKHOCAAF_02413 | PHI:10510 | ggt | 99.2 | 0 | 1 | 661 | 1.0000 | 1.0000 | rodents | nosocomial infection | gamma-glutamyltransferase | reduced virulence |
CKHOCAAF_02460 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
CKHOCAAF_02521 | PHI:11869 | otsB | 99.3 | 9.6e-163 | 1 | 283 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein B | unaffected pathogenicity |
CKHOCAAF_02525 | PHI:7809 | adeN | 100 | 0 | 1 | 678 | 1.0000 | 1.0000 | moths | nosocomial infection | TetR type regulator | increased virulence (hypervirulence) |
CKHOCAAF_02559 | PHI:124383 | GigC | 100 | 6.5e-170 | 1 | 295 | 1.0000 | 1.0000 | rodents | nosocomial infection | LysR family regulator | reduced virulence |
CKHOCAAF_02567 | PHI:8937 | nuoI (PA2644) | 77.4 | 1.8e-82 | 4 | 180 | 0.9833 | 0.9615 | moths | nosocomial infection | NADH-quinone oxidoreductase | unaffected pathogenicity |
CKHOCAAF_02639 | PHI:10391 | pcoB (ABUW_3227) | 98 | 1.6e-145 | 1 | 251 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein B | reduced virulence |
CKHOCAAF_02640 | PHI:10392 | pcoA (ABUW_3228) | 97.5 | 0 | 1 | 644 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein A | reduced virulence |
CKHOCAAF_02673 | PHI:7668 | gigA | 100 | 1.5e-191 | 1 | 322 | 1.0000 | 1.0000 | moths | nosocomial infection | noncanonical two-component system (TCS) response regulator (RR) harboring a protein phosphatase domain | reduced virulence |
CKHOCAAF_02674 | PHI:7669 | gigB | 99.4 | 3.7e-93 | 1 | 173 | 1.0000 | 0.9301 | moths | nosocomial infection | anti-sigma factor antagonist | reduced virulence |
CKHOCAAF_02689 | PHI:9285 | trxA | 100 | 2.1e-57 | 1 | 108 | 1.0000 | 1.0000 | rodents | pneumonia | thioredoxin A | reduced virulence |
CKHOCAAF_02691 | PHI:123501 | lirL (ABUW_3278) | 81.4 | 1.5e-15 | 1 | 81 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipoprotein | reduced virulence |
CKHOCAAF_02716 | PHI:11295 | relA (ABUW_3302) | 100 | 0 | 1 | 768 | 1.0000 | 1.0000 | moths | nosocomial infection | GTP pyrophosphokinase | reduced virulence |
CKHOCAAF_02720 | PHI:11841 | barA | 100 | 0 | 1 | 935 | 1.0000 | 1.0000 | rodents | pneumonia | histidine kinase | unaffected pathogenicity |
CKHOCAAF_02791 | PHI:6438 | Ndk | 73.4 | 5.7e-55 | 1 | 143 | 1.0000 | 1.0000 | rodents | nosocomial infection | host-responsive regulator/nucleoside diphosphate kinase | increased virulence (hypervirulence) |
CKHOCAAF_02811 | PHI:3040 | ClpP | 77.6 | 5.7e-85 | 9 | 200 | 0.9552 | 0.9275 | rodents | food poisoning | proteolytic component | reduced virulence |
CKHOCAAF_02859 | PHI:124242 | gltP | 73.1 | 2.7e-169 | 1 | 424 | 0.9907 | 0.9703 | rodents | neonatal meningitis | glutamate transporters | reduced virulence |
CKHOCAAF_02870 | PHI:9979 | leuB (PXO_02610) | 72.9 | 1.5e-144 | 1 | 358 | 0.9972 | 1.0000 | monocots | bacterial leaf blight | 3-isopropylmalate dehydrogenase | reduced virulence |
CKHOCAAF_02872 | PHI:9980 | leuD (PXO_02612) | 72.5 | 1.5e-91 | 1 | 211 | 0.9814 | 0.9814 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase small subunit | reduced virulence |
CKHOCAAF_02873 | PHI:9981 | leuC (PXO_02613) | 74 | 1.2e-208 | 38 | 507 | 0.9234 | 0.9751 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase large subunit | reduced virulence |
CKHOCAAF_02879 | PHI:6089 | katG | 96.4 | 0 | 1 | 718 | 1.0000 | 1.0000 | moths | bacteremia | catalase-peroxidase | increased virulence (hypervirulence) |
CKHOCAAF_02999 | PHI:7860 | RpoB | 99.9 | 0 | 1 | 1357 | 0.9963 | 1.0000 | nematodes | nosocomial infection | beta-subunit of the RNA polymerase | reduced virulence |
CKHOCAAF_03007 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
CKHOCAAF_03015 | PHI:123173 | gspD | 96.7 | 0 | 1 | 758 | 1.0000 | 1.0000 | rodents | urinary tract infection | type II secretion (T2S) system that is responsible for secretion of InvL | reduced virulence |
CKHOCAAF_03029 | PHI:4996 | AbuO | 99.8 | 3.8e-246 | 1 | 448 | 1.0000 | 1.0000 | nematodes | nosocomial infection | outer membrane protein | reduced virulence |
CKHOCAAF_03036 | PHI:11772 | dksA (AlS_0248 ) | 100 | 4.4e-97 | 1 | 178 | 1.0000 | 1.0000 | rodents | nosocomial infection | RNA polymerase-binding transcription factor | reduced virulence |
CKHOCAAF_03048 | PHI:6601 | gacA | 100 | 8e-114 | 1 | 211 | 1.0000 | 1.0000 | bony fishes | bacteremia | response regulator | reduced virulence |
CKHOCAAF_03072 | PHI:11092 | oprD | 99.5 | 9.7e-255 | 1 | 438 | 1.0000 | 1.0000 | rodents | pneumonia | outer membrane protein | reduced virulence |
CKHOCAAF_03141 | PHI:9117 | TonB-dependent copper receptor | 99.3 | 0 | 1 | 704 | 1.0000 | 1.0000 | rodents | nosocomial infection | TonB-dependent copper receptor, outer membraneprotein | reduced virulence |
CKHOCAAF_03197 | PHI:11261 | abaM (ABUW_3775) | 98.6 | 1.3e-75 | 1 | 138 | 1.0000 | 1.0000 | moths | nosocomial infection | DUF4902 domain-containing protein | reduced virulence |
CKHOCAAF_03198 | PHI:8774 | abaI | 95.7 | 1.3e-99 | 1 | 183 | 1.0000 | 1.0000 | moths | nosocomial infection | acyl-homoserine-lactone synthase | reduced virulence |
CKHOCAAF_03263 | PHI:124392 | wzc | 93.8 | 3.3e-98 | 1 | 191 | 1.0000 | 0.9492 | moths | nosocomial infection | multidrug-resistant factor | unaffected pathogenicity |
CKHOCAAF_03420 | PHI:8042 | lpxA | 99.8 | 9.7e-258 | 1 | 454 | 1.0000 | 1.0000 | rodents | pneumonia | N-acetylglucosamine-1-phosphate uridyltransferase | reduced virulence |
CKHOCAAF_03490 | PHI:10612 | lpxC | 100 | 1.6e-171 | 1 | 300 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acyl-N-acetylglucosamine deacetylase | reduced virulence |
CKHOCAAF_03594 | PHI:10701 | hisF (A1S_3245) | 100 | 1.5e-143 | 1 | 252 | 1.0000 | 1.0000 | rodents | pneumonia | imidazole glycerol phosphate synthase cyclase subunit | reduced virulence |
CKHOCAAF_03768 | PHI:11120 | rplN | 74.6 | 3.2e-46 | 1 | 122 | 1.0000 | 1.0000 | primates | pertussis | 50S ribosomal protein | unaffected pathogenicity |
IPHMMGCP_00022 | PHI:10160 | ksgA | 100 | 2e-154 | 1 | 270 | 1.0000 | 1.0000 | nematodes | skin infection; soft tissue infection; urinary tract infection; meningitis; wound infection | 16S rRNA methyltransferase | reduced virulence |
IPHMMGCP_00029 | PHI:5093 | PLD2 | 99.4 | 5.59999999999536e-313 | 1 | 541 | 1.0000 | 0.9963 | moths | nosocomial infection | phospholipases D | reduced virulence |
IPHMMGCP_00080 | PHI:5094 | PLD3 | 99 | 2.2e-284 | 1 | 487 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
IPHMMGCP_00109 | PHI:3243 | lsfA | 79.7 | 2.3e-100 | 1 | 212 | 0.9953 | 1.0000 | rodents | opportunistic infection | 1-Cys peroxiredoxin with thioldependent peroxidase activity | reduced virulence |
IPHMMGCP_00110 | PHI:5240 | secA | 100 | 0 | 1 | 907 | 1.0000 | 1.0000 | moths | nosocomial infection | iron utilization | reduced virulence |
IPHMMGCP_00131 | PHI:9283 | OmpA | 99.7 | 1.7e-201 | 1 | 356 | 1.0000 | 1.0000 | nematodes | pneumonia | outer membrane protein | reduced virulence |
IPHMMGCP_00137 | PHI:11030 | bipA | 70.9 | 2.1e-247 | 4 | 607 | 0.9885 | 0.9852 | rodents | pneumonic plague | putative GTPase | reduced virulence |
IPHMMGCP_00160 | PHI:10421 | PilG (XC_1183) | 75.8 | 2.9e-50 | 8 | 127 | 0.9449 | 0.9023 | eudicots | black rot | single domain response regulator | reduced virulence |
IPHMMGCP_00240 | PHI:6388 | adeK | 100 | 5.8e-269 | 1 | 484 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
IPHMMGCP_00241 | PHI:6387 | adeJ | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
IPHMMGCP_00242 | PHI:6386 | adeI | 100 | 2.5e-220 | 1 | 416 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
IPHMMGCP_00290 | PHI:7130 | greA | 70.9 | 6.7e-57 | 1 | 158 | 1.0000 | 1.0000 | rodents | salmonellosis | transcription elongation factor | loss of pathogenicity |
IPHMMGCP_00292 | PHI:6594 | carA | 71.8 | 3.1e-156 | 1 | 372 | 0.9815 | 0.9841 | eudicots | bacterial speck (tomato) | encodes the predicted small chain of carbamoylphosphate synthetase | reduced virulence |
IPHMMGCP_00317 | PHI:123702 | dgkA (PALES_47610) | 73.8 | 5.1e-44 | 3 | 124 | 0.9839 | 0.9919 | rodents | nosocomial infection | diacyl glycerol kinase | reduced virulence |
IPHMMGCP_00386 | PHI:123761 | pal | 83.5 | 1.4e-82 | 3 | 187 | 0.9893 | 0.9947 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
IPHMMGCP_00387 | PHI:123760 | tolB | 99.8 | 1.5e-244 | 1 | 426 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
IPHMMGCP_00390 | PHI:123757 | TolQ | 99.6 | 5.7e-121 | 1 | 232 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
IPHMMGCP_00498 | PHI:10561 | pstS | 100 | 2.4e-192 | 1 | 343 | 1.0000 | 1.0000 | primates | nosocomial infection | phosphate-binding protein | reduced virulence |
IPHMMGCP_00563 | PHI:3711 | PCC21 _023220 | 72.9 | 1.4e-83 | 8 | 206 | 0.9614 | 0.9614 | eudicots | soft rot | putative DNA-binding protein | reduced virulence |
IPHMMGCP_00575 | PHI:11832 | basD | 96.9 | 0 | 1 | 980 | 1.0000 | 1.0000 | rodents | pneumonia | acinetobactin non-ribosomal peptide synthetase subunit | reduced virulence |
IPHMMGCP_00578 | PHI:11014 | basG | 100 | 7.7e-232 | 1 | 383 | 1.0000 | 1.0000 | rodents | nosocomial infection | histidine decarboxylase | reduced virulence |
IPHMMGCP_00700 | PHI:6492 | lipA | 100 | 5.6e-202 | 1 | 337 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
IPHMMGCP_00728 | PHI:2962 | glyA | 70.7 | 3.8e-168 | 5 | 416 | 0.9880 | 0.9880 | bony fishes | enteric septicemia | serine hydroxymethyltransferase | reduced virulence |
IPHMMGCP_00757 | PHI:124230 | dctA | 72 | 7.6e-170 | 3 | 431 | 0.9491 | 0.9720 | rodents | salmonellosis | primary dicarboxylate importer | unaffected pathogenicity |
IPHMMGCP_00768 | PHI:123321 | thiG (pspto_0434) | 71.8 | 1.3e-102 | 3 | 257 | 0.9770 | 0.9659 | eudicots | bacterial speck | thiazole synthase | reduced virulence |
IPHMMGCP_00851 | PHI:11447 | csrA | 100 | 6.1e-41 | 1 | 84 | 1.0000 | 1.0000 | moths | nosocomial infection | carbon storage regulator | reduced virulence |
IPHMMGCP_00866 | PHI:11207 | clpB | 100 | 0 | 1 | 859 | 1.0000 | 1.0000 | rodents | nosocomial infection | protein disaggregation chaperone | reduced virulence |
IPHMMGCP_00876 | PHI:124297 | TrmB (OB946_12575) | 99.2 | 3.3e-140 | 1 | 238 | 1.0000 | 0.9675 | rodents | nosocomial infection | tRNA methyltransferase | reduced virulence |
IPHMMGCP_00884 | PHI:11383 | ahpC | 71.7 | 5.5e-82 | 1 | 187 | 1.0000 | 1.0000 | moths | salmonellosis | peroxiredoxin | reduced virulence |
IPHMMGCP_00896 | PHI:8812 | CopA (ABUW_2707) | 98.7 | 0 | 1 | 823 | 1.0000 | 1.0000 | rodents | nosocomial infection | copper-translocating P-type ATPase | unaffected pathogenicity |
IPHMMGCP_00993 | PHI:6782 | kdpE | 98.3 | 7.4e-132 | 1 | 238 | 1.0000 | 1.0000 | rodents | pneumonia | potassium-dependent protein | reduced virulence |
IPHMMGCP_01017 | PHI:11023 | hfq | 85.1 | 9.1e-28 | 1 | 67 | 0.3988 | 0.7283 | moths | pleuropneumonia (pig) | RNA chaperone | reduced virulence |
IPHMMGCP_01211 | PHI:10611 | lpxD | 99.7 | 1.6e-202 | 1 | 356 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acylglucosamine N-acyltransferase | reduced virulence |
IPHMMGCP_01212 | PHI:10610 | lpxA | 100 | 7e-86 | 1 | 157 | 0.9752 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
IPHMMGCP_01213 | PHI:10610 | lpxA | 99.6 | 6.6e-150 | 1 | 262 | 1.0000 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
IPHMMGCP_01216 | PHI:10380 | RecA | 100 | 2e-194 | 1 | 349 | 1.0000 | 1.0000 | nematodes | nosocomial infection | DNA strand exchange and recombination protein | reduced virulence |
IPHMMGCP_01278 | PHI:11208 | clpS | 100 | 2.3e-77 | 1 | 137 | 1.0000 | 1.0000 | rodents | nosocomial infection | ATP-dependent Clp protease adapter protein | reduced virulence |
IPHMMGCP_01471 | PHI:6263 | adeA | 99 | 4e-215 | 1 | 396 | 1.0000 | 1.0000 | moths | nosocomial infection | RND MDR efflux system | reduced virulence |
IPHMMGCP_01472 | PHI:6384 | adeB | 99.5 | 0 | 1 | 1036 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
IPHMMGCP_01473 | PHI:6385 | adeC | 97.2 | 1.2e-255 | 1 | 465 | 1.0000 | 0.9915 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
IPHMMGCP_01495 | PHI:5092 | PLD1 | 98.6 | 1.3e-295 | 1 | 508 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
IPHMMGCP_01566 | PHI:6492 | lipA | 75.5 | 1.2e-148 | 1 | 319 | 0.9726 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
IPHMMGCP_01590 | PHI:123759 | tolA | 98.4 | 4.9e-63 | 1 | 124 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
IPHMMGCP_01644 | PHI:6892 | iscU | 83.2 | 3.8e-58 | 1 | 125 | 0.9766 | 0.9766 | rodents | salmonellosis | Fe-S cluster sensor | reduced virulence |
IPHMMGCP_01763 | PHI:11868 | otsA | 100 | 0 | 1 | 813 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein A | reduced virulence |
IPHMMGCP_01931 | PHI:6090 | katE | 100 | 0 | 1 | 712 | 1.0000 | 1.0000 | moths | bacteremia | hydroperoxidase | increased virulence (hypervirulence) |
IPHMMGCP_02055 | PHI:5090 | tssM | 97 | 0 | 28 | 1274 | 0.9788 | 1.0000 | moths | nosocomial infection | T6SS effector | effector (plant avirulence determinant) |
IPHMMGCP_02094 | PHI:7862 | vgrG | 73 | 3.7e-98 | 742 | 996 | 0.2410 | 0.8339 | rodents | nosocomial infection | T6SS component (valine-glycine repeat G) | reduced virulence |
IPHMMGCP_02270 | PHI:9898 | ata | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | primates | nosocomial infection | trimeric autotransporter adhesin | reduced virulence |
IPHMMGCP_02376 | PHI:7520 | VK055_1952 | 75.2 | 2.3e-212 | 8 | 490 | 0.9857 | 0.9918 | rodents | pneumonia | betaine aldehyde dehydrogenase | unaffected pathogenicity |
IPHMMGCP_02413 | PHI:10510 | ggt | 99.2 | 0 | 1 | 661 | 1.0000 | 1.0000 | rodents | nosocomial infection | gamma-glutamyltransferase | reduced virulence |
IPHMMGCP_02460 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
IPHMMGCP_02521 | PHI:11869 | otsB | 99.3 | 9.6e-163 | 1 | 283 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein B | unaffected pathogenicity |
IPHMMGCP_02525 | PHI:7809 | adeN | 100 | 0 | 1 | 678 | 1.0000 | 1.0000 | moths | nosocomial infection | TetR type regulator | increased virulence (hypervirulence) |
IPHMMGCP_02559 | PHI:124383 | GigC | 100 | 6.5e-170 | 1 | 295 | 1.0000 | 1.0000 | rodents | nosocomial infection | LysR family regulator | reduced virulence |
IPHMMGCP_02567 | PHI:8937 | nuoI (PA2644) | 77.4 | 1.8e-82 | 4 | 180 | 0.9833 | 0.9615 | moths | nosocomial infection | NADH-quinone oxidoreductase | unaffected pathogenicity |
IPHMMGCP_02639 | PHI:10391 | pcoB (ABUW_3227) | 98 | 1.6e-145 | 1 | 251 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein B | reduced virulence |
IPHMMGCP_02640 | PHI:10392 | pcoA (ABUW_3228) | 97.5 | 0 | 1 | 644 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein A | reduced virulence |
IPHMMGCP_02673 | PHI:7668 | gigA | 100 | 1.5e-191 | 1 | 322 | 1.0000 | 1.0000 | moths | nosocomial infection | noncanonical two-component system (TCS) response regulator (RR) harboring a protein phosphatase domain | reduced virulence |
IPHMMGCP_02674 | PHI:7669 | gigB | 99.4 | 3.7e-93 | 1 | 173 | 1.0000 | 0.9301 | moths | nosocomial infection | anti-sigma factor antagonist | reduced virulence |
IPHMMGCP_02689 | PHI:9285 | trxA | 100 | 2.1e-57 | 1 | 108 | 1.0000 | 1.0000 | rodents | pneumonia | thioredoxin A | reduced virulence |
IPHMMGCP_02691 | PHI:123501 | lirL (ABUW_3278) | 81.4 | 1.5e-15 | 1 | 81 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipoprotein | reduced virulence |
IPHMMGCP_02716 | PHI:11295 | relA (ABUW_3302) | 100 | 0 | 1 | 768 | 1.0000 | 1.0000 | moths | nosocomial infection | GTP pyrophosphokinase | reduced virulence |
IPHMMGCP_02720 | PHI:11841 | barA | 100 | 0 | 1 | 935 | 1.0000 | 1.0000 | rodents | pneumonia | histidine kinase | unaffected pathogenicity |
IPHMMGCP_02791 | PHI:6438 | Ndk | 73.4 | 5.7e-55 | 1 | 143 | 1.0000 | 1.0000 | rodents | nosocomial infection | host-responsive regulator/nucleoside diphosphate kinase | increased virulence (hypervirulence) |
IPHMMGCP_02811 | PHI:3040 | ClpP | 77.6 | 5.7e-85 | 9 | 200 | 0.9552 | 0.9275 | rodents | food poisoning | proteolytic component | reduced virulence |
IPHMMGCP_02859 | PHI:124242 | gltP | 73.1 | 2.7e-169 | 1 | 424 | 0.9907 | 0.9703 | rodents | neonatal meningitis | glutamate transporters | reduced virulence |
IPHMMGCP_02870 | PHI:9979 | leuB (PXO_02610) | 72.9 | 1.5e-144 | 1 | 358 | 0.9972 | 1.0000 | monocots | bacterial leaf blight | 3-isopropylmalate dehydrogenase | reduced virulence |
IPHMMGCP_02872 | PHI:9980 | leuD (PXO_02612) | 72.5 | 1.5e-91 | 1 | 211 | 0.9814 | 0.9814 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase small subunit | reduced virulence |
IPHMMGCP_02873 | PHI:9981 | leuC (PXO_02613) | 74 | 1.2e-208 | 38 | 507 | 0.9234 | 0.9751 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase large subunit | reduced virulence |
IPHMMGCP_02879 | PHI:6089 | katG | 96.4 | 0 | 1 | 718 | 1.0000 | 1.0000 | moths | bacteremia | catalase-peroxidase | increased virulence (hypervirulence) |
IPHMMGCP_02999 | PHI:7860 | RpoB | 99.9 | 0 | 1 | 1357 | 0.9963 | 1.0000 | nematodes | nosocomial infection | beta-subunit of the RNA polymerase | reduced virulence |
IPHMMGCP_03007 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
IPHMMGCP_03015 | PHI:123173 | gspD | 96.7 | 0 | 1 | 758 | 1.0000 | 1.0000 | rodents | urinary tract infection | type II secretion (T2S) system that is responsible for secretion of InvL | reduced virulence |
IPHMMGCP_03029 | PHI:4996 | AbuO | 99.8 | 3.8e-246 | 1 | 448 | 1.0000 | 1.0000 | nematodes | nosocomial infection | outer membrane protein | reduced virulence |
IPHMMGCP_03036 | PHI:11772 | dksA (AlS_0248 ) | 100 | 4.4e-97 | 1 | 178 | 1.0000 | 1.0000 | rodents | nosocomial infection | RNA polymerase-binding transcription factor | reduced virulence |
IPHMMGCP_03048 | PHI:6601 | gacA | 100 | 8e-114 | 1 | 211 | 1.0000 | 1.0000 | bony fishes | bacteremia | response regulator | reduced virulence |
IPHMMGCP_03072 | PHI:11092 | oprD | 99.5 | 9.7e-255 | 1 | 438 | 1.0000 | 1.0000 | rodents | pneumonia | outer membrane protein | reduced virulence |
IPHMMGCP_03141 | PHI:9117 | TonB-dependent copper receptor | 99.3 | 0 | 1 | 704 | 1.0000 | 1.0000 | rodents | nosocomial infection | TonB-dependent copper receptor, outer membraneprotein | reduced virulence |
IPHMMGCP_03197 | PHI:11261 | abaM (ABUW_3775) | 98.6 | 1.3e-75 | 1 | 138 | 1.0000 | 1.0000 | moths | nosocomial infection | DUF4902 domain-containing protein | reduced virulence |
IPHMMGCP_03198 | PHI:8774 | abaI | 95.7 | 1.3e-99 | 1 | 183 | 1.0000 | 1.0000 | moths | nosocomial infection | acyl-homoserine-lactone synthase | reduced virulence |
IPHMMGCP_03263 | PHI:124392 | wzc | 93.8 | 3.3e-98 | 1 | 191 | 1.0000 | 0.9492 | moths | nosocomial infection | multidrug-resistant factor | unaffected pathogenicity |
IPHMMGCP_03420 | PHI:8042 | lpxA | 99.8 | 9.7e-258 | 1 | 454 | 1.0000 | 1.0000 | rodents | pneumonia | N-acetylglucosamine-1-phosphate uridyltransferase | reduced virulence |
IPHMMGCP_03490 | PHI:10612 | lpxC | 100 | 1.6e-171 | 1 | 300 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acyl-N-acetylglucosamine deacetylase | reduced virulence |
IPHMMGCP_03594 | PHI:10701 | hisF (A1S_3245) | 100 | 1.5e-143 | 1 | 252 | 1.0000 | 1.0000 | rodents | pneumonia | imidazole glycerol phosphate synthase cyclase subunit | reduced virulence |
IPHMMGCP_03768 | PHI:11120 | rplN | 74.6 | 3.2e-46 | 1 | 122 | 1.0000 | 1.0000 | primates | pertussis | 50S ribosomal protein | unaffected pathogenicity |
Gene Name | cazy_id | identity | evalue | qstart | qend | query_coverage | subject_coverage |
---|---|---|---|---|---|---|---|
JJEBMEPF_00070 | QAS32082.1|GT2 | 100 | 5.08e-184 | 1 | 254 | 1 | 1 |
JJEBMEPF_00071 | QAS32083.1|GT4 | 100 | 2.1e-244 | 1 | 344 | 1 | 1 |
JJEBMEPF_00073 | AOX78865.1|GT25 | 100 | 1.29e-180 | 1 | 251 | 1 | 1 |
JJEBMEPF_00270 | WGE29869.1|GT51 | 73 | 9.7e-121 | 8 | 232 | 0.9534 | 0.9664 |
JJEBMEPF_00323 | ATR86548.1|GH23 | 100 | 4.39e-206 | 1 | 287 | 1 | 1 |
JJEBMEPF_00326 | AOX98022.1|GH23 | 100 | 2.66e-267 | 1 | 370 | 1 | 1 |
JJEBMEPF_00355 | QIX37454.1|GT83 | 100 | 0 | 1 | 548 | 1 | 1 |
JJEBMEPF_00357 | APQ88223.1|GT2 | 100 | 2.42e-234 | 1 | 326 | 1 | 1 |
JJEBMEPF_00458 | APQ84458.1|GT2 | 100 | 6.05999999999999e-310 | 1 | 416 | 1 | 1 |
JJEBMEPF_00514 | ANA38132.1|CBM50 | 100 | 1.13e-182 | 1 | 276 | 1 | 1 |
JJEBMEPF_00662 | QJJ19891.1|GH23 | 99.8 | 0 | 1 | 1323 | 1 | 1 |
JJEBMEPF_00674 | ATR88521.1|GH108 | 97.8 | 1.57e-126 | 1 | 181 | 1 | 1 |
JJEBMEPF_00717 | ATU48435.1|GH103 | 100 | 1.32e-246 | 1 | 333 | 1 | 1 |
JJEBMEPF_00753 | QEY30565.1|GT51 | 100 | 0 | 1 | 798 | 1 | 1 |
JJEBMEPF_00783 | AKG15280.2|GH103 | 70.4 | 3.79e-259 | 1 | 510 | 0.9942 | 0.9941 |
JJEBMEPF_00807 | AML67670.1|GT2 | 100 | 1.59e-158 | 1 | 214 | 1 | 1 |
JJEBMEPF_00910 | ATU53314.1|GH108 | 100 | 8.75e-133 | 1 | 181 | 1 | 1 |
JJEBMEPF_00967 | QIX37992.1|CE4 | 100 | 0 | 1 | 609 | 1 | 1 |
JJEBMEPF_00968 | APJ22767.1|GT2 | 100 | 9.68000000000016e-311 | 1 | 415 | 1 | 1 |
JJEBMEPF_01152 | BBK05597.1|GH108 | 98.9 | 3.29e-128 | 1 | 181 | 1 | 1 |
JJEBMEPF_01605 | ADX03790.1|GT19 | 100 | 2.15e-279 | 1 | 391 | 1 | 1 |
JJEBMEPF_01678 | AJB47685.1|GH24 | 100 | 1.66e-122 | 1 | 169 | 1 | 1 |
JJEBMEPF_01689 | AVO91316.1|GH23 | 96.5 | 0 | 1 | 1230 | 1 | 1 |
JJEBMEPF_02172 | QCO83219.1|CBM50|GH23 | 100 | 0 | 1 | 1020 | 0.9524 | 0.9524 |
JJEBMEPF_02197 | QEK75169.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
JJEBMEPF_02204 | QIT17608.1|GH23 | 77.9 | 0 | 1 | 1436 | 1 | 1 |
JJEBMEPF_02312 | AVE91107.1|GT51 | 100 | 6.95e-163 | 1 | 225 | 1 | 1 |
JJEBMEPF_02364 | AYX93578.1|GT2 | 100 | 4.81999999999389e-313 | 1 | 419 | 1 | 1 |
JJEBMEPF_02365 | ARG24489.1|CE4|GH153 | 100 | 0 | 1 | 664 | 1 | 1 |
JJEBMEPF_02505 | ARG29438.1|CBM50 | 100 | 1.7e-107 | 1 | 157 | 1 | 1 |
JJEBMEPF_02522 | ATP88286.1|GT20 | 100 | 0 | 1 | 476 | 1 | 1 |
JJEBMEPF_02776 | AYY15968.1|GT2 | 100 | 8.16e-186 | 1 | 246 | 1 | 1 |
JJEBMEPF_02794 | AVI31166.1|GT4 | 99.8 | 2.49999999867454e-315 | 1 | 428 | 1 | 1 |
JJEBMEPF_02796 | ANC37654.1|GH3 | 99.7 | 5.56e-242 | 1 | 339 | 1 | 1 |
JJEBMEPF_02858 | QDM65392.1|GT4 | 99.5 | 1.37e-267 | 1 | 366 | 1 | 1 |
JJEBMEPF_03084 | QJG77902.1|GH25 | 100 | 8.84e-193 | 1 | 252 | 1 | 1 |
JJEBMEPF_03093 | SCD14283.1|GH23 | 100 | 8.33e-115 | 1 | 162 | 1 | 1 |
JJEBMEPF_03144 | QBR75888.1|CBM50 | 100 | 4.4e-289 | 1 | 384 | 1 | 1 |
JJEBMEPF_03248 | QHB12949.1|GT4 | 98.4 | 3.86e-279 | 1 | 385 | 1 | 1 |
JJEBMEPF_03249 | AIL74106.1|GT4 | 94.6 | 4.28e-251 | 1 | 367 | 1 | 1 |
JJEBMEPF_03253 | AHB32859.1|GT2 | 99.4 | 5.07e-232 | 1 | 318 | 1 | 1 |
JJEBMEPF_03338 | AFI97357.1|GH103 | 99.8 | 4.1600000011936e-315 | 1 | 430 | 1 | 1 |
JJEBMEPF_03447 | AFU36206.1|CBM50 | 100 | 0 | 1 | 746 | 1 | 1 |
JJEBMEPF_03467 | AML72438.1|CE4 | 100 | 7.64e-249 | 1 | 321 | 1 | 1 |
JJEBMEPF_03484 | QJF29347.1|GT28 | 100 | 1.52e-259 | 1 | 365 | 1 | 1 |
JJEBMEPF_03490 | APO57399.1|CE11 | 100 | 1.04e-215 | 1 | 300 | 1 | 1 |
JJEBMEPF_03509 | QDQ58752.1|GT30 | 100 | 0 | 1 | 430 | 1 | 1 |
JJEBMEPF_03644 | AJB65579.1|GT51 | 100 | 0 | 1 | 851 | 1 | 1 |
JJEBMEPF_03809 | CAD7285530.1|AA6 | 87.3 | 2.25e-104 | 19 | 184 | 0.8426 | 1 |
JJEBMEPF_03817 | AOX90633.1|GH23 | 100 | 0 | 1 | 661 | 1 | 1 |
CKHOCAAF_00070 | QAS32082.1|GT2 | 100 | 5.08e-184 | 1 | 254 | 1 | 1 |
CKHOCAAF_00071 | QAS32083.1|GT4 | 100 | 2.1e-244 | 1 | 344 | 1 | 1 |
CKHOCAAF_00073 | AOX78865.1|GT25 | 100 | 1.29e-180 | 1 | 251 | 1 | 1 |
CKHOCAAF_00270 | WGE29869.1|GT51 | 73 | 9.7e-121 | 8 | 232 | 0.9534 | 0.9664 |
CKHOCAAF_00323 | ATR86548.1|GH23 | 100 | 4.39e-206 | 1 | 287 | 1 | 1 |
CKHOCAAF_00326 | AOX98022.1|GH23 | 100 | 2.66e-267 | 1 | 370 | 1 | 1 |
CKHOCAAF_00355 | QIX37454.1|GT83 | 100 | 0 | 1 | 548 | 1 | 1 |
CKHOCAAF_00357 | APQ88223.1|GT2 | 100 | 2.42e-234 | 1 | 326 | 1 | 1 |
CKHOCAAF_00458 | APQ84458.1|GT2 | 100 | 6.05999999999999e-310 | 1 | 416 | 1 | 1 |
CKHOCAAF_00514 | ANA38132.1|CBM50 | 100 | 1.13e-182 | 1 | 276 | 1 | 1 |
CKHOCAAF_00662 | QJJ19891.1|GH23 | 99.8 | 0 | 1 | 1323 | 1 | 1 |
CKHOCAAF_00674 | ATR88521.1|GH108 | 97.8 | 1.57e-126 | 1 | 181 | 1 | 1 |
CKHOCAAF_00717 | ATU48435.1|GH103 | 100 | 1.32e-246 | 1 | 333 | 1 | 1 |
CKHOCAAF_00753 | QEY30565.1|GT51 | 100 | 0 | 1 | 798 | 1 | 1 |
CKHOCAAF_00783 | AKG15280.2|GH103 | 70.4 | 3.79e-259 | 1 | 510 | 0.9942 | 0.9941 |
CKHOCAAF_00807 | AML67670.1|GT2 | 100 | 1.59e-158 | 1 | 214 | 1 | 1 |
CKHOCAAF_00910 | ATU53314.1|GH108 | 100 | 8.75e-133 | 1 | 181 | 1 | 1 |
CKHOCAAF_00967 | QIX37992.1|CE4 | 100 | 0 | 1 | 609 | 1 | 1 |
CKHOCAAF_00968 | APJ22767.1|GT2 | 100 | 9.68000000000016e-311 | 1 | 415 | 1 | 1 |
CKHOCAAF_01152 | BBK05597.1|GH108 | 98.9 | 3.29e-128 | 1 | 181 | 1 | 1 |
CKHOCAAF_01605 | ADX03790.1|GT19 | 100 | 2.15e-279 | 1 | 391 | 1 | 1 |
CKHOCAAF_01678 | AJB47685.1|GH24 | 100 | 1.66e-122 | 1 | 169 | 1 | 1 |
CKHOCAAF_01689 | AVO91316.1|GH23 | 96.5 | 0 | 1 | 1230 | 1 | 1 |
CKHOCAAF_02172 | QCO83219.1|CBM50|GH23 | 100 | 0 | 1 | 1020 | 0.9524 | 0.9524 |
CKHOCAAF_02197 | QEK75169.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
CKHOCAAF_02204 | QIT17608.1|GH23 | 77.9 | 0 | 1 | 1436 | 1 | 1 |
CKHOCAAF_02312 | AVE91107.1|GT51 | 100 | 6.95e-163 | 1 | 225 | 1 | 1 |
CKHOCAAF_02364 | AYX93578.1|GT2 | 100 | 4.81999999999389e-313 | 1 | 419 | 1 | 1 |
CKHOCAAF_02365 | ARG24489.1|CE4|GH153 | 100 | 0 | 1 | 664 | 1 | 1 |
CKHOCAAF_02505 | ARG29438.1|CBM50 | 100 | 1.7e-107 | 1 | 157 | 1 | 1 |
CKHOCAAF_02522 | ATP88286.1|GT20 | 100 | 0 | 1 | 476 | 1 | 1 |
CKHOCAAF_02776 | AYY15968.1|GT2 | 100 | 8.16e-186 | 1 | 246 | 1 | 1 |
CKHOCAAF_02794 | AVI31166.1|GT4 | 99.8 | 2.49999999867454e-315 | 1 | 428 | 1 | 1 |
CKHOCAAF_02796 | ANC37654.1|GH3 | 99.7 | 5.56e-242 | 1 | 339 | 1 | 1 |
CKHOCAAF_02858 | QDM65392.1|GT4 | 99.5 | 1.37e-267 | 1 | 366 | 1 | 1 |
CKHOCAAF_03084 | QJG77902.1|GH25 | 100 | 8.84e-193 | 1 | 252 | 1 | 1 |
CKHOCAAF_03093 | SCD14283.1|GH23 | 100 | 8.33e-115 | 1 | 162 | 1 | 1 |
CKHOCAAF_03144 | QBR75888.1|CBM50 | 100 | 4.4e-289 | 1 | 384 | 1 | 1 |
CKHOCAAF_03248 | QHB12949.1|GT4 | 98.4 | 3.86e-279 | 1 | 385 | 1 | 1 |
CKHOCAAF_03249 | AIL74106.1|GT4 | 94.6 | 4.28e-251 | 1 | 367 | 1 | 1 |
CKHOCAAF_03253 | AHB32859.1|GT2 | 99.4 | 5.07e-232 | 1 | 318 | 1 | 1 |
CKHOCAAF_03338 | AFI97357.1|GH103 | 99.8 | 4.1600000011936e-315 | 1 | 430 | 1 | 1 |
CKHOCAAF_03447 | AFU36206.1|CBM50 | 100 | 0 | 1 | 746 | 1 | 1 |
CKHOCAAF_03467 | AML72438.1|CE4 | 100 | 7.64e-249 | 1 | 321 | 1 | 1 |
CKHOCAAF_03484 | QJF29347.1|GT28 | 100 | 1.52e-259 | 1 | 365 | 1 | 1 |
CKHOCAAF_03490 | APO57399.1|CE11 | 100 | 1.04e-215 | 1 | 300 | 1 | 1 |
CKHOCAAF_03509 | QDQ58752.1|GT30 | 100 | 0 | 1 | 430 | 1 | 1 |
CKHOCAAF_03644 | AJB65579.1|GT51 | 100 | 0 | 1 | 851 | 1 | 1 |
CKHOCAAF_03809 | CAD7285530.1|AA6 | 87.3 | 2.25e-104 | 19 | 184 | 0.8426 | 1 |
CKHOCAAF_03817 | AOX90633.1|GH23 | 100 | 0 | 1 | 661 | 1 | 1 |
IPHMMGCP_00070 | QAS32082.1|GT2 | 100 | 5.08e-184 | 1 | 254 | 1 | 1 |
IPHMMGCP_00071 | QAS32083.1|GT4 | 100 | 2.1e-244 | 1 | 344 | 1 | 1 |
IPHMMGCP_00073 | AOX78865.1|GT25 | 100 | 1.29e-180 | 1 | 251 | 1 | 1 |
IPHMMGCP_00270 | WGE29869.1|GT51 | 73 | 9.7e-121 | 8 | 232 | 0.9534 | 0.9664 |
IPHMMGCP_00323 | ATR86548.1|GH23 | 100 | 4.39e-206 | 1 | 287 | 1 | 1 |
IPHMMGCP_00326 | AOX98022.1|GH23 | 100 | 2.66e-267 | 1 | 370 | 1 | 1 |
IPHMMGCP_00355 | QIX37454.1|GT83 | 100 | 0 | 1 | 548 | 1 | 1 |
IPHMMGCP_00357 | APQ88223.1|GT2 | 100 | 2.42e-234 | 1 | 326 | 1 | 1 |
IPHMMGCP_00458 | APQ84458.1|GT2 | 100 | 6.05999999999999e-310 | 1 | 416 | 1 | 1 |
IPHMMGCP_00514 | ANA38132.1|CBM50 | 100 | 1.13e-182 | 1 | 276 | 1 | 1 |
IPHMMGCP_00662 | QJJ19891.1|GH23 | 99.8 | 0 | 1 | 1323 | 1 | 1 |
IPHMMGCP_00674 | ATR88521.1|GH108 | 97.8 | 1.57e-126 | 1 | 181 | 1 | 1 |
IPHMMGCP_00717 | ATU48435.1|GH103 | 100 | 1.32e-246 | 1 | 333 | 1 | 1 |
IPHMMGCP_00753 | QEY30565.1|GT51 | 100 | 0 | 1 | 798 | 1 | 1 |
IPHMMGCP_00783 | AKG15280.2|GH103 | 70.4 | 3.79e-259 | 1 | 510 | 0.9942 | 0.9941 |
IPHMMGCP_00807 | AML67670.1|GT2 | 100 | 1.59e-158 | 1 | 214 | 1 | 1 |
IPHMMGCP_00910 | ATU53314.1|GH108 | 100 | 8.75e-133 | 1 | 181 | 1 | 1 |
IPHMMGCP_00967 | QIX37992.1|CE4 | 100 | 0 | 1 | 609 | 1 | 1 |
IPHMMGCP_00968 | APJ22767.1|GT2 | 100 | 9.68000000000016e-311 | 1 | 415 | 1 | 1 |
IPHMMGCP_01152 | BBK05597.1|GH108 | 98.9 | 3.29e-128 | 1 | 181 | 1 | 1 |
IPHMMGCP_01605 | ADX03790.1|GT19 | 100 | 2.15e-279 | 1 | 391 | 1 | 1 |
IPHMMGCP_01678 | AJB47685.1|GH24 | 100 | 1.66e-122 | 1 | 169 | 1 | 1 |
IPHMMGCP_01689 | AVO91316.1|GH23 | 96.5 | 0 | 1 | 1230 | 1 | 1 |
IPHMMGCP_02172 | QCO83219.1|CBM50|GH23 | 100 | 0 | 1 | 1020 | 0.9524 | 0.9524 |
IPHMMGCP_02197 | QEK75169.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
IPHMMGCP_02204 | QIT17608.1|GH23 | 77.9 | 0 | 1 | 1436 | 1 | 1 |
IPHMMGCP_02312 | AVE91107.1|GT51 | 100 | 6.95e-163 | 1 | 225 | 1 | 1 |
IPHMMGCP_02364 | AYX93578.1|GT2 | 100 | 4.81999999999389e-313 | 1 | 419 | 1 | 1 |
IPHMMGCP_02365 | ARG24489.1|CE4|GH153 | 100 | 0 | 1 | 664 | 1 | 1 |
IPHMMGCP_02505 | ARG29438.1|CBM50 | 100 | 1.7e-107 | 1 | 157 | 1 | 1 |
IPHMMGCP_02522 | ATP88286.1|GT20 | 100 | 0 | 1 | 476 | 1 | 1 |
IPHMMGCP_02776 | AYY15968.1|GT2 | 100 | 8.16e-186 | 1 | 246 | 1 | 1 |
IPHMMGCP_02794 | AVI31166.1|GT4 | 99.8 | 2.49999999867454e-315 | 1 | 428 | 1 | 1 |
IPHMMGCP_02796 | ANC37654.1|GH3 | 99.7 | 5.56e-242 | 1 | 339 | 1 | 1 |
IPHMMGCP_02858 | QDM65392.1|GT4 | 99.5 | 1.37e-267 | 1 | 366 | 1 | 1 |
IPHMMGCP_03084 | QJG77902.1|GH25 | 100 | 8.84e-193 | 1 | 252 | 1 | 1 |
IPHMMGCP_03093 | SCD14283.1|GH23 | 100 | 8.33e-115 | 1 | 162 | 1 | 1 |
IPHMMGCP_03144 | QBR75888.1|CBM50 | 100 | 4.4e-289 | 1 | 384 | 1 | 1 |
IPHMMGCP_03248 | QHB12949.1|GT4 | 98.4 | 3.86e-279 | 1 | 385 | 1 | 1 |
IPHMMGCP_03249 | AIL74106.1|GT4 | 94.6 | 4.28e-251 | 1 | 367 | 1 | 1 |
IPHMMGCP_03253 | AHB32859.1|GT2 | 99.4 | 5.07e-232 | 1 | 318 | 1 | 1 |
IPHMMGCP_03338 | AFI97357.1|GH103 | 99.8 | 4.1600000011936e-315 | 1 | 430 | 1 | 1 |
IPHMMGCP_03447 | AFU36206.1|CBM50 | 100 | 0 | 1 | 746 | 1 | 1 |
IPHMMGCP_03467 | AML72438.1|CE4 | 100 | 7.64e-249 | 1 | 321 | 1 | 1 |
IPHMMGCP_03484 | QJF29347.1|GT28 | 100 | 1.52e-259 | 1 | 365 | 1 | 1 |
IPHMMGCP_03490 | APO57399.1|CE11 | 100 | 1.04e-215 | 1 | 300 | 1 | 1 |
IPHMMGCP_03509 | QDQ58752.1|GT30 | 100 | 0 | 1 | 430 | 1 | 1 |
IPHMMGCP_03644 | AJB65579.1|GT51 | 100 | 0 | 1 | 851 | 1 | 1 |
IPHMMGCP_03809 | CAD7285530.1|AA6 | 87.3 | 2.25e-104 | 19 | 184 | 0.8426 | 1 |
IPHMMGCP_03817 | AOX90633.1|GH23 | 100 | 0 | 1 | 661 | 1 | 1 |
Gene Name | tcid | identity | evalue | qstart | qend | query_coverage | subject_coverage | class_field | class_term | subclass | subclass_term | family | family_term |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JJEBMEPF_00031 | 1.B.6.1.26 | 100 | 7.5e-88 | 1 | 159 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
JJEBMEPF_00131 | 1.B.6.1.24 | 99.7 | 3.9e-201 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
JJEBMEPF_00157 | 2.A.6.3.3 | 100 | 0 | 22 | 1032 | 0.9797 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00240 | 2.A.6.2.29 | 100 | 1.3e-268 | 1 | 484 | 1.0000 | 1.1635 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00241 | 2.A.6.2.29 | 99.9 | 0 | 1 | 1058 | 1.0000 | 2.5433 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00242 | 2.A.6.2.29 | 100 | 5.7e-220 | 1 | 416 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00388 | 1.C.1.2.4 | 93.6 | 2.4e-192 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
JJEBMEPF_00409 | 1.B.63.1.1 | 100 | 4.8e-142 | 1 | 246 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.63 | The Imipenum resistance-associated porin, CarO (CarO) Family |
JJEBMEPF_00473 | 2.A.23.1.8 | 80.1 | 1e-198 | 1 | 463 | 0.9978 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
JJEBMEPF_00705 | 1.B.39.3.1 | 99.2 | 1.8e-203 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.39 | The Bacterial Porin, OmpW (OmpW) Family |
JJEBMEPF_00729 | 2.A.6.2.44 | 99.6 | 9e-262 | 1 | 482 | 1.0000 | 1.1872 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00730 | 2.A.6.2.44 | 99.8 | 0 | 1 | 1059 | 1.0000 | 2.6084 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00731 | 2.A.6.2.44 | 100 | 2.1e-219 | 1 | 406 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_00737 | 3.A.1.3.29 | 72.3 | 1.5e-101 | 6 | 258 | 0.9806 | 1.1096 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
JJEBMEPF_00738 | 2.A.7.1.11 | 100 | 1.6e-52 | 1 | 109 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
JJEBMEPF_00757 | 2.A.23.1.10 | 73.3 | 1.8e-171 | 3 | 429 | 0.9447 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
JJEBMEPF_00823 | 1.B.11.6.1 | 99.5 | 0 | 1 | 832 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.11 | The Outer Membrane Fimbrial Usher Porin (FUP) Family |
JJEBMEPF_00873 | 1.B.6.13.5 | 100 | 1.1e-256 | 1 | 471 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
JJEBMEPF_00887 | 1.B.25.1.38 | 94 | 3.6e-238 | 1 | 420 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
JJEBMEPF_00889 | 2.A.46.1.1 | 79.9 | 1.7e-173 | 1 | 388 | 0.9773 | 0.9848 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.46 | The Benzoate:H+ Symporter (BenE) Family |
JJEBMEPF_00935 | 2.A.23.1.3 | 72.4 | 1.4e-160 | 14 | 426 | 0.9560 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
JJEBMEPF_01072 | 2.A.117.1.1 | 97.6 | 1.3e-90 | 1 | 170 | 1.0000 | 0.9497 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.117 | The Chlorhexadine Exporter (CHX) Family |
JJEBMEPF_01078 | 2.A.1.3.43 | 99 | 9.2e-262 | 1 | 492 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_01319 | 1.B.25.1.38 | 98.1 | 1.2e-249 | 1 | 418 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
JJEBMEPF_01385 | 1.B.20.1.12 | 96.4 | 0 | 1 | 581 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.20 | The Two-Partner Secretion (TPS) Family |
JJEBMEPF_01396 | 2.A.7.21.5 | 73.2 | 5.4e-53 | 1 | 142 | 0.9861 | 0.9404 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
JJEBMEPF_01397 | 2.A.7.21.5 | 76.2 | 8.5e-57 | 5 | 151 | 0.9671 | 0.9735 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
JJEBMEPF_01471 | 2.A.6.2.40 | 99 | 8.9e-215 | 1 | 396 | 1.0000 | 0.9925 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_01472 | 2.A.6.2.40 | 99.5 | 0 | 1 | 1036 | 1.0000 | 2.5965 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_01473 | 2.A.6.2.40 | 97.2 | 2.7e-255 | 1 | 465 | 1.0000 | 1.1654 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
JJEBMEPF_01517 | 9.B.153.4.2 | 100 | 9.3e-191 | 1 | 315 | 1.0000 | 1.0000 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.153 | The Putative Beta-Barrel Porin/Alpha Amylase or Phenol_MetA-deg (BBP/AA) Family |
JJEBMEPF_01549 | 2.A.51.1.4 | 70.6 | 4.6e-183 | 9 | 447 | 0.9777 | 0.9648 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.51 | The Chromate Ion Transporter (CHR) Family |
JJEBMEPF_01628 | 2.A.1.3.63 | 99 | 6.6e-265 | 1 | 479 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_01679 | 1.E.25.1.7 | 88.1 | 1.1e-27 | 1 | 67 | 0.7614 | 0.8072 | 1 | Channels/Pores | 1.E | Holins | 1.E.25 | The <i>Pseudomonas</i> phage F116 Holin (F116 Holin) Family |
JJEBMEPF_01781 | 2.A.21.2.3 | 71.7 | 1e-199 | 1 | 495 | 0.9980 | 0.9783 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.21 | The Solute:Sodium Symporter (SSS) Family |
JJEBMEPF_01825 | 3.A.1.3.22 | 75.5 | 1.8e-104 | 3 | 243 | 0.9757 | 0.9877 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
JJEBMEPF_01889 | 2.A.70.1.2 | 79.3 | 4.1e-104 | 9 | 254 | 0.9685 | 1.5092 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
JJEBMEPF_01890 | 2.A.70.1.2 | 71.2 | 2.1e-38 | 1 | 125 | 0.8993 | 0.7669 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
JJEBMEPF_01911 | 1.S.8.1.1 | 74.4 | 8.2e-131 | 5 | 308 | 0.9806 | 0.9967 | 1 | Channels/Pores | 1.S | Bacterial Micro/NanoCompartment Shell Protein Pores | 1.S.8 | The Bacterial/Archaeal Nanocompartment Encapsulin Shell Protein3 (BANC-SP3) Family |
JJEBMEPF_01974 | 2.A.1.15.4 | 90.2 | 8.5e-208 | 10 | 416 | 0.9784 | 0.9831 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_02048 | 3.A.23.4.1 | 98.9 | 1.2e-149 | 1 | 268 | 1.0000 | 0.7363 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02049 | 3.A.23.4.1 | 98.7 | 1.7e-257 | 1 | 454 | 1.0000 | 1.2473 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02050 | 3.A.23.4.1 | 95.6 | 4.7e-202 | 1 | 364 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02051 | 3.A.23.4.1 | 97.2 | 0 | 1 | 892 | 1.0000 | 2.4533 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02055 | 3.A.23.4.1 | 97 | 0 | 28 | 1274 | 0.9788 | 3.4396 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02057 | 3.A.23.4.1 | 95.5 | 2.8e-185 | 1 | 332 | 1.0000 | 0.9121 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02058 | 3.A.23.4.1 | 98.2 | 0 | 1 | 603 | 1.0000 | 1.6566 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02061 | 3.A.23.4.1 | 99.4 | 2.7e-285 | 1 | 493 | 1.0000 | 1.3544 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
JJEBMEPF_02270 | 1.B.40.2.6 | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.40 | The Autotransporter-2 (AT-2) Family |
JJEBMEPF_02383 | 9.B.143.1.2 | 76.3 | 2e-89 | 1 | 232 | 0.9872 | 0.9788 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.143 | The 6 TMS DUF1275/Pf06912 (DUF1275) Family |
JJEBMEPF_02388 | 1.B.25.3.1 | 96.9 | 1.5e-266 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
JJEBMEPF_02414 | 2.A.1.3.62 | 99.8 | 1.1e-286 | 1 | 507 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_02426 | 3.A.15.2.1 | 84.3 | 2.6e-165 | 11 | 354 | 0.9690 | 2.4397 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.15 | The Outer Membrane Protein Secreting Main Terminal Branch (MTB) Family |
JJEBMEPF_02501 | 9.B.8.2.5 | 96.4 | 1.8e-267 | 1 | 506 | 0.8533 | 0.9806 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.8 | The DUF2157 (DUF2157) Family |
JJEBMEPF_02639 | 1.B.76.1.2 | 95.2 | 4.4e-143 | 1 | 251 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.76 | The Copper Resistance Putative Porin (CopB) Family |
JJEBMEPF_02753 | 3.A.1.122.18 | 99.8 | 4.5e-231 | 1 | 446 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
JJEBMEPF_02754 | 3.A.1.122.18 | 99.8 | 0 | 1 | 664 | 1.0000 | 1.4921 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
JJEBMEPF_02859 | 2.A.23.1.1 | 73.1 | 6.1e-169 | 1 | 424 | 0.9907 | 0.9703 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
JJEBMEPF_02895 | 2.A.66.1.21 | 99.6 | 3e-243 | 1 | 448 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
JJEBMEPF_02960 | 1.A.54.5.3 | 96.2 | 8.5e-159 | 1 | 286 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.54 | The Presenilin ER Ca2+ Leak Channel (Presenilin) Family |
JJEBMEPF_03083 | 2.A.1.3.85 | 98.9 | 2.4e-259 | 1 | 463 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_03108 | 2.A.1.2.110 | 98.3 | 2.2e-151 | 1 | 286 | 1.0000 | 0.7079 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_03127 | 2.A.1.2.110 | 98.8 | 5.3e-215 | 1 | 404 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
JJEBMEPF_03154 | 3.A.2.1.1 | 79.6 | 3.5e-210 | 1 | 464 | 1.0000 | 5.8228 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
JJEBMEPF_03156 | 3.A.2.1.1 | 75.4 | 5.9e-219 | 3 | 514 | 0.9961 | 6.4810 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
JJEBMEPF_03240 | 2.A.14.1.1 | 72.8 | 3.5e-233 | 2 | 553 | 0.9982 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.14 | The Lactate Permease (LctP) Family |
JJEBMEPF_03258 | 9.B.18.2.4 | 72.4 | 5e-153 | 2 | 350 | 0.9915 | 0.9887 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.18 | The Xanthan Glycosyl Transferase, GumD (GumD) Family |
JJEBMEPF_03342 | 1.A.33.1.2 | 70.1 | 4e-249 | 1 | 645 | 0.9985 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.33 | The Cation Channel-forming Heat Shock Protein-70 (Hsp70) Family |
JJEBMEPF_03374 | 8.A.120.1.4 | 99.5 | 2.4e-121 | 1 | 217 | 1.0000 | 1.0000 | 8 | Accessory Factors Involved in Transport | 8.A | Auxiliary transport proteins | 8.A.120 | The Mitochondrial StAR-related Lipid Transfer Protein (StAR) Family |
JJEBMEPF_03398 | 2.A.66.1.31 | 99.8 | 6.7e-243 | 1 | 447 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
JJEBMEPF_03504 | 1.B.1.2.1 | 99.6 | 1.6e-145 | 1 | 255 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.1 | The General Bacterial Porin (GBP) Family |
JJEBMEPF_03523 | 1.A.1.28.6 | 99.6 | 2.3e-122 | 1 | 230 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.1 | The Voltage-gated Ion Channel (VIC) Superfamily |
JJEBMEPF_03524 | 2.A.15.1.9 | 77.1 | 3.3e-291 | 1 | 640 | 0.9953 | 0.9712 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.15 | The Betaine/Carnitine/Choline Transporter (BCCT) Family |
JJEBMEPF_03693 | 2.A.1.2.51 | 99.8 | 3.3e-220 | 1 | 409 | 1.0000 | 0.9903 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_00031 | 1.B.6.1.26 | 100 | 7.5e-88 | 1 | 159 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
CKHOCAAF_00131 | 1.B.6.1.24 | 99.7 | 3.9e-201 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
CKHOCAAF_00157 | 2.A.6.3.3 | 100 | 0 | 22 | 1032 | 0.9797 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00240 | 2.A.6.2.29 | 100 | 1.3e-268 | 1 | 484 | 1.0000 | 1.1635 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00241 | 2.A.6.2.29 | 99.9 | 0 | 1 | 1058 | 1.0000 | 2.5433 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00242 | 2.A.6.2.29 | 100 | 5.7e-220 | 1 | 416 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00388 | 1.C.1.2.4 | 93.6 | 2.4e-192 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
CKHOCAAF_00409 | 1.B.63.1.1 | 100 | 4.8e-142 | 1 | 246 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.63 | The Imipenum resistance-associated porin, CarO (CarO) Family |
CKHOCAAF_00473 | 2.A.23.1.8 | 80.1 | 1e-198 | 1 | 463 | 0.9978 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
CKHOCAAF_00705 | 1.B.39.3.1 | 99.2 | 1.8e-203 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.39 | The Bacterial Porin, OmpW (OmpW) Family |
CKHOCAAF_00729 | 2.A.6.2.44 | 99.6 | 9e-262 | 1 | 482 | 1.0000 | 1.1872 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00730 | 2.A.6.2.44 | 99.8 | 0 | 1 | 1059 | 1.0000 | 2.6084 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00731 | 2.A.6.2.44 | 100 | 2.1e-219 | 1 | 406 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_00737 | 3.A.1.3.29 | 72.3 | 1.5e-101 | 6 | 258 | 0.9806 | 1.1096 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
CKHOCAAF_00738 | 2.A.7.1.11 | 100 | 1.6e-52 | 1 | 109 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
CKHOCAAF_00757 | 2.A.23.1.10 | 73.3 | 1.8e-171 | 3 | 429 | 0.9447 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
CKHOCAAF_00823 | 1.B.11.6.1 | 99.5 | 0 | 1 | 832 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.11 | The Outer Membrane Fimbrial Usher Porin (FUP) Family |
CKHOCAAF_00873 | 1.B.6.13.5 | 100 | 1.1e-256 | 1 | 471 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
CKHOCAAF_00887 | 1.B.25.1.38 | 94 | 3.6e-238 | 1 | 420 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
CKHOCAAF_00889 | 2.A.46.1.1 | 79.9 | 1.7e-173 | 1 | 388 | 0.9773 | 0.9848 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.46 | The Benzoate:H+ Symporter (BenE) Family |
CKHOCAAF_00935 | 2.A.23.1.3 | 72.4 | 1.4e-160 | 14 | 426 | 0.9560 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
CKHOCAAF_01072 | 2.A.117.1.1 | 97.6 | 1.3e-90 | 1 | 170 | 1.0000 | 0.9497 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.117 | The Chlorhexadine Exporter (CHX) Family |
CKHOCAAF_01078 | 2.A.1.3.43 | 99 | 9.2e-262 | 1 | 492 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_01319 | 1.B.25.1.38 | 98.1 | 1.2e-249 | 1 | 418 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
CKHOCAAF_01385 | 1.B.20.1.12 | 96.4 | 0 | 1 | 581 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.20 | The Two-Partner Secretion (TPS) Family |
CKHOCAAF_01396 | 2.A.7.21.5 | 73.2 | 5.4e-53 | 1 | 142 | 0.9861 | 0.9404 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
CKHOCAAF_01397 | 2.A.7.21.5 | 76.2 | 8.5e-57 | 5 | 151 | 0.9671 | 0.9735 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
CKHOCAAF_01471 | 2.A.6.2.40 | 99 | 8.9e-215 | 1 | 396 | 1.0000 | 0.9925 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_01472 | 2.A.6.2.40 | 99.5 | 0 | 1 | 1036 | 1.0000 | 2.5965 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_01473 | 2.A.6.2.40 | 97.2 | 2.7e-255 | 1 | 465 | 1.0000 | 1.1654 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
CKHOCAAF_01517 | 9.B.153.4.2 | 100 | 9.3e-191 | 1 | 315 | 1.0000 | 1.0000 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.153 | The Putative Beta-Barrel Porin/Alpha Amylase or Phenol_MetA-deg (BBP/AA) Family |
CKHOCAAF_01549 | 2.A.51.1.4 | 70.6 | 4.6e-183 | 9 | 447 | 0.9777 | 0.9648 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.51 | The Chromate Ion Transporter (CHR) Family |
CKHOCAAF_01628 | 2.A.1.3.63 | 99 | 6.6e-265 | 1 | 479 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_01679 | 1.E.25.1.7 | 88.1 | 1.1e-27 | 1 | 67 | 0.7614 | 0.8072 | 1 | Channels/Pores | 1.E | Holins | 1.E.25 | The <i>Pseudomonas</i> phage F116 Holin (F116 Holin) Family |
CKHOCAAF_01781 | 2.A.21.2.3 | 71.7 | 1e-199 | 1 | 495 | 0.9980 | 0.9783 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.21 | The Solute:Sodium Symporter (SSS) Family |
CKHOCAAF_01825 | 3.A.1.3.22 | 75.5 | 1.8e-104 | 3 | 243 | 0.9757 | 0.9877 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
CKHOCAAF_01889 | 2.A.70.1.2 | 79.3 | 4.1e-104 | 9 | 254 | 0.9685 | 1.5092 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
CKHOCAAF_01890 | 2.A.70.1.2 | 71.2 | 2.1e-38 | 1 | 125 | 0.8993 | 0.7669 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
CKHOCAAF_01911 | 1.S.8.1.1 | 74.4 | 8.2e-131 | 5 | 308 | 0.9806 | 0.9967 | 1 | Channels/Pores | 1.S | Bacterial Micro/NanoCompartment Shell Protein Pores | 1.S.8 | The Bacterial/Archaeal Nanocompartment Encapsulin Shell Protein3 (BANC-SP3) Family |
CKHOCAAF_01974 | 2.A.1.15.4 | 90.2 | 8.5e-208 | 10 | 416 | 0.9784 | 0.9831 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_02048 | 3.A.23.4.1 | 98.9 | 1.2e-149 | 1 | 268 | 1.0000 | 0.7363 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02049 | 3.A.23.4.1 | 98.7 | 1.7e-257 | 1 | 454 | 1.0000 | 1.2473 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02050 | 3.A.23.4.1 | 95.6 | 4.7e-202 | 1 | 364 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02051 | 3.A.23.4.1 | 97.2 | 0 | 1 | 892 | 1.0000 | 2.4533 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02055 | 3.A.23.4.1 | 97 | 0 | 28 | 1274 | 0.9788 | 3.4396 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02057 | 3.A.23.4.1 | 95.5 | 2.8e-185 | 1 | 332 | 1.0000 | 0.9121 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02058 | 3.A.23.4.1 | 98.2 | 0 | 1 | 603 | 1.0000 | 1.6566 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02061 | 3.A.23.4.1 | 99.4 | 2.7e-285 | 1 | 493 | 1.0000 | 1.3544 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
CKHOCAAF_02270 | 1.B.40.2.6 | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.40 | The Autotransporter-2 (AT-2) Family |
CKHOCAAF_02383 | 9.B.143.1.2 | 76.3 | 2e-89 | 1 | 232 | 0.9872 | 0.9788 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.143 | The 6 TMS DUF1275/Pf06912 (DUF1275) Family |
CKHOCAAF_02388 | 1.B.25.3.1 | 96.9 | 1.5e-266 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
CKHOCAAF_02414 | 2.A.1.3.62 | 99.8 | 1.1e-286 | 1 | 507 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_02426 | 3.A.15.2.1 | 84.3 | 2.6e-165 | 11 | 354 | 0.9690 | 2.4397 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.15 | The Outer Membrane Protein Secreting Main Terminal Branch (MTB) Family |
CKHOCAAF_02501 | 9.B.8.2.5 | 96.4 | 1.8e-267 | 1 | 506 | 0.8533 | 0.9806 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.8 | The DUF2157 (DUF2157) Family |
CKHOCAAF_02639 | 1.B.76.1.2 | 95.2 | 4.4e-143 | 1 | 251 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.76 | The Copper Resistance Putative Porin (CopB) Family |
CKHOCAAF_02753 | 3.A.1.122.18 | 99.8 | 4.5e-231 | 1 | 446 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
CKHOCAAF_02754 | 3.A.1.122.18 | 99.8 | 0 | 1 | 664 | 1.0000 | 1.4921 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
CKHOCAAF_02859 | 2.A.23.1.1 | 73.1 | 6.1e-169 | 1 | 424 | 0.9907 | 0.9703 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
CKHOCAAF_02895 | 2.A.66.1.21 | 99.6 | 3e-243 | 1 | 448 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
CKHOCAAF_02960 | 1.A.54.5.3 | 96.2 | 8.5e-159 | 1 | 286 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.54 | The Presenilin ER Ca2+ Leak Channel (Presenilin) Family |
CKHOCAAF_03083 | 2.A.1.3.85 | 98.9 | 2.4e-259 | 1 | 463 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_03108 | 2.A.1.2.110 | 98.3 | 2.2e-151 | 1 | 286 | 1.0000 | 0.7079 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_03127 | 2.A.1.2.110 | 98.8 | 5.3e-215 | 1 | 404 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
CKHOCAAF_03154 | 3.A.2.1.1 | 79.6 | 3.5e-210 | 1 | 464 | 1.0000 | 5.8228 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
CKHOCAAF_03156 | 3.A.2.1.1 | 75.4 | 5.9e-219 | 3 | 514 | 0.9961 | 6.4810 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
CKHOCAAF_03240 | 2.A.14.1.1 | 72.8 | 3.5e-233 | 2 | 553 | 0.9982 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.14 | The Lactate Permease (LctP) Family |
CKHOCAAF_03258 | 9.B.18.2.4 | 72.4 | 5e-153 | 2 | 350 | 0.9915 | 0.9887 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.18 | The Xanthan Glycosyl Transferase, GumD (GumD) Family |
CKHOCAAF_03342 | 1.A.33.1.2 | 70.1 | 4e-249 | 1 | 645 | 0.9985 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.33 | The Cation Channel-forming Heat Shock Protein-70 (Hsp70) Family |
CKHOCAAF_03374 | 8.A.120.1.4 | 99.5 | 2.4e-121 | 1 | 217 | 1.0000 | 1.0000 | 8 | Accessory Factors Involved in Transport | 8.A | Auxiliary transport proteins | 8.A.120 | The Mitochondrial StAR-related Lipid Transfer Protein (StAR) Family |
CKHOCAAF_03398 | 2.A.66.1.31 | 99.8 | 6.7e-243 | 1 | 447 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
CKHOCAAF_03504 | 1.B.1.2.1 | 99.6 | 1.6e-145 | 1 | 255 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.1 | The General Bacterial Porin (GBP) Family |
CKHOCAAF_03523 | 1.A.1.28.6 | 99.6 | 2.3e-122 | 1 | 230 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.1 | The Voltage-gated Ion Channel (VIC) Superfamily |
CKHOCAAF_03524 | 2.A.15.1.9 | 77.1 | 3.3e-291 | 1 | 640 | 0.9953 | 0.9712 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.15 | The Betaine/Carnitine/Choline Transporter (BCCT) Family |
CKHOCAAF_03693 | 2.A.1.2.51 | 99.8 | 3.3e-220 | 1 | 409 | 1.0000 | 0.9903 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_00031 | 1.B.6.1.26 | 100 | 7.5e-88 | 1 | 159 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
IPHMMGCP_00131 | 1.B.6.1.24 | 99.7 | 3.9e-201 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
IPHMMGCP_00157 | 2.A.6.3.3 | 100 | 0 | 22 | 1032 | 0.9797 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00240 | 2.A.6.2.29 | 100 | 1.3e-268 | 1 | 484 | 1.0000 | 1.1635 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00241 | 2.A.6.2.29 | 99.9 | 0 | 1 | 1058 | 1.0000 | 2.5433 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00242 | 2.A.6.2.29 | 100 | 5.7e-220 | 1 | 416 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00388 | 1.C.1.2.4 | 93.6 | 2.4e-192 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
IPHMMGCP_00409 | 1.B.63.1.1 | 100 | 4.8e-142 | 1 | 246 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.63 | The Imipenum resistance-associated porin, CarO (CarO) Family |
IPHMMGCP_00473 | 2.A.23.1.8 | 80.1 | 1e-198 | 1 | 463 | 0.9978 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
IPHMMGCP_00705 | 1.B.39.3.1 | 99.2 | 1.8e-203 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.39 | The Bacterial Porin, OmpW (OmpW) Family |
IPHMMGCP_00729 | 2.A.6.2.44 | 99.6 | 9e-262 | 1 | 482 | 1.0000 | 1.1872 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00730 | 2.A.6.2.44 | 99.8 | 0 | 1 | 1059 | 1.0000 | 2.6084 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00731 | 2.A.6.2.44 | 100 | 2.1e-219 | 1 | 406 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_00737 | 3.A.1.3.29 | 72.3 | 1.5e-101 | 6 | 258 | 0.9806 | 1.1096 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
IPHMMGCP_00738 | 2.A.7.1.11 | 100 | 1.6e-52 | 1 | 109 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
IPHMMGCP_00757 | 2.A.23.1.10 | 73.3 | 1.8e-171 | 3 | 429 | 0.9447 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
IPHMMGCP_00823 | 1.B.11.6.1 | 99.5 | 0 | 1 | 832 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.11 | The Outer Membrane Fimbrial Usher Porin (FUP) Family |
IPHMMGCP_00873 | 1.B.6.13.5 | 100 | 1.1e-256 | 1 | 471 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
IPHMMGCP_00887 | 1.B.25.1.38 | 94 | 3.6e-238 | 1 | 420 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
IPHMMGCP_00889 | 2.A.46.1.1 | 79.9 | 1.7e-173 | 1 | 388 | 0.9773 | 0.9848 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.46 | The Benzoate:H+ Symporter (BenE) Family |
IPHMMGCP_00935 | 2.A.23.1.3 | 72.4 | 1.4e-160 | 14 | 426 | 0.9560 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
IPHMMGCP_01072 | 2.A.117.1.1 | 97.6 | 1.3e-90 | 1 | 170 | 1.0000 | 0.9497 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.117 | The Chlorhexadine Exporter (CHX) Family |
IPHMMGCP_01078 | 2.A.1.3.43 | 99 | 9.2e-262 | 1 | 492 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_01319 | 1.B.25.1.38 | 98.1 | 1.2e-249 | 1 | 418 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
IPHMMGCP_01385 | 1.B.20.1.12 | 96.4 | 0 | 1 | 581 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.20 | The Two-Partner Secretion (TPS) Family |
IPHMMGCP_01396 | 2.A.7.21.5 | 73.2 | 5.4e-53 | 1 | 142 | 0.9861 | 0.9404 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
IPHMMGCP_01397 | 2.A.7.21.5 | 76.2 | 8.5e-57 | 5 | 151 | 0.9671 | 0.9735 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
IPHMMGCP_01471 | 2.A.6.2.40 | 99 | 8.9e-215 | 1 | 396 | 1.0000 | 0.9925 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_01472 | 2.A.6.2.40 | 99.5 | 0 | 1 | 1036 | 1.0000 | 2.5965 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_01473 | 2.A.6.2.40 | 97.2 | 2.7e-255 | 1 | 465 | 1.0000 | 1.1654 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
IPHMMGCP_01517 | 9.B.153.4.2 | 100 | 9.3e-191 | 1 | 315 | 1.0000 | 1.0000 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.153 | The Putative Beta-Barrel Porin/Alpha Amylase or Phenol_MetA-deg (BBP/AA) Family |
IPHMMGCP_01549 | 2.A.51.1.4 | 70.6 | 4.6e-183 | 9 | 447 | 0.9777 | 0.9648 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.51 | The Chromate Ion Transporter (CHR) Family |
IPHMMGCP_01628 | 2.A.1.3.63 | 99 | 6.6e-265 | 1 | 479 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_01679 | 1.E.25.1.7 | 88.1 | 1.1e-27 | 1 | 67 | 0.7614 | 0.8072 | 1 | Channels/Pores | 1.E | Holins | 1.E.25 | The <i>Pseudomonas</i> phage F116 Holin (F116 Holin) Family |
IPHMMGCP_01781 | 2.A.21.2.3 | 71.7 | 1e-199 | 1 | 495 | 0.9980 | 0.9783 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.21 | The Solute:Sodium Symporter (SSS) Family |
IPHMMGCP_01825 | 3.A.1.3.22 | 75.5 | 1.8e-104 | 3 | 243 | 0.9757 | 0.9877 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
IPHMMGCP_01889 | 2.A.70.1.2 | 79.3 | 4.1e-104 | 9 | 254 | 0.9685 | 1.5092 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
IPHMMGCP_01890 | 2.A.70.1.2 | 71.2 | 2.1e-38 | 1 | 125 | 0.8993 | 0.7669 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
IPHMMGCP_01911 | 1.S.8.1.1 | 74.4 | 8.2e-131 | 5 | 308 | 0.9806 | 0.9967 | 1 | Channels/Pores | 1.S | Bacterial Micro/NanoCompartment Shell Protein Pores | 1.S.8 | The Bacterial/Archaeal Nanocompartment Encapsulin Shell Protein3 (BANC-SP3) Family |
IPHMMGCP_01974 | 2.A.1.15.4 | 90.2 | 8.5e-208 | 10 | 416 | 0.9784 | 0.9831 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_02048 | 3.A.23.4.1 | 98.9 | 1.2e-149 | 1 | 268 | 1.0000 | 0.7363 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02049 | 3.A.23.4.1 | 98.7 | 1.7e-257 | 1 | 454 | 1.0000 | 1.2473 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02050 | 3.A.23.4.1 | 95.6 | 4.7e-202 | 1 | 364 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02051 | 3.A.23.4.1 | 97.2 | 0 | 1 | 892 | 1.0000 | 2.4533 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02055 | 3.A.23.4.1 | 97 | 0 | 28 | 1274 | 0.9788 | 3.4396 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02057 | 3.A.23.4.1 | 95.5 | 2.8e-185 | 1 | 332 | 1.0000 | 0.9121 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02058 | 3.A.23.4.1 | 98.2 | 0 | 1 | 603 | 1.0000 | 1.6566 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02061 | 3.A.23.4.1 | 99.4 | 2.7e-285 | 1 | 493 | 1.0000 | 1.3544 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
IPHMMGCP_02270 | 1.B.40.2.6 | 79.8 | 0 | 1 | 1780 | 0.7859 | 0.9466 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.40 | The Autotransporter-2 (AT-2) Family |
IPHMMGCP_02383 | 9.B.143.1.2 | 76.3 | 2e-89 | 1 | 232 | 0.9872 | 0.9788 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.143 | The 6 TMS DUF1275/Pf06912 (DUF1275) Family |
IPHMMGCP_02388 | 1.B.25.3.1 | 96.9 | 1.5e-266 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
IPHMMGCP_02414 | 2.A.1.3.62 | 99.8 | 1.1e-286 | 1 | 507 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_02426 | 3.A.15.2.1 | 84.3 | 2.6e-165 | 11 | 354 | 0.9690 | 2.4397 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.15 | The Outer Membrane Protein Secreting Main Terminal Branch (MTB) Family |
IPHMMGCP_02501 | 9.B.8.2.5 | 96.4 | 1.8e-267 | 1 | 506 | 0.8533 | 0.9806 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.8 | The DUF2157 (DUF2157) Family |
IPHMMGCP_02639 | 1.B.76.1.2 | 95.2 | 4.4e-143 | 1 | 251 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.76 | The Copper Resistance Putative Porin (CopB) Family |
IPHMMGCP_02753 | 3.A.1.122.18 | 99.8 | 4.5e-231 | 1 | 446 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
IPHMMGCP_02754 | 3.A.1.122.18 | 99.8 | 0 | 1 | 664 | 1.0000 | 1.4921 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
IPHMMGCP_02859 | 2.A.23.1.1 | 73.1 | 6.1e-169 | 1 | 424 | 0.9907 | 0.9703 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
IPHMMGCP_02895 | 2.A.66.1.21 | 99.6 | 3e-243 | 1 | 448 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
IPHMMGCP_02960 | 1.A.54.5.3 | 96.2 | 8.5e-159 | 1 | 286 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.54 | The Presenilin ER Ca2+ Leak Channel (Presenilin) Family |
IPHMMGCP_03083 | 2.A.1.3.85 | 98.9 | 2.4e-259 | 1 | 463 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_03108 | 2.A.1.2.110 | 98.3 | 2.2e-151 | 1 | 286 | 1.0000 | 0.7079 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_03127 | 2.A.1.2.110 | 98.8 | 5.3e-215 | 1 | 404 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
IPHMMGCP_03154 | 3.A.2.1.1 | 79.6 | 3.5e-210 | 1 | 464 | 1.0000 | 5.8228 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
IPHMMGCP_03156 | 3.A.2.1.1 | 75.4 | 5.9e-219 | 3 | 514 | 0.9961 | 6.4810 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
IPHMMGCP_03240 | 2.A.14.1.1 | 72.8 | 3.5e-233 | 2 | 553 | 0.9982 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.14 | The Lactate Permease (LctP) Family |
IPHMMGCP_03258 | 9.B.18.2.4 | 72.4 | 5e-153 | 2 | 350 | 0.9915 | 0.9887 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.18 | The Xanthan Glycosyl Transferase, GumD (GumD) Family |
IPHMMGCP_03342 | 1.A.33.1.2 | 70.1 | 4e-249 | 1 | 645 | 0.9985 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.33 | The Cation Channel-forming Heat Shock Protein-70 (Hsp70) Family |
IPHMMGCP_03374 | 8.A.120.1.4 | 99.5 | 2.4e-121 | 1 | 217 | 1.0000 | 1.0000 | 8 | Accessory Factors Involved in Transport | 8.A | Auxiliary transport proteins | 8.A.120 | The Mitochondrial StAR-related Lipid Transfer Protein (StAR) Family |
IPHMMGCP_03398 | 2.A.66.1.31 | 99.8 | 6.7e-243 | 1 | 447 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
IPHMMGCP_03504 | 1.B.1.2.1 | 99.6 | 1.6e-145 | 1 | 255 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.1 | The General Bacterial Porin (GBP) Family |
IPHMMGCP_03523 | 1.A.1.28.6 | 99.6 | 2.3e-122 | 1 | 230 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.1 | The Voltage-gated Ion Channel (VIC) Superfamily |
IPHMMGCP_03524 | 2.A.15.1.9 | 77.1 | 3.3e-291 | 1 | 640 | 0.9953 | 0.9712 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.15 | The Betaine/Carnitine/Choline Transporter (BCCT) Family |
IPHMMGCP_03693 | 2.A.1.2.51 | 99.8 | 3.3e-220 | 1 | 409 | 1.0000 | 0.9903 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |